var title_f28_26_29088="Scapholunate advanced collapse";
var content_f28_26_29088=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F75552&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F75552&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Scapholunate advanced collapse wrist",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 327px; height: 432px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGwAUcDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5WLHPWk3H1pKKAJI5WToTXS+CtamsNRdUY4kXofUVy1WLCXyb2GQdnFAHtI8RSi2VhJtZ/u+3FM0rxPLczJFvKOpLEluwrnvEkXk6bDJCGHmjH0rI01pLWB2HzSTLtDdx60AehD4hR22rF1WQwl8HJ7etVdZ+JaSrJ5bNnBxxgfjXmdyWijkLHPpWG7s7cnigDprjxVfPKXWZuueas6dqlxdTtc3MhZzwM9hXJRDfIq1t2+Vj46CgDuItdZUX5v1q7a68zSqN5wOevSuAEj9cnmtDTJGLFuc9KAPYfDPiMW+oQvI5Ck7c/WvQG1Zbm6WMNyeeK+eYJZnBVDz6+lel+CbzykiFy+bkY+Zj/KgD1+wUxoJCpJPNabXAKfKQCfWubgvmjbDMcHnrVtLtJMFxj3zQBdmuZEU5yD2xUUd9v4JximmQKuVO9T1FZGtTR2UAuN37s8YPY0AW9Q1gQRsuecd68d8Q6ww16csxGSD1ra1LWJJRLIW6qf8AIryzxHf/APE1lYtggAHmgDsrjxH5cIRJMP8AWsOXWZJJCd5LfWuPF67kkkgdq1dG0+e/lVgCsZ6sfSgD6C+BniO5hlkS4ZmtJeGB/hP96vdLu3ivYOG6jKuteF+A7GOx0pfLxuYDJrprHxhcaTdmLAmtc4KE9PoaANXWbPUNPkZ5IzJFn5ZE5H4+lUG1gQwklug5JrutH1/T9Xi/0eVd5HMb8H8u9Vdb8J6Xq8TiSNoXbq8R2mgDya71/wC0zgqx6kCm2euD7Wnz4+bnjtXSXnwnfczWWq4yMASR9Pyqta/CnUEmDS6nb7c/woc0AeYfHvxJsk05UfghjwfavMPDC6x4m1SPT9Dtpru7kbkIOFHqx7D3r6l1L4GaHrlxZy+ILy7uhb5xHEfLVs+vevQ/DnhzRPCmnfZtEsLawtlGWKKAT7s3U/jQBznwt8ExeBPDrvqE6S6jKvmXU/8ACoAztHsK+efiZ4y/4SHxHe3kLExB/LgHoq8D/Gu0+PXxUS9gl8OeHJiYCdt3dJ0cf3F9vU14FcOyxv5WVXIGKAPWfBOvF9PiDMd2cHmvSLHXPIVMk7cZPPSvF/BUcn2SDKDA5A7/AFrtJJXCMqtz0FAHoDaupK3Fu+f7yg1evNeQaNJKeWCHvxXnOnSypImD8pOGye1aXjKP+z/C1/LGxCLGW6+1AHyp4j1eS78RajO7lmkmY5z71lyXZY8E1UlYyTyP/eYn9aaw9aAJLiQyYyagpTSUAKDzRQKKAEooooAKchw4PoaSgDke9AHs97bpdeDrd2xldpH5Vy9oPmCHGAfSulvnaPwZbYHUqPrxXLWMubhQPXvQBleJIjaoUHRjmubXk4A5rr/HMe1hg8cGucsYgRubvQA23gkL5GOK043AADjB701FCjA707ZknPagB5kUkAN1OMVpw3MMEI5BPpWfZQo8wJHA9asahaKNjRjnODQB1nhhTN5cjD73OB6V3thbq8sYIx8w6Vy/w+gM182UISJMBscV6Baxqkodc4jyR9aANEas1vuGN+CF5q/BqimSNFOWY8+wrmZQX3zJguf4e2fWocNCDeXbFcdAO59KAPR7W8jYKA43mqPjbD6PtwMEg8VwaahPNcLgtEBggDrWxr19eL4fchwXK/LkdKAOP8SSx6bYhmkXz3XCR98+tearE08rGQliTlj6mrs1zPe3TPdSs7j5cntT4I9hwABnvQBHb2QnuI0OApPSu7sLJoAoCkAAYwOlY/h7TpJNQiZo22ZBziu+kt2xiNQAD1oA3/DOpK1gMMAR8uPetGOyW4ffKx+gHU1yWjwyW7vI2RED8o9/Wuz0uZJjjeS2M4PagDQgtI4VyoKt2OaW08W6rYybY5FniHRZef161WkugoZc9R0rDLKTwcjdwPWgD0O2+II8sfabFg3/AEzfj9aqT/FvS4JCj2F7vHYhR+tcOW3FwDwO3YVS8QW0cunyTbRviGVOOvtQBqeLf2gW0+zlOj6JvmTAzcS/KPwFecjx14u8ZwS3Ou3/AJNi2dlrbjy48e/c/jWNq2lm8Ai2nDvlj7Vp+StvZLAg28fdHpQBzc9rgsSPmOefeqhswVCE4BOWat6dB5ZJXnpTNGsGu9Uhh6jduIAzQB2XhuxW3sldxnC96u+X85ZhhevJq6Iktov3nyxovfvXH6rrD3EzQwttjxkn1FAG4dSQOotxkqcZPT8Ku/GS+a0+FNxKWHmSosec85Y4rhLG6fzw27cA3TNdB+0HJn4aaaq8CWRDj9aAPmRDTmqaK355pJbdlPFAFY0lOZSOtNoAUUUCigBKKKKAHLTohmaMerAfrSKOKnsk331uvcuB+tAHqviGXyPCtjCRjcQf0ri4ZgkoOehrpvGL4ht4CR8iCuSQ/vFUDOTQBs65bPqGmLNjO0YJFctb4Cbcciu/0sK2ntAx+Vxx7VxGo2r2l7JFjHORQAR9vWpyODg1WiDZ5xU+TjkUAWrM4Jz3q07eaY/TcKo2xyOh4q5bYa7tkbgM46fWgD3LwXpS2WgQyyRlZZBk8c1f1GOOKIBSQzc59fepI7sNpMaIwLRIFGDz0rLmuxIEZuT0OeQKAIoXUOBIS2MnI6VlanrUd3LsQnYp4WptSvljt/JVQC3Jx6Vyqy7buQryrdR60AdPFflZAcAZ4AxWr4jvVXRraJWy8gP4CuUsG33PznKLyfWm6nqUlxqCtwIo179AKAOYkTybmYNwdxzVrTHjN0hn5TPeqF1crd3sjJgBj19qlPyoB70Aej6fcPGQIwuAOeODWsNUlaRVaEYPp3rlNPeVNOtmzjcMkmtrSbhHu15PfGaAOvtDDcxrGo+71XoTWzaweUhDEAsOuKxtHsjLcCVl27fmyK0tRvg8UiLw6rgNQBhaxqS25KRPuIyXYHP4Vl2uoxna7OQSckN2rJupNszb8E8gkcc+tZly7yBIkwGJGGPXHegDvbWZpJHJcYx27mrGsTxW+jZmOdx6DvXK6HHegpGpDc4zniuk8S2wiso1mIZ+CM9qAOaCiUPcFdidhWRLIPOfnIPbPStPUJdkBQEDmslEM8wRVwW74oAWOFrmQKDx1HFdnodha+HtPk1DUSPPcfKPQVF4dtILaFrh8NGnTPtXL+KNak1WdkZiIFPAHc0AJrHiSS/uGTlIGPAz/OsSWVtpaIHzDhR9KFtGkLEJjnFbOn6W3lgMQB64oAo2kJRR8p8xjzzXQ/FiGTWvAGlIhJMEihsD2pWsgkqgBcJgnFdGfLbRLm02gvt3Lnn5hQB4PD4WiWE+a583HAHasPVNIuLM7mRinqBXpMkLtdlvK8xTyfqO1bFhpov0WK6MRYnGwjjHp9aAPALoDHTmqtekfFPwidGEV5bKRbOxUj0NecAUAAooHWigBKKKKAJUzVzREMms2aj/AJ6D+dVBwK1fC6A6qsr8LEpfP8qAOl8VTeZdOATgMBg/SsjT1LSMxHyjvUt1uuQRuBYsRn8a0bKy8iAJ1L9e9AFu0kYKucAYqn4mtPOgW6XqOtW0hcOQeAB0/Gr1vEZ45beXlWXjPrQBw8AycYqy65pstu1tcvFICGU4qZiNvcZoAigyDxTzIUdWH8JBqOMgNgdaJATgk8elAHtXhq7N1pKSJzvj5qrqF0kMojTIYrwB61zfw91B/wCzpoCd2w8CtDW59zl0GG659KAKWq3LPs3Agnnrn8Kp2/7yRSTyDmonkLcsc56HNT2UW0BiMj37UAaNuT5jbCd7EgnNZfiCX7NbFMkSSnHPYVt6TClxOWLfKDn8q5TxVdC51qQKfki+UUAUbUHerVfDmSVV7k8cVno2cbevStzw3ZSTXwlnTEUfzE+9AHU3B8mCCHOCEwcVHazmC6icE8MOPWoLiQzSOQSc9KZPNHY2f2mflf4V7k0AewC7TTtKSUnBddwrltQ19HDbVfcR7YqrJeSah4W0+6kJGUxj0rl7mfEhweMUATTXbFd5JJJyKrQu00heQjPYg9qgY73+U5HQY6VuaLpyTSoJX2R5H40Adr4VgZrOJpBgu2fwqPxnKW8xxkrGQDjpgVqoqWsEflOoGMACud8RSO9nKrn5W4oA5E3W9m3jOO1W7HKr50hAY9FA6VkmNlc7SRnr9KttMYrQ7Wxwc0AaqawDafZ4iCASH5rPisWuZj5Cjax5JOK5DTrmWK9kmYloy3K+pr0rw7Il3a/aT+7K9FI60AMg0SdQMtGzY446VYSyu4igj2sScEDqK1Y5wpHmDPFWNKQXExdTlVbJagCG0ghilVbiIlycNu9PWlvgsasdPkRgOiuOntmuimto54jG4AIH3h1FcZrYaC58piy45BHQ+9ACeGbm2m1WbT9ZskhLtmN1HBz71o694Xl06RZ4HaSBmzlR0ri7LUgdaltp/vMRtfPQjv7V6jZayYrAQ3q7+gyejD1BoAyNf8NDxb4RmgMWx9nyk9Qw6V8k31tJZX09tMMSQuUYe4OK+6dBvrOUNDb7cPyP8K+U/jpoTaL48upAu2C8/fLx370AefIMmipIF5xRQBWpR1pKVRlhQBLitzQlEdrNIf4zgfhWNjFdBoUYljhCDOD8woA29DsGnkaQoNpJat57JgAyg4AzirmgafcXMii1iZgecDofpXdWvhi/FsTOkSHbg7qAPNxZMRuKkN0y3U0scJS4hB+8OcnvXX6vpt5DHLIWQgHjaOtc5HHI19GJUJAPJYdPpQBzfjWxaC6SdQGDjBx6+9YUcDOuW49q7fxzPFHHFaod0hAYnOcVyUR4ODQBTkg2cLUTMSpzWnJEzr8oqNtODrlmINAF3wFctHqzRk/K46V1Wvnawx8vHNcd4dsXh1qAwvkk9K7rX7fMYbqccg9qAOU35k68A1o2hd42BBCnimxwLtz3AyRitfTrdXVQAOvSgCzpR+zafdTHG2NOteZmZp7mSQ9WYkmvVPG1udL8JTSL1lABA7V5LZD15oA3dNg3OGbCoO9dbYzKkBjQBR1z2NcvacQRDPHU1tRSHy1AK7cYAHc0AXLaNmkOQVWud8YXryTpEv8AqEHBHQmtue6McBiJYe+a5DWG3bvmOSaAPV9HnL+ArQDnAA+lcffylGL7uldN4YOPAkOTgBea4++O+fYvTPJNAGppymRVcdQMgV1Ph9i9wIpM5HIIrkdPZ4GxG3B7Gu28NIoZ5N3IGD7UAbMzF1JDlSvRh0FYl1f/AGq4W0kIwDw+fvVe16+XT7VjzufjArig7SgyE8Zyp7/WgDXuYgkjAD5R1rndbulAaNCAfatW+uTcW+A5LY2k9M1xlzuiuzHIckNj1oA39C0uS7lWCJSzdeR+dd/dRx6RpCxHbvPXNWNFjg0fSY2IU3Dxh2YjpmuR8SXz3MjOJAxJxt/woAgl1aVZ2VCNrHsegr0bwwFg05HwGaTJwT0rg/D2lpOVnukIjT7uR1NdREJQ26NiEzxj2oA7SKUFGD4QY6da4Px1qVvbTLHGd84Bzg9M+tbLm4MTM7nbjnivPNXiM99PO+Smep70Ac1LcyDVkfJGTg4969Va5I8ORbmJfI2j0FeQGdrrVktrMfMXHOM13WqX8VpbQWglMkqj52z0PoKANKz159MdJI5CWB/WrPxm0iPxp8P49csFDX1h+8kQddv8Q/rXAXN4yozMQxz1rpPBHiJ7a6kgmkLWlwmxkboRigDwe0G4+9FdH4q0ddJ16c2/NnKxaM/3faigDkKkhHz59KjqaDvQBKRkc1p+HrpLS6LTOyxN97FZZrsPB/hCfXCJZnMFmOr92+lAHR2PxNj0SAJpVhFLKBw8uaST4v8Aimdt0kVt5Z/hWEjj611mh6BomlTCOKwjkYc+ZMu4n8a7e1OlMgV7S1IPbYMUAeOw/Eie7Kx3lqAxOMpnrXQPfWSxK4V2mIyxxkg11+o6J4Yv/wDWafBC4PyyIcc1yWt6RBprma1dpIQTlT1FAHD6vbz3V3JMWMjHsOw9Kqx2MypuaNse1byahbrdq0SA/Ng56Ct+Gwc7QitycggcEUAcSo4A59KVz8taniG3FvfFcAHAJxWY4+XPP0oAfo7BNYtTyPnAr1bW7GO805ZCdrKvbvXkFvJsv7dueJB3969klkX+yskmgDgHtZBKQeee1bGh27NcxqQeWpZ4hkygfgK2PCoWS8j3DJU5oApfFyRV0q1tT0dgCB7V5EsJgkI/hPSvUfi7MGntF4wGJrgmiWeA9PagBlrMDFsZuh4q79oKSqMcAYU561i5MbEHgikaZhwGODQBq3N2BHjd859aw76ZmI6+gpS+eWyfrVR23SKM9SBQB7Lp7eV4JC7eRGo5rjJGG4kn5q7YADwjhv7gyK4dV3z8ZODx70AaOmHLYH3h1zXonhyIpYGR1I384x2Fcp4csFluU3rkE5bBrutQmjtLF2HyoqYUelAHCeL783GpiJSfLQdB3NZ5mjsole4fbv8A4ByTUOpXkdmkl243TSElM84rlGuZLidpZXLO3r0oA6WfWLfafJRx1ADfzrDErTXXmOf4u3eq5k+SrlrCWaCMAlmYfzoA9c1IkwwkE5aJQPyrmBbQvdBpWdgOQOgrqtUcRQxqoxJsVenbFYUsO6MsMKRQBo2t6xQ7sMF6DGOK1dLlWUArkfSuZsUbITdyTnPZRXR3F0ljZeaBg9jjGKANjxHd22naGHduQpcjNeI61rM1+WH3Ij0Uf1ra8X69JdxmN24bgL6VxzHPfFAG14Lt/KkudSfpENseehY1NeXCyznGQS2c1Z03Z/ZkUI+7tJz2zTLWx86TegwgOCx5/KgCpKhNqzEr6jNVLJzGAc7nTkYroGigL7Y0345O7nmraWNvIAWt1UkdhQByOoy/bI083HPODyaK2bnw8GVmtJAMn7rHNFAHj1WIPuVXqxF/q+KAJ7SJp7mNFGSzACvdNJBsrWO2G0MiAbB1zXi+iSRwajbSyD5VcGvUNT1NvtltcwgDzF4H0FAHUTWRuUD+c6nH4ZrPi8yO4bzPNH8Oc4/KtKz1KMrALhBuxuB6DPpUN1q8c+oeV5UbJ1Ut60ANia4SeOMA4J6kcHNRa8/kARO5O0Yb3rYs1W4ktWyxKS4YdeK5nxbMz6jMu7btcjA64FAHM6nbxZE9uCN3DL2zWjpfiK6s7ZY3RXAGAc81Tnc/ZyH4ycVSIxxQBLe3Ml3cNPLyznp6VXbI9wRT8AA8/Sm4P4UAU2wLiNsHhxz+Nez2apLpYB6YGRXjU52yoRjqDj8a9i0Yk6UpUDhcigDGuVKBsZ2/yrU8Jxlb0N6ZqhPgFgfvHnmt/wANoqqWABOOaAOC+LLhtRtsdea46B8Kea6f4oPu1mBfRSf1rlEHy0ALe24ddyHntWPI+w4YYPvW0HGCDVS8jV0wVGaAMmWYbTzUFq5n1C3jXu4qe4gCE8cVN4atfN1uHjIU5oA9h1LCeGI4xwxwK5K2iH2gBDkDn3rptZJSwhU5IxmudsMtcNg/lQB3HhiNEAXkuxzjFM+IV9Ha2aW+4hnwABWj4dh8mE3LkbFXgk968x+IWrtda55Rk3Ki4IHrQBj65cefcKA2FUYANZqOfWmXD9AOg6UzdgZoAsht8yj8663wXCL3X7VG4SNtxrjLRszEnPFeifDy32rNdkHGcA+woA9D1CTbdyKEUp0Ge9UGhgnDBU2ydxVeO8aUKZB1OfrzUqMVwVyCOQff0oAfDYgT7ugIzis/xrfR2NgTNy3REzW7NMq2M1wf+Wa5b2rxrxDq82r6g8sjEoDhF9BQBTmle6laVySSfyox2HWkRSoBT8qUyqOTjcKAL1jfNbssT8xHp6iuge/jmthHYDMmMfT3rgru+WNxs5IPrXQWsyWNsjliJnAZzjPXoKANyACzG5i24jDMDmqq6u7OSoJRTkE89+prEl1RZ5OZGHv6fhTRMJIxskH3SNw/rQB1NlqAlZQwZ92SM8ECiqGhxhpVMjhDt65ooA8lq1bjMdVat23+qoAkzhfevSPCpGq6FG6rumt3w3PT3rzcV3/wTvVi8SyWM5BiuoyuD60Ab+rTym2UKvCtjPTOKNPhM5QHKsnzZP8AEO9bviDTFstSgh5KoSTjvk1DHCkc24cgDaoFAG54b3+YwIycfLz6VheMrMLM924wDyTWxoFwIrq3Z+gfBFN+NAW1sraOEACRuSKAPMTI0hDP07AUHOaIB+7zntTsY6igBv3hxSM20YBpzYB4qNgOQRxQBUm5kXHrXsmgDdpiKB/D6+1eMyth1OMHNe0+GwW0+McfdoApXNuG3dK2tAiaG1d26Vn3SbJCARyetaloxXTpFPHf60AeR/EGTzvEWM/dSsVVG3rV/wAYSbvEEucdKz4xleOtADWXiq0h+XvxVo9CDVWY44z17UAUrofuz3rf+HdoJr+RyMgYFc9cklCO9egfDG02Wwlb+M5oA0vE0nlyLD0CrWJp0fmS4Xrnr6VreLsm6ZgAD9azNDLyTog7tzQB2dzex2Hh92kU52k9cV4he3pu7yWdhyzE4rv/AIl6oLfTEtEb5nwv4V5gnAoAtby7ZPalduKjTAWmu49elAFm2J3KgPzMcCva/Dtn9j8ObSvzsuBj1NeO+FrVr7WYMjIBzXvZiFrpMZdgXx8q0AZVzthRIx1A5+tFl5uVLNhD29Kr3Eqxqbiflc8L6mmQXDGJry4YBV5UDtQAnjjW4dO0o2kL5llHOBXl0WGqzrWoNqGpSyscrnAqBWAHOaAJ+OcGsrU5cHAPPtVuSVQpasOdzI5OfpQBFklwDySa63XNsXlx9GWJc/lXP6BZNfavDHjKKdzfQVra8/mXbnacZ/OgDKckuDnH0qVDuwSSjDqQahVsHoQak69D+FAG3pImkk5mJAHr1opnh2dY5y8n3BkfWigDhqt2pzGRVSrFqfvCgCYVq+Er06d4n064zgLMoP0NZS96UHZKjjqpBoA+ofGNt5wsbyMAhl5IrDgRRGMrzkkmt3TphqPgqwueWdUBwPpWQiGISZGM859KAK9jGf7ViIIKGQVc+NcJfT7SXH3HHP1FVbQ4uAe+4c1t/FSL7R4VDjsqtQB45ByPcVIQoJ5qKAlRmpDjNAA+D2FQvyp56VKfwpjDGewoAzpuZU6ckV7f4WT/AEGLJHKivEZh+/Xn+Idq9z8KDOnxZAxtH8qAIL5P9JJzwD0q9Iyrp5PAJqlOmZmJJ61bvcf2cOxxQB4n4nbdrk5NU4m444qfW2361ck54bFVjgelADzx1IPcVWkYEnNPLZBqpIcE4NAFSdt8gVepOK9i8F2wg0ZTjGFzXk2mQ/adUiQDPzZxXtdon2bRygAGVAoA5rWj5txjuTxWrodgkVublly4X5aySjSXwXqCeldJrciaZofLY2pkn0oA8c8d3TXWtum/cI+KwACBzU1zMbm7lmJzvYmm8ZoAYznHFNjUs3Jp0nQ1NZxl2RAMs5xQB6P8LNKEshuGXknA+grudbuwCRuA2nGfasjw7s0rSEK8HaBWPqV+LmURx5Uk8knNAF25Bv5o0STKr0FY/jLUxa2iWNu2CRzj0rUgY2WnyXMpG7Bx9K83v7x7y8kmYk5PH0oAIuM8VI0nGR6VX3YGKhnn2qQOtADL2cn5F/SqZY4p+CTknrV3RtOfUr9IQPkyNx9qAOl8FWYtNOuL6dSGlG1MjtWdeGOS4cg8A10+oNHb2rQxDEaLsXiuUnTL4TmgCGSJWAKfjSxW4ZflXcScCr1rZs0bufvYwo96ra7crp8As4SDcEfvGH8PtQBQluUgJiiOXzyR0FFZEf3uaKAKtSQnD/Wo6VThgaALi9frQ3ANIDnmn9vrQB9F/Ce6+3eAVjP341ZPyp8qlflJPOetc58Cbwf2ZeWpOSr5C+xroL59t5IrH7rGgCvGVSbOOciul8SD7Z4QbIziMiuRumw/TrzxXVae323w/cQddoPHqMUAeKw5BA9DzU5bpxUNwPKvJo8dGIxTh2oAdkE5zUbEEHpQ7jOaY+NuTwKAKko3TJ/vDtXvHhNP9AiGB92vClwbqAEZ+cDH417/AOG1VdMB6DZ/SgDJmPl3DDOQW446Vf1QD7AMdNtZd3JifJ9c49a1roGTS944G3igDwXVz/xN7rgZL1WLfLT9WONYucnJDmoScrzQAP05qrc8DnFTMcZxVS6OBQB0Pw8sjd6szkfKlepa24gsUjBAyMmuf+F+lm105J3XDy/N+FXdeuPPuXUcqDigBvhu2NzqAdgdicmsn4t6kYbBoFOC/wAuK7PwzD5FiZWGC38q8d+JmofbdeaFTlYz+tAHJQg7amUH0oiXA5qbb8vSgCnLwOa3PB1t9q1FGIyqVizDt3rufCFk1lYtcnrjP40Abus3zQhIYz93gj1rPsczXCbVwSazLu6M05LjBJrXsithp73Uo+cggUAUfG+pbIUtI256HHpXGqwFS3kk+oXkkzjAJ4zSx2n985oAhZ2Y/IuaBAerHmrhiC4wKZJwKAKvllmVFGSeMV6B4a0sadZ+Y6/vXHU1jeEdJ+1XAnlGFXpmuvvZlVWxwiDAHrQBzutyhX2AdKoWFsJJN7A4PpVh42u7hi+dufzrUYwaZpxuZVwwB2qe9AFDXL6LSbRFjAa5b7oP8PvXAzyNNI7yHc7HJJ71b1G7kvrp5pSSSePYVTYYoAYhw1FIDhqKAKtFFFAFmI5UVKfucVWhParK9CM9aAPSfgpe+V4hkhzxKgOM9wa9D8RYj1SfoFZq8X+Hd79i8VWT9i20/jXt3itQblGAwHQH8aAMJ8d2+YNjmuj8JXRW5a3IGJFxzXJyuRwOoPIq9p900NxFMPvKaAOS8bWZ0/xPcrghGO9ffNZKyV3fxPt1urS31KPGQME+xrztHBHOMelAFrdk/TvTXclenFR7s8dqYze+cdaAFtPn1K2GOTIBg/WvoXTB5WjEgY+TFfP+hAza/ZovP7wV9DPiDRRz1HFAHGX9wBKenFb1hN52jqOwrkr5/wDStxOR3roNCuV+xyRBsnGcUAeLeKIjb+IbxMdX3CqQOc59K6H4iQbNbEuAN64rmkYhMk9aAEJwTUmlWL6nqkNsgzuYbvYVXd/SvRfh1o/2aB764UCRxgEjoKAO1iRdP03AAGECrXITSs9yd2eTxitPWdUMpKIcR9AKytHVrnVIkxwzDP0oA7S6ddN8P7mwu2Mkk/SvnK/uDealPOxzvcmvbvivqH2Pw/JEhwX+UAV4bCnIJoAsKAAMdaceKkReBTZTzigCxoWnNqWpxRBSVzk16bf2iWdnFbKB0yapfD/ShZ2D31ymCwypPpVi6m+1XZLDknjFACaPo8dzdBmQBRySRWb8QNQiRlsbcKABzj0rr5JU0zRWmYgErnPc15FdzPfXstxIclicewoAZEMDOPpTxnAz0704rjHYUo4AyRmgBhwRSWlu13dpEo69abI/OFFdl4Q0gRwm5nGMjcfpQBp2duNPsERAAzdQPSqF2/muEAO0damvLlpZX2dB09BRp1u1xJyPlzyaAFsrZEVp5RiNeRXDeJ9VbUb0qhxChwBXR+NtVWCIWNo2CfvYrhAKAGMuBUElWZDxgVVkPagCEn5qKax5ooAiooooAdGfmqypzVUcGrCGgC9pMpg1O2k6bZAf1r6L1lRdaPa3AzkoOa+aQxBz3Fe/6Tf+f4O09nORJGFJ9Md6AMqRij7ZRhv6UkU6jaO55AqteXJlIXZk+tMTchUMDnOAPagDduJReadLaT7Wjdcdc4NeZ3UElldSQyDkHj6V2RuCcDkEccVS1my/tCI8BZl5RvX60Acz5hwSByajkb5Sc0x/MhmeOUbWXgg1BNLkBRzk9qAOk+Hts134mh2AkJya9v8AEd0lvawwdwOea4f4baUmj6cb27AFzKNwXuB2qTxHqMkt+wdgwZRQBBcnzHLKDycGrelS+WdjH5mGARz0rHSbYylWyx5K1ZLPG0ZVhgcnFAFD4kWfnWgmRRlea8zMmP8A9devasDeWzL1XHOO1ecS6FMuoFCCYCchh3FAC+GtLfU71WcYhQ5JPevS55THbi2g4QDGayNGSOzg2FdsKDt3PpV29uAVVYsAnng9M0AZ1y2QVU5A74rT8HpnVY2PbnGKogJJIUBBNb3hmP8A4mahRgKCSR9KAOQ+Mt2z3drajoMuf5V59EgAGBXV/FBzL4rdT0jQCuYHDAUAPb5QDxW/4O8OS6zerNMhW0Q5J/vH0pui6OkwWe/z5fVY+havQ4biO20wLbKsYC7Qo7UAM1u6jiiWztMCNeDiqei2TXFyqqeOpzWZNIxlJzkmum8PkQ2U1w/BC4z6UAc58RtQIWOyjP1APYVxEQ2gACrWt3bX2rTys24bsL9BVce5oAMnuKa7YBJpxZV6GrOmWD6hOBgiIHkigCfw1pTX92sjIfKU9+9dxqk62dsttFgMR82KSEQaRZKkYAfH5VjPK91O2PmY85oAsWNu88m0YyeBitDXLqLQ9LYceYR09TWjpdqLGx+0S4D4OCe1eY+LdWOo6iyoxMMZwM9zQBi3c73U7yyHLMc1ERgU7GKYx70ARSHiqkhqxK3WqcrUARE/NRSCigBKKKKACp4zxUFSRmgCbtXrvhm8I8I2KEfKQwJ988V5F1r0nwxctJ4ft41XITIx7UAabFg5LA5xzjsf/r0i7pAWyw4wPap4Mxh2lPzZA471e2bWUr91vvflQBnxMScN0xjnuaZIyqvUk+tWjHv6DPIK1A8YBfgZXp9KAMLV7UajGTCmLpOB6uPSneFvD5a5W5vlxsORG3r71veHIk/t2381SU3gEnt6V2HjDSRaStMrBFkHQDqaAMm51IRYAIYYPQ9PSuavL0uwZmySCMnrV67tx9kVg3ODjj3rCuI3WRC4bqcUAbGmbi6u5zg46dq2Q9v5jhXByAQp7etc3YljCm4lQAQccVPEwG1mOFwAG9aANm5Mfluu5g7cZHQ1ZuLSNtKUIuZNu4NjvWFdXPlzKCw5IPXOK6Dzi2nRvHk5GMUAc1vwiqeQDlvc1LFEJQJiep6DjinzWiwylGlwCCQfU1WacM6xpJhs4+YdKALCnzJgYfu+tdZ4Znjt4ZWcKZXAX6VzMShLYGMqy8Z9a6axhhNriJSfMAZSx5oA8q+Izb/Fl0fQD+VZ2gaedS1OGDnaTlj6AVa8YFp/ElwQMvwK2/CUCwW0m19krD5mHXHpQBrSoFcKoAjTgEd/ap7jjcoYgAZx/SpUmhVdy43jGCfWs/UZFjjEgO53HIzQAhQHkDNamozC38KTOhIY5BxWLayALiUkLjoetT6xcx3GjXcUZKnblVI6AUAefxkHlmpxbb/nrUdrbzXEgWNS3qfSul0vw98waYEnrz0oAz9M0uW9kBIIWuuRIdNtwsQAcdaSaaCwgKxsMgYJFY8lyZhknC+lAFm5uprl8dQetbOgadlw5XKLyTWTpsReRQFyCeK6HWr1NF0Rzn52HA96AMPx74hEcX2CzbDkYcjsK86A5znipJ5nuZ3lkJLsck0w8DFADSahkbsKlfiq0hHrQBFKfWqchyamlaq5oABRQKKAEooooAKchwabSjrQBYXmur8H3bbHtwxBX5lA71ySGtXQLhbXVbeRzhNwDfSgD0mV2SWJpOjE8fyrWtb6IRo5XBBwQTnism8sZpYYWXlVOVIOcg1RghkVFV5Gyn3sfWgDclu4ppOFIRTgYPbvUsMDSRIu1SvT5RyRnismFSrrz8xOOK27O6hsrSWSQgBV5Y9qALMemyvMmFCnd174Fej69p8d9oVvO74lRQea8f0LxNcatqrR6dAxjBwHPOT7CvTfDtpqMsDx37MCTnDcYH0oA5270wy25RVBUfd4xWBqOleQxMqMVfkE84r0vUNPWCNSZPlBycnmss20Vy+HlWQAYxjpmgDzMxMHKxsMAg8DtSeUSQzsgCkHHXvXa694XaRjLaKAvRgDg/XFcre6S8UoVgy8dCO1AFb7HNd3DrFtOe5rstIsLiKxjVthZR07Vh6RakXv+wQM4rvINptVjHy44zigDz3XFdJw5BLRsWwRxisS6DlwQm1T0Ppmuu8SJmeQIcJjrnr+NZVrGLlfKmBKKQw5oApIwEkcAcZUdQeMe5roNMuXjijVQjZG3cG6fSsWTTSbhpMnYf7v8qm0tzHIkbA/KeM/WgDG1yzB8UzZXDeXzj+dRwTmzBRxlSOO1W9VuM+Np+PlERB/Gm6oiAIRgkrjBoASwE97KqRgq2c57fStS9tRBEu4l3XliBU3hC0ZpPMVDuPA9DWlfW5y6yRknBDetAHG3Fz9oOCMkn7oGK0dLsPNjee+Y+SPlCA9eOlQWumm31Itc5EYHy+9a15PGlm6xnGPu4oAyo7tLVNkNvHGg6KF61Xn1WS4mRJCeOcqMAVn3UxOHbK9gP61XiuCjlsZBPQjrQBcnBldtuQAehNOjVchWGc96iWcMpO3J6VJEfugnCkZAH8qAOk0SNVRSMEk/L7eprkfHuqG81LyEY+VFxjPet6K7NqjOeG2/KB2FefzsZriWQnJZiSTQA1Rge9B6GlxTJDxQBFIc8ZxVSZsVLIeuaqSNk0ARSHmo6Vjk0lACiigUUAJRTmADEA5GetNoAKKKKAJYzVhCMVUU4NTxtQB2XhTxZPpZEF2TNa9ADztrqpPEOh3UTyRTGC4P8G3hq8sU1KgB5FAHejV0Qs3fNY/iPWZdR8qyjbZAvDY/iNYiyvs27jj60w/fXbndnigD6H+Cmi22j6HcXcsKm7Y/JuGSOOtGt63cW92zRu+9jngZH0p3w4vTFb+TOxJlhAHtWP4wuI4rxlZ9pduCq5/OgDQm1wX1urEmOTHTOQabpDNCWba7sDk89VrM0W3Z0E/VQcZQZq5K8yswiB2r/EaAOwWSO4UFTyw5Gelcx4ghyrHnKMe3JFJp9xP5oyHEmRkdquarsuElLvyV5APSgDO0aB3lJA/h5PQ1qSObfO8sVxWNBejTpAXDEMdvtms/wARajeX9ylrbA7yPmEdAFHxDfLO5hibjPJByKqW7mJAF6EdSK04/Dwt1j+2yDzBglByfx9KuS2NtsKnfjpjHSgDNtrmJZAGlVCfXipLk7VEqgOAuPlOe9VbzRorhCVlkQHoQM1g3+hTwp5sGpEYPIYEfyoApavdY1+SdeS8Q/OrJugWVpSinA2jNc/dW1y14qBxI54DKa3tM8NTzONzs4HXPAoA9M+H0B+xy3B2ELyApyKu3TeZK7SIVB5zjpWf4T0l7XTZ4CcGVTjDelVXsNVglLRO5PYZzxQBU16zkSIyH5kzlW9u9YUn71REoJJ5I966XULfVLjSp49kiyqN6nbnn0rg4dWks7gC+t5EYH5mA4/EUAWbyxfYAVJXGT7Gst1EbZHy47V2MV/aXdqXWQMjDg4yM1yerIm92TJ56Z4FAEAl+YcBQe+OTWrZwGUZCjC9axbdWmmUbSe2a6lpYNG04zXJJyvypnljQBk61IsFhNIx/eOdg/8ArVyIwOR0q3qeoy6hNvkICj7qDoKpg46UAKx71BI1OdsZqvI/BoAimaqkhx+NSyNk1XY5OaAEooooAUUUCigAYYYg9QcUlOcYYjOcHrTaACiiigAqaNqhpynBoAto1ToSDkVUQ1OhoAsCQ9qms2/0uLPPzDiqvbmpI2KMrDqDQB6bBrE9rJGYJCoUDae+fSoNRvZLtml8x35+aNjgAe1c0uprcwBdu2UDDDPWp4boNEI3OCfuk9R7UAemeB7lP7LkQH5g5J57Gtn7Mrybhuw46A5z+NcL4KL/AG7ZGPMR/vqO1enSSWtvbr+8QuDwEYEg/WgB1hp7ZUuh2Y+XHT2qtqGneSCrxgvIe/pU8/iu0sYUjt2We4PUZ4U1VfUhdRy3crHYoy2e1AHJ6qFvNUt7EEohfcx3cY9Klmuks7qWOz+RR8u4ck/jWB/bStqNxdlcgEqmKv2hM0Blj2gyN0bt70AdD4St217xdpGi+b9nbUJJIzPt37NsMkuduRnPl46jrntisGzu5NQsba5TKedAsuAc7cgHGe9db8Lbdovil4Pdx8xurgZz/wBOVxXCaArpoWmlCRus4u3faKANqNGljAjk7HrxWLrMO0yBiuG54711WnxtJn93lVIA3dCe9Zvie3EUpkRV2gUAcz4VsI57id2AbyxuOR+VaCXM0UhfawA5wBxirHgWIXNhqMyHEjt2pk1rsvA00heNThgvYe1AGxpuq/ZzG0r5JPAq5e36lg0Mo2tyRnpXNXtxBJI4RSCDhccDpxWU9x5aFZM78Z47UAdj/b+1vKjlye7Zx+FVrpLXWIGF2iBm6ShcHNcbFcjzSwY9M8jvXT+GrOe8ZmkB2J0bsaAOMv8AS7vSb+VLfd5JOSOx96q3QkYB2GR14r0fVo5ChhkiIVR1YZJrhtV/c3DoF2q2eD60AM0zVrbTpGM0JkcgEAVm+JdXOr3KsgKxL0Wqs6bmOSd2KqdfwoAjPBpCePelcjNQSHPQ0ANkb0qtI1PkaoCetAEbnio6c/Wm0AFFFFACiigUUAK/32z1yelNpWGGIznBxSUAFFFFABRRRQBNGeKnRqqxnBxUynmgC0DnrTlqNDlakWgCReCas2ty8UyZYsgPINVhTo1LuqjqTgUAdVFf318q2OgRMgzud14P4n0rsNF077Hp7i8u/tFywzsVuAaxNIlW1s47C3YxBjukkA+8fStV7pI8JAjAgZD5zuoA3bFraLabiBI1XksByTVLWZ7nWg9jaq0VuOT2yPU1UtphLNi6O5eNue3HWtBJ5FJVTtyQDtHXigDEvNOj0+yG0cep78cmtjw3JbmwjEgB8wcH0NUNdtydOkZ3YbX59xWVolysd1AobYq8kHkUAex/DC3u9Q8e+Gry1sryWys764866Fs4iT/RZ0wXI2/eZR17ivNFtdU0Cz0jT9R0+8sbk2qlku7d48hQobG4AHBPavav2ZtcE8/ibR2k3hZo76I/3ty+W+PYeWh/4FXH/GbVk1X4o6rExJgsIIrBcHgkDzGI990m0/7lAHH2d5LukdP9Xu75qHVrxpbK78xsqsBP40s6rEgQP8v5fnWbrcoHh6/ZQFfYFJHXk4oAteGWe10UGE4M43ZHYUXEm5XjYlXX5g/t6Zo8ON5uh6eBxsQg/nSapE32lWzmPGAKAK06uYTux2+bvWVevuKlDlehwOQRV1HmSEoSpUnOM9KgitZLibgEBuSvpQBoeHdBF9tkcnyychfWvVrS0TT7ONLdAo24C4rn/CVp5UUYKbWAxXTXt0vljJ5XjigCm0UZWSeZgSvGCOvtXk3iK33TkiMqzMTke9eh6vqH7qSJMBie/wBK4TVpN+QrZXG33JoA4+eMpKAzck9+9Zc4CTyKOxIrq3tQ6s00e0omfTn0rk5Tunkb3oAgnbjFVHf0NS3JJPFViT3oAazZNROakaon6GgCM80lFFABRRRQAoooFFACsMMQexxTaVuGODkZ60lABRRRQAUUUUALUyHpUFSRmgC3EamFVYzzVtMFaAJFOat6U8ceo27Tf6sP830qovFKAfyNAHr40QSWEbWiK2V3B+oIqhNaTRhEZfmPQnjFM+HusS2EQjuHzbHkBjnH0r0Bp4mjlR7eNpAPlJ75oA4ey3OxWVD5hJC981o2UnkyrFPjZJwCTjDVb1KJNqvDshlzkge1VNWtmk08zheUOWPY+9ADtZhEtiYHXBJyT64rl4Y40Do3IYlQV65rqIbtdRsM8/aY12tj+L3rn7hMkhY2B68UAdZ8F9bh8MfEPT7y6lEdlPHNaXMjcBVZd4P/AH3Gg/GuaOqS6teX19cx5mvZZL1tp5VpHLlfoN2PwrGvkWeye2dfkY7iueevH8q0LWcRy7vL4IIKjnFAE88zMxzldxHHrUOtRSN4fvAg+X5c/nWhCEMYYrukI4UjpU2oo76dPgDaV+6OxoAr+FYymhwFuW2HgdqiupHkV1cklTxxyKXwjJaMxtry4+zt1VmPyt7Vv6rp2nxQ+Yb+3CjqS4/pQBzNvAJCWJJAIwRWzaRxWYLSqpfqADXP6l4lsNNUpp4+1TnjeR8i/wCNO8NrNqUhv7ubMbNtJY8D2oA7rTdUCPtdQFY8CtK6eSSMNu4z261xl7ciCTbEcDoJO1WbfUzdS+THKvmrjdHnG73FAEl6CJW34yuC24c59axbsIxfyvvhhy3r3rZuYH3yNC7Sh+GBOT/kGsnXPNt4CyfKWGGJ4FAHPa1cpbWskUTguQSTnPJrj9xxWjqk/nAqgIjHc9zWY3A60ARy4PUVVbvViTFV26mgCJ+OlQueKmeoXoAZRRRQAUUUUAKKKBRQAMCGIPUUlOf77ZOTnr602gAooooAKKKKACnIcGm0tAFhTg1bgPOKpKcirMLdKALQJpy8CvSfgX8M4viVq+rwXV7cWNrY2yuJYFVj5rthQQe2Ffjg8Dmu2179mDxHaln0PW9N1BByFuEe2c+wxvBP1IoA8SgvZFVCrFSvGM8GvV9Ov31TQrWS3IMqLh+eRil8Ifs/eKNQ1q/svEtlJpcUdlLJa3izJJG1wCojHyk5By2QcHAPeuC0CbUvCniW4stThkhkgma3uYG/hYHB/wAQe45oA7BppHk2tkqo5NbOlxx3Fu0bM2xgQ4J4AqW50tLiGOeAgxOM/LxRaxNbyrhTs6EEUAcXqjS6BrHzqTGDg4/iX1rUnCXab4GXLruUjuK3/EelRaxZ7flNwo/dH+97V5xZ3Uun6lLZXJMcYbgt/D7fSgDTuLYRMGCkyEelX9Kt4ydxALcDJ65oaJi6urBkPOVOf1pbWZYXGcId2SaANqKyG3eRjHI56Co9UZLaxdwDvYdB3qc6xaG2yn71wMFV6Vn2Vhc63d5kyI07AcY9qAOaisJZwzIhOORgVoW3hmeYFTG2CNx46V6bo2h2+nxp5qgsOx4/Oqmq62kG+C2IMg+7tHT2NAHm+peDVjhMmGBA6YrnSLnRWHkljb5yR2zXoVxqst66yO5j52lV6c+tZ19DDc8yKEJHXHX60AUtK1GG9h2sBn0/wqZ7RY2QqWH8Qeubv7ObSrkPEx8vPI9K17S8NzANuTjnjrQBuSzzR2/mABtp2lCe3rXMa1M94f8ASHKQIMsegA/rWzhPLaSeQRxIMkt2rhvEGp/2hMY7cFLZT8o7t7mgDOvZkkkIhDCIHjPU+9QNnFPAAHqKGAoArPnoTVdxVtlzmoJF4oArNUL9KsOKgfpQBHRRRQAUUUUAKKKBRQAsg2uwHQHFNpzghiCcnNNoAKKKKACiiigAooooAkiPap4zg1VU4OasKemKAPp39lLxn4P8LaFq8Ou61b6fqt9dqdtwrIvlIg2nzMbfvNJxn+dfUWlarp2r2/n6Vf2l9B/z0tpllX81JFfmRC/NW7WeW0uBPaSyW869JInKOPoRzQB+nFfN/wC1R4Z022utP8TW9xbw6lOy2tzalwJLpBwsir1JTof9kj+6K4uy/aCv9C+HGk6Loj3Oo6+IWN1qupO0nlszFgqBjlyoIXJ+X5ejVwst7f6yyanqdzNe6jdoWmuJ33MRk8eyjsBgCgDq/BHiEWzCzu1LQdFbrtrvLrT450863KsjDjBrxyweOJwqkqw6Me9dlomrXUKqsUnB6DqDQBuXMU0YK4wMcEDpXA+O7NLiG3vtuLnd5cmOj+hr0EasWtWWeE+Yf7h6iuM8QJPeSHNuUhB+Uep9aAOKtPtCDCs6qTzgkVa/s+eaRQzPnPrmtQxLaFTLkIWVORwWJwMfiRWpbskURlKE8HtQBBoemPbSqJ1byj97FegW2qWtrbqkKrGoXA4549a5PTdcjZkBKxt/Cr9DWpLLFeHMsS/KOChoAsajq0l2kirJiMqc7T1rBIUWysH3uRjnPNaEkHl4VPu4yvY1XMa+4IJIGe9AHPDbFIFCuysdzZ4OasR3Hz/IvmRv6jBFac6RSALt69CB0qpJBDa/MrnAbPI6+1AEFzai6tJVcDZtOCTzXnkV5d2crLFMylSRx3rutY1OOzs2KH5mGACeSa4DlmZj1JyaALF1fXd3GFuJmZOu3oKqFMGpCw6UxmGaAGEY4prnjpSu/vWv4btYp5JbiddyQ4wMdTQBhsjjkqwHriq830rvr4o0LAwrjGQMcEVxmqwrHNmMYRhkD0oAzHGBUEg4NWT71BKODQBXooooAKKKKAFFFAooAWT77Z65ptKaSgAooooAKKKKACiiigAqaM5FQ1JEeaALEZwatR8mqanmrcXIFAD2XvXcWEoTTbeTIULHtHNcSDla6nQZRcaesQVS6naM0AbvnAwRMI1IYfwjmpra4K5CRncSBx0/GshLgxI6sf3i+tWrC9kWdd7KqsOSfWgDsNI1vGPOQDvyK6qw1myfCOIycZwRXl32sxzIQeCCp+vvViK5miaJiwLx579QaAPTIvDdv441UaVaxRB1tLm93AdJFTy4s/8AbSVGA7+X9azLJdO1DTIZo40j8yMFox1XIzgivQv2Y9OZ7PX9cmBLTTR2URP92Nd7EfVpSD/ue1efeLoV0DxZ4g0t4EEcF60kR/6Zy/vVA9gH2/8AAaAK83hayu13Rt8w6gHBrGfR7mwJ8meROcAda2bPVYGxt2hzgnHatePUbaWLDqCRzkigDgzql7ASk+yTGcblxmmxay0o+a3w2MgjtXb3NvYTt++ijIK44bkGs6bStLcfJG6oBgkN1oA5iTVBtwkTZ+uKp3txcT2zIkYRz91ic1u6ppVp5O62Y7lAJB6gVgbHD8H5cjOe1AHDXTzSysbliXBwc9qjiilnkEcEbySN0VRk1oeI4/K1F8fx8kY712Xh+GPRdLilWMPeyjczHqq0Ac3D4M1eWPe0Sw+znBqWHwDrM7hf9HUf3mfiuqbWZmkGWdjgg+mKW41k+WyLuycBdvOc0AYsnwwvkUGS7jfPUJ2/OurtvB9ppGkLBaXayT/6yTd1Y+lZL6rcBGZZMgEDGT+tRRXtw8jsX3bcc96AMO6do5JVI2spPHr7VzusRDyQw/hP5ZrqPEkebnzowMSLkgHgEVz9ypbTpXYEcGgDmWIyfSoZF+U1MeTTSMqaAKFFKwwxpKACiiigBRRQKKAFYAMQDkZ602lYYYgHIz1pKACiiigAooooAKKKKACnIcMKbSjrQBYHWpom5xUC1KvagC4vIrT8PTeXqaR5wshx+NZULVPC5iuoZF6q4P60AdbrINrqTouQRgkHvVeN1kuQzfLnqvWtnXIftN4soA2tEH3D+KstBHFcAYO5hk0AakapIhD7dzDdnsCKuWO10QMFLFsZz0qhbuT5asuSuc5qxbmTBUArGT09aAPQvBvxK8R+E9Ch0fTU0T7LC8kgae0laRi7s7ZImAPLHsOABWP4j8VXviPxE+qat9gS7e3S3AtIGjQhSxDEM7Zb58Z9AK5hnJJAHCHANQS7hIhGdoOTQBorqDLOcBdw46YzWjBf+YiochtwyM1ixRSDl/mYjb7Vc0+F/MJJwScA0AaTXrqzMoPK4Ix3pVvAVQJIcc8Ed6oyBncqCQB2AqFvlIALcnOPSgC8dQhy7PIASoXjjNJe2sL2bz2zEsmC2DWLcEqm0rxyc5q7od0IVkSZsxMCGFAHL69AZtWs1X/loQP1rq7ySNiqg8oAMAc4rD1G4iOs2Py8R5yen0rTQyuzMwDc/iKAIHBKBSRuyevFQtKIQsS8byQSBnBqeVXVTyue3Gaj/wBZGxwoZW570AMdMBioyq89ep+lMJdC0gYqzLk46VcARSeccdqzZH5Idug7daAF1CRprQFhyp5PvWVe5bTZNoG0Kc+xrVjZZIJiv8WOvaqF5Fs065914oA4thzScZp0nWmN60AU51w5qOrF0OhqvQAUUUUAKKKBRQAEEEg9aSlJJJJ6mkoAKKKKACiiigAooooAKKKKAJ05WpFNQxniplOaALEJwanHK571VQ4NWojmgDvdKlW98PWxlb5oiY8nv6VVuY/Kl2kBh/eHY1U8Izkx3FrnkESqMdcdRV2VyztkbTnt1oAt2wVHUtk5zn6Vd25kyMYwD6VThLH7vI6gHqKsw7jIrM49qALbH52T5cOeNozVeaIEIpb5QScCrKgFg+COQCf51LLGgVe4BIOKAK0LgqAO3yjPr61JGzYK7jxwAOe9S2yJIHBUZJPTtRLH85Bwq8H8qAHZDJ8hwoPPuKiL5fIypJ/M05+gQEc/ypkjM8bK67cZOQKAK1zh48ZHUn8KqBlichuEb2qeZPmVSedo6Uy/h8m3a6mwsaDIVu9AHN63IBelUPzL3Fafh3WpW/0ObaW6oxHP0rl5ZXmmeRvvMc02OZ4ZklQkMhDCgD0C5djIwI4GelVtuyRxy2/AFTQMt3axXCZ2SjOPfHSoz5qSIvUZHbtQATyN5RD/AHgOPcGs6cruO04Y5ALc5rSvCzLlhtPTJ9BVGUbmKkDbj8qAFtkLKA7ZyQTTdWi26ddAHgLmptNBOQoGPU9wKl8SQhNFuJVPBXpQB5tIDn8KY1THlfWonFAEEoyhqrVs9DVVhhiKAEooooAUUUCigBKKKKACiiigAooooAKKKKACiiigCVB8tSoeajQ/LTloAmFWoTxxVZORU8BwQKANfRbo2epwTH7mcN9DXVX8QSaTHzcjB9utcSDwPWu302ZdR0yCRj84Xy3PuOlABajljg9M/StCFS8HHRTkVVtoX8s54Iz+hqzakGJhznPAoAsxj5iPm3cnH4cVJLkKpAxkZP1p9uDu4PI5570rpuUAMRnnNADoEzJnGBt7dqjugMyA8kfdxViNQHbngg9DSXMeUOOTjr6UAVkOSvygqw/WlnXKnLYApAgXaTkFSD9RTyC6kA5OTkYoAigtg9xsAJIPX2Nc54+vc3SWMTZWPlsevpXcWRS1s7q7lB/dxk89uOK8juJXu72WeQ5Z2LUARKOlJKParATAOaa6kigDpPBNx59vLaHBkiO9B7d625AS+7pjgmuG0G8Gn6zbz5+Xdtb6GvS7+3CSgxnKuNw460AZFzGXjDEDK4696y2V5Gc/xdSPat65gIVixG0jtWJKoWR1U847UAOseJlAYAZ6ev1rR8WRFfCtwx747Vm2eRcRnqe+PWtzxiufBkrA9SDQB5H29qbIMnipFwV5HAqNuc0AQP7VWlHzVacVXlHegCKiiigBRRQKKAEooooAKKKKACiiigAooooAKKKKAJU+7Tlpifdp60ATLU8XUVAtTR9aAL0fKcVv+DrnZePaSHCSjI9jWFDylKrvDIkqHDoQaAPTnt2JwQApB6VFDCFCnocYq/oNymq6QkyAF8YYU2dNhHGOcUANgUhl3ZGV6DuamgUBdrclM0RhRx3HIp6oMZQHLHI/qKADCYJ9cY5psjgyHORnggCngBiGUD5WAAoLDaDjK7qAKs2Q5B6HgH04pEGJNq55HORSlS244BUkGrFjEZLhQOSaAI/GEgs/B7ovymc8euK8sg5IFekfFCQR21rbggDGMV51AMMO9AFjbzTJBgg4wKmIxgmmPyM4oAzrlSASOK9Y8O3C6n4btZQcyRjY1eXXK8YruPhHchpLqxkOR95QfWgDavxsj2hSBjORzXOyHEpbnONufWut12NoBINo7DFcpdKQ4KEHk8UANsA32gEbfvYya3fGqMPBUuSCR6Vj2eVlUZQ5P4V0Pi5N/gefaMcc80AeLofkP0qOnxdMUxuvFAEMnWoJBwasSdagegCvRSnrSUAKKKBRQAlFFFABRRRQAUUUUAFFFFABRRRQBIvSpEqJelSpQBMoqeMc1ClWIuAKALlvwKfKMpikhINTSoCMc0AdT8MdQMOoPaSEhJBkV3epWoSTbgYzwa8i0ac2mr2sqnGHFe03TC4s4ZcenNAGM0YBOX79MVPGgEZAwuCCBTWGCVPXOKkjyrbiOOM80AUy4WV88jvj1qePYFA/hJOOe1RzJncB1PP5UmQpzkZxn6UAQlQUJHQEir2hKDeKuTu689qqYzyM8g5FaXh4KdQ3YPSgDj/ilJv1WGM/wiuQiULXUfEfnWVJGeK5lBjFAEnGeOlIw6HtShckU2T0GQKAIJwMHjrWv8PLr7L4rt17SfLWUVBHOaTR5Tb6/YyZxiZefxoA9u8VwKvHTcMnivP5VAHzHnJwa9S8Xxb7C3cEZaPIJ9a8wu1/fsOijjFACWyYZQMMCa63XI/O8FXK8cKe3tXKQDEigt97H412oXzvDV2mOCvT8KAPAIupFMcfMcVIRsnlX0Yj9abJyRQBDJ0qBhVh+lQOKAK7feNNp0nWm0AKKKBRQAlFLSUAFFP8t/7jflSMrL95SPqKAG0UU/y3/uN+VADKKcylfvAj6im0AFFFFAD16VMlQpU6CgCVPerEQzUCirMIoAtQVfUbkyRzVBeMda0ofujigCqw2OrjqrZr2rw7ILzREIP8Ga8alTKtwcV6V8Mr0zae0BP3Pl/CgDTuo8NgdfWhuUYHBAq7dRHzXXoCcVV2hSR0GKAIGVce2O9VJFIZvcVfkB2ZK5wO3aq7KSsXXJ9aAI1K56dq0tFXZdbh93BwazwoJG7IPcdq1NNGyRcZFAHAfEEg6vHnPINc3HXR/EEH+1IwemDXNxgkjrQBMq8Z9KZJ19qn6LgA5qPBx0oAix8hP6VRbKXsDDs6n9a0VHyniqkke66hAHVwP1oA+hfEQE2j2Z6/J/SvNbtPKkOcHIr0jUiDotsnJ+UA/lXn+pxlHyRQBRiG5kB4JORXcaF8+kXMR5BXriuJhYljjIBOQfSuz8Lybopl45joA8I1OPyNYvI8fdkb+dV5ByOa1vF8PkeJr1cYBfNZbcpxQBXkqB6sOPzqBhQBBJUdSydKioAUUUCigD//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The radiograph above shows the wrist of a patient who presented in delayed fashion following an injury. This PA view taken with the patient's fist clenched, shows an abnormal widening at the scapholunate articulation (arrowhead), early proximal migration of the capitate (thin arrow), and radioscaphoid joint space narrowing (thick arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kenneth E Burroughs, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_26_29088=[""].join("\n");
var outline_f28_26_29088=null;
var title_f28_26_29089="Calculator: Lean body weight (adult female)";
var content_f28_26_29089=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"LeanBodyWgtF_form\" name=\"LeanBodyWgtF_form\" onkeydown=\"clrResults();\" onkeypress=\"return validNumberField(event);\" onkeyup=\"LeanBodyWgtF_fx();\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: Lean body weight (adult female)",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <center>",
"     <div id=\"calc_equation\">",
"      <table cellpadding=\"10\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"       <tr>",
"        <td align=\"left\" bgcolor=\"#6c9a9c\">",
"         <span class=\"medCalcFontFormuli\">",
"          LBW[kg] = (9270 * TotalBodyWeight[kg]) / (8780 + (244 * BMI[kg/m",
"          <sup>",
"           2",
"          </sup>",
"          ]))",
"         </span>",
"        </td>",
"       </tr>",
"      </table>",
"      <br/>",
"      &nbsp;",
"      <br/>",
"     </div>",
"    </center>",
"    <div id=\"calc_main\">",
"     <center>",
"      <table cellpadding=\"6\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"95%\">",
"       <tr>",
"        <td align=\"right\" width=\"50%\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Input:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Total Body Weight",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Total_Body_Weight_param\" onblur=\"LeanBodyWgtF_fx(); minMaxCheck();\" onchange=\"LeanBodyWgtF_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Total_Body_Weight_unit\" onchange=\"LeanBodyWgtF_fx();\" style=\"width:105px;\">",
"              <option selected=\"selected\" value=\"1|0|kg\">",
"               kg",
"              </option>",
"              <option value=\"0.45359237|0|lb\">",
"               lb",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Height",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Height_param\" onblur=\"LeanBodyWgtF_fx(); minMaxCheck();\" onchange=\"LeanBodyWgtF_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Height_unit\" onchange=\"LeanBodyWgtF_fx();\" style=\"width:105px;\">",
"              <option selected=\"selected\" value=\"1|0|cm\">",
"               cm",
"              </option>",
"              <option value=\"2.54|0|in\">",
"               in",
"              </option>",
"              <option value=\"100|0|m\">",
"               m",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"        </td>",
"        <td align=\"left\" bgcolor=\"#eeeeee\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Results:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table bgcolor=\"#eeeeee\" cellspacing=\"4\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              LBW",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"LBW_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"            <td valign=\"top\">",
"             <span class=\"medCalcFontOne\">",
"              <select class=\"medCalcFontSelect\" name=\"LBW_unit\" onchange=\"LeanBodyWgtF_fx();\" style=\"width:105px;\">",
"               <option selected=\"selected\" value=\"1|0|kg\">",
"                kg",
"               </option>",
"               <option value=\"0.45359237|0|lb\">",
"                lb",
"               </option>",
"              </select>",
"             </span>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td colspan=\"3\">",
"             &nbsp;",
"             <br/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"center\" colspan=\"3\">",
"             <span class=\"medCalcFontOneBold\">",
"              Decimal Precision:",
"             </span>",
"             <select class=\"medCalcFontSelect\" name=\"decpts\" onchange=\"LeanBodyWgtF_fx();\">",
"              <option>",
"               0",
"              </option>",
"              <option>",
"               1",
"              </option>",
"              <option selected=\"selected\">",
"               2",
"              </option>",
"              <option>",
"               3",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"         <br/>",
"         &nbsp;",
"         <br/>",
"         <center>",
"          <span class=\"medCalcFontOne\">",
"           <input name=\"reset\" type=\"reset\" value=\"Reset form\"/>",
"          </span>",
"         </center>",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_hints\">",
"     <span class=\"medCalcFontOne\">",
"     </span>",
"    </div>",
"    <div id=\"calc_notes\">",
"     <span class=\"medCalcFontOneBold\">",
"      Notes",
"     </span>",
"     <ul class=\"medCalcFontOne\">",
"      <li>",
"       The formula depicted, which is based on gender, total body weight, and height, can be used to estimate LBW for adult females who are of normal weight or obese.",
"      </li>",
"      <li>",
"       This calculation is not applicable to individuals with abnormal body water composition (eg, fluid overload).",
"      </li>",
"      <li>",
"       This calculator is not validated in individuals at extremes of height, those with highly muscular builds or in underweight individuals.",
"      </li>",
"      <li>",
"       The equation on which the calculator was based was derived from data on a population of individuals with bodyweights up to 216.5 kg  or body mass index (BMI) up to 69.9 kg/m",
"       <sup>",
"        2",
"       </sup>",
"       , but was not validated in individuals weighing greater than 131.7 kg or with BMI over 38.4 kg/m",
"       <sup>",
"        2",
"       </sup>",
"       .",
"      </li>",
"      <li>",
"       A separate calculator is available for estimating ideal body weight (method of Devine) and adjusted dosing weight.",
"      </li>",
"     </ul>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_refs\">",
"     <span class=\"medCalcFontRef\">",
"      <b>",
"       References",
"      </b>",
"     </span>",
"     <ol>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Janmahasatian S, Duffull SB, Ash S, et. al. Quantification of lean bodyweight.",
"        <i>",
"         Clin Pharmacokinet",
"        </i>",
"        . 2005;44(10):1051-65.",
"       </span>",
"      </li>",
"     </ol>",
"    </div>",
"   </form>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_26_29089=[" ",
"",
"",
"function log(i){",
"return Math.log(i) * Math.LOG10E;   ",
"}",
"",
"function ln(i){",
"return Math.log(i);",
"}",
"",
"function sq(i){",
"return i * i;",
"}",
"",
"function sqr(i){",
"return Math.sqrt(i);",
"}",
"",
"",
"function power(x,y){",
"return Math.pow(x,y);",
"}",
"",
"function eTo(x){",
"return Math.exp(x);",
"}",
"",
"",
"function fixDP(r, dps) {",
"if (isNaN(r)) return \"NaN\";",
"var msign = '';",
"if (r < 0) msign = '-';",
"x = Math.abs(r);",
"if (x > Math.pow(10, 21)) return msign + x.toString();",
"var m = Math.round(x * Math.pow(10, dps)).toString();",
"if (dps == 0) return msign + m;",
"while (m.length <= dps) m = \"0\" + m;",
"return msign + m.substring(0, m.length - dps) + \".\" + m.substring(m.length - dps);",
"}",
"",
"function alertNaN(){",
"alert('This field is improperly formatted. You may only input the digits 0-9 and a decimal point.');  ",
"doCalc = false; ",
"clrResults();",
"}",
"",
"",
"function validNumberField(event) {",
"var field = event.target;",
"",
"if(field && field != 'undefined' && field.attributes.type.nodeValue && (field.attributes.type.nodeValue == 'number')) {",
"var val = field.value;",
"var charCode = event.charCode;",
"var key = String.fromCharCode(charCode);",
"",
"if(charCode == 0) {",
"return true;",
"}",
"",
"if(key == ' ') {",
"alert('Numeric field cannot contain spaces.');",
"return false;",
"}	",
"		",
"if(val.length == 0) {",
"if(key == '+') { return true; }",
"if(key == '-') { return true; }	",
"if(key == '.') { return true; }",
"}",
"		",
"if(key == '.') { return validFloat(val, key); }",
"",
"if(isNaN(parseInt(key))) {",
"alertNaN();",
"return false;",
"}",
"	",
"return validFloat(val, key);",
"}",
"return true;",
"}",
"",
"",
"function validFloat(val, key) {",
"var currentVal = parseFloat(val + key);",
"if(isNaN(val + key) || isNaN(currentVal)) {",
"alertNaN();",
"}",
"return true;",
"}",
"",
"var currenttimeout;",
"",
"",
"var calctxt = ''; ",
"var xmltxt = ''; ",
"var htmtxt = ''; ",
"",
"",
"",
"function LeanBodyWgtF_fx() {",
"",
"currenttimeout = self.setTimeout('minMaxCheck();', 2000);",
"",
"with(document.LeanBodyWgtF_form){",
"",
"",
"doCalc = true;",
"param_value = parseFloat(Total_Body_Weight_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Total_Body_Weight_unit.options[Total_Body_Weight_unit.selectedIndex].value.split('|');",
"Total_Body_Weight = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"param_value = parseFloat(Height_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Height_unit.options[Height_unit.selectedIndex].value.split('|');",
"Height = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"dp = decpts.options[decpts.selectedIndex].text;",
"BMI =  Total_Body_Weight / sq(Height / 100);",
"",
"LBW =  (9270 * Total_Body_Weight) / (8780 + (244 * BMI));",
"",
"unit_parts = LBW_unit.options[LBW_unit.selectedIndex].value.split('|');",
"if (doCalc) LBW_param.value = fixDP((LBW - parseFloat(unit_parts[1])) / parseFloat(unit_parts[0]), dp);",
"",
"",
"",
"",
"",
"}",
"",
"}",
"",
"function minMaxCheck(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.LeanBodyWgtF_form){",
"",
"if (Total_Body_Weight_param.value && isNaN(Total_Body_Weight_param.value)){ Total_Body_Weight_param.value = ''; alertNaN(); }",
"if (Total_Body_Weight_param.value && Total_Body_Weight < 47) {",
"Total_Body_Weight = 0;",
"Total_Body_Weight_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Total Body Weight is 47 kg.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Height_param.value && isNaN(Height_param.value)){ Height_param.value = ''; alertNaN(); }",
"if (Height_param.value && Height < 122) {",
"Height = 0;",
"Height_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Height is 122 cm.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Height_param.value && Height > 213) {",
"Height_param.value = \"\";",
"clrResults();",
"Height = 0;",
"doCalc = false;",
"alert(\"The maximum value for Height is 213 cm.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"",
"",
"}",
"",
"}",
"",
"",
"function clrResults(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.LeanBodyWgtF_form){",
"",
"LBW_param.value = '';",
"",
"",
"}",
"",
"}",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
""].join("\n");
var outline_f28_26_29089=null;
var title_f28_26_29090="Patient information: Multiple myeloma (The Basics)";
var content_f28_26_29090=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?36/7/36978\">",
"         Patient information: Low back pain in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?16/23/16754\">",
"         Patient information: Monoclonal gammopathy of undetermined significance (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/57/28562\">",
"         Patient information: Nausea and vomiting in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?22/8/22658\">",
"         Patient information: Urinary incontinence (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/16/37121\">",
"         Patient information: What are clinical trials? (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?12/16/12547\">",
"         Patient information: Multiple myeloma symptoms, diagnosis, and staging (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?30/40/31366\">",
"         Patient information: Multiple myeloma treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Multiple myeloma (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/multiple-myeloma-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H559313614\">",
"      <span class=\"h1\">",
"       What is multiple myeloma?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Multiple myeloma is a cancer of one type of white blood cell. White blood cells fight infections in the body. They are made in the bone marrow, which is the middle part of bones. When people have multiple myeloma, the bone marrow makes too many of these white blood cells and not enough of the normal blood cells a person&rsquo;s body needs. This can cause symptoms.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H559313621\">",
"      <span class=\"h1\">",
"       What are the symptoms of multiple myeloma?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Multiple myeloma can cause many different symptoms. These include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Bone pain or bones that break easily",
"       </li>",
"       <li>",
"        Nausea, vomiting, confusion, or feeling more thirsty than usual",
"       </li>",
"       <li>",
"        Feeling more weak, tired, or short of breath than usual",
"       </li>",
"       <li>",
"        Blurry vision",
"       </li>",
"       <li>",
"        Numbness, tingling, or weakness in the chest, lower back, or legs",
"       </li>",
"       <li>",
"        Getting sick more easily",
"       </li>",
"       <li>",
"        Losing weight without trying to",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      All of these symptoms can also be caused by conditions that are not multiple myeloma. But if you have these symptoms, let your doctor or nurse know.",
"     </p>",
"     <p>",
"      Sometimes, symptoms of multiple myeloma can be a medical emergency. For example, it is an emergency if multiple myeloma cells or pieces of broken bone push down on a person's spinal cord. The spinal cord is the group of nerves that runs down a person&rsquo;s back. See a doctor immediately if you have:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Severe back pain",
"       </li>",
"       <li>",
"        Weakness, numbness, or tingling in the legs",
"       </li>",
"       <li>",
"        No control over your bladder or bowel (that is a new problem)",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H559313628\">",
"      <span class=\"h1\">",
"       Is there a test for multiple myeloma?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor or nurse will do an exam and tests. Tests can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Blood or urine tests",
"       </li>",
"       <li>",
"        Bone marrow biopsy &ndash; A doctor will take a very small sample of the bone marrow. Another doctor will look at the sample under a microscope to see if cancer cells are present.",
"       </li>",
"       <li>",
"        X-ray or other imaging tests &ndash; Imaging tests create pictures of the inside of the body.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H559313635\">",
"      <span class=\"h1\">",
"       How is multiple myeloma treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People with multiple myeloma often have one or more of the following treatments:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         &ldquo;Watch and wait&rdquo;",
"        </strong>",
"        &ndash; Some people have a condition called &ldquo;smoldering myeloma&rdquo; before they get multiple myeloma. These people do not have any symptoms and might not receive treatment right away. But their doctor does follow them. When they start to have symptoms, they will have active treatment.",
"       </li>",
"       <li>",
"        <strong>",
"         Chemotherapy",
"        </strong>",
"        &ndash; Chemotherapy is the term doctors use to describe a group of medicines that kill cancer cells.",
"       </li>",
"       <li>",
"        <strong>",
"         Steroid medicines",
"        </strong>",
"        &ndash; These medicines can kill cancer cells and slow cancer growth. (These steroids are not the same steroids that athletes take to build muscle.)",
"       </li>",
"       <li>",
"        <strong>",
"         Medicines called &ldquo;immune modulating medicines&rdquo;",
"        </strong>",
"        &ndash; These medicines stop the cancer from growing.",
"       </li>",
"       <li>",
"        <strong>",
"         Bone marrow transplant",
"        </strong>",
"        &ndash; The bone marrow makes blood cells, including white blood cells. During a bone marrow transplant, a doctor removes some bone marrow from the body. Then, the person gets medicines called &ldquo;chemotherapy.&rdquo; These medicines are usually used to kill cancer cells, but they also kill bone marrow cells. After chemotherapy, the doctor puts the bone marrow back into the person&rsquo;s body.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      People with multiple myeloma",
"      <strong>",
"      </strong>",
"      also have treatment for any symptoms they have. For example, doctors might treat bone symptoms with pain medicines, medicines to stop bone loss, or radiation therapy. Radiation can kill cancer cells.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H559313642\">",
"      <span class=\"h1\">",
"       What happens after treatment?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After treatment, you will be checked every so often to see if the cancer comes back. Treatment does not usually cure the disease, but it can reduce symptoms and",
"      <strong>",
"      </strong>",
"      help people live longer. Follow-up tests can include blood tests, urine tests, imaging tests, or bone marrow biopsy.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H559313649\">",
"      <span class=\"h1\">",
"       What happens if the multiple myeloma comes back?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If the multiple myeloma comes back, you might get more chemotherapy, immune modulating medicines, steroid medicines, or bone marrow transplant.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H559313656\">",
"      <span class=\"h1\">",
"       What else should I do?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It is important to follow all your doctors&rsquo; instructions about visits and tests. It&rsquo;s also important to talk to your doctor about any side effects or problems you have during treatment.",
"     </p>",
"     <p>",
"      Getting treated for multiple myeloma involves making many choices, such as what treatment to have and when. Always let your doctors and nurses know how you feel about a treatment. Any time you are offered a treatment, ask:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        What are the benefits of this treatment? Is it likely to help me live longer? Will it reduce or prevent symptoms?",
"       </li>",
"       <li>",
"        What are the downsides to this treatment?",
"       </li>",
"       <li>",
"        Are there other options besides this treatment?",
"       </li>",
"       <li>",
"        What happens if I do not have this treatment?",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H559313663\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/7/36978?source=see_link\">",
"       Patient information: Low back pain in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?22/8/22658?source=see_link\">",
"       Patient information: Urinary incontinence (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/57/28562?source=see_link\">",
"       Patient information: Nausea and vomiting in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/16/37121?source=see_link\">",
"       Patient information: What are clinical trials? (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/23/16754?source=see_link\">",
"       Patient information: Monoclonal gammopathy of undetermined significance (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?12/16/12547?source=see_link\">",
"       Patient information: Multiple myeloma symptoms, diagnosis, and staging (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?30/40/31366?source=see_link\">",
"       Patient information: Multiple myeloma treatment (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?28/26/29090?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15531 Version 4.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-190.111.122.2-6B4A64F196-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_26_29090=[""].join("\n");
var outline_f28_26_29090=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H559313614\">",
"      What is multiple myeloma?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H559313621\">",
"      What are the symptoms of multiple myeloma?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H559313628\">",
"      Is there a test for multiple myeloma?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H559313635\">",
"      How is multiple myeloma treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H559313642\">",
"      What happens after treatment?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H559313649\">",
"      What happens if the multiple myeloma comes back?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H559313656\">",
"      What else should I do?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H559313663\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/7/36978?source=related_link\">",
"      Patient information: Low back pain in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/23/16754?source=related_link\">",
"      Patient information: Monoclonal gammopathy of undetermined significance (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?12/16/12547?source=related_link\">",
"      Patient information: Multiple myeloma symptoms, diagnosis, and staging (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/40/31366?source=related_link\">",
"      Patient information: Multiple myeloma treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/57/28562?source=related_link\">",
"      Patient information: Nausea and vomiting in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/8/22658?source=related_link\">",
"      Patient information: Urinary incontinence (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/16/37121?source=related_link\">",
"      Patient information: What are clinical trials? (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_26_29091="Scabies burrow 2";
var content_f28_26_29091=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F53715&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F53715&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Scabetic burrow",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 347px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This erythematous linear lesion between the fingers is consistent with a scabetic burrow.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_26_29091=[""].join("\n");
var outline_f28_26_29091=null;
var title_f28_26_29092="Teduglutide: Patient drug information";
var content_f28_26_29092=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Teduglutide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/33/10772?source=see_link\">",
"     see \"Teduglutide: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F16116959\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Gattex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F16160451\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F16160453\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat short bowel syndrome.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F16160452\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4155484",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to teduglutide or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F16160457\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697221",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have gallbladder disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697318",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have pancreatitis, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F16160458\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698108",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Gas.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F16160459\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698624",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4155486",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling at the stoma site.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F16160455\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the fatty part of the skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696367",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Your doctor will teach you how to give the shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4156274",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Give the shot within 3 hours of getting it ready for use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away needles in a needle/sharp disposal box and take the box back to your doctor when it is full.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F16160456\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F16160460\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature. Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away any part not used after 3 months.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F16160461\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 88324 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-FD0A04FE88-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_26_29092=[""].join("\n");
var outline_f28_26_29092=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16116959\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160451\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160453\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160452\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160457\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160458\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160459\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160455\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160456\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160460\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16160461\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?10/33/10772?source=related_link\">",
"      Teduglutide: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_26_29093="Hypothyroid myopathy";
var content_f28_26_29093=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hypothyroid myopathy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/26/29093/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29093/contributors\">",
"     Marc L Miller, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29093/contributors\">",
"     Devon I Rubin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/26/29093/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29093/contributors\">",
"     Michael J Aminoff, MD, DSc",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29093/contributors\">",
"     Jeremy M Shefner, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29093/contributors\">",
"     Douglas S Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/26/29093/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29093/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/26/29093/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 19, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Muscle involvement in a variety of forms is a frequent problem in both congenital and adult-onset hypothyroidism. This topic will discuss the clinical manifestations, pathogenesis, and treatment of hypothyroid myopathy. Other neurologic manifestations of hypothyroidism are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/46/36585?source=see_link\">",
"     \"Neurologic manifestations of hypothyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14503?source=see_link\">",
"     \"Clinical manifestations of hypothyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CONGENITAL HYPOTHYROIDISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Kocher-Debre-Semelaigne syndrome describes infants with typical features of cretinism associated with diffuse muscular hypertrophy and muscle weakness that is predominantly proximal. These infants have motor and cognitive developmental delay, constipation, myxedema, enlarged tongue, and coarse hair and skin typical of cretinism. Despite a very muscular, almost muscle-bound appearance, they are in fact weak and often have difficulty with sitting and head control [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39864?source=see_link&amp;anchor=H5#H5\">",
"     \"Iodine deficiency disorders\", section on 'Cretinism'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Serum creatine kinase (CK) and other muscle enzymes are often elevated in these infants. The electromyogram may be normal or show scattered low amplitude motor unit potentials in involved muscles. Muscle biopsy shows variable muscle fiber size with predominantly type I fiber atrophy. There is also increased interstitial connective tissue related to the duration of the hypothyroidism and abnormal glycogen accumulation. Muscle fiber necrosis and inflammation are not prominent features of this disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Treatment with thyroid hormone results in prompt improvement in muscle strength and normalization of serum CK concentrations, even in infants with longstanding congenital hypothyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ADULT HYPOTHYROIDISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Muscle involvement in adults with hypothyroidism is common; in one series, 79 percent of patients with hypothyroidism had muscle complaints (weakness, cramps, myalgias) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/4\">",
"     4",
"    </a>",
"    ]. Patients with more severe or longstanding untreated hypothyroidism are more likely to develop clinically significant muscle disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Elevation in serum creatine kinase",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum creatine kinase (CK) elevation occurs in most (57 to 90 percent) patients with hypothyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. The degree of CK elevation does not clearly correlate with the severity of other clinical manifestations of muscle disease, but some have found a correlation between CK and serum thyrotropin (TSH) levels [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/8\">",
"     8",
"    </a>",
"    ]. However, in asymptomatic patients, CK elevation is usually mild, less than 10 times greater than normal [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CK elevation may be present for several years before clinical manifestations of hypothyroidism appear. Hypothyroidism should be excluded in patients with an unexplained increase in serum CK of skeletal muscle origin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Myalgia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonspecific muscle stiffness or diffuse myalgias, often exacerbated after exercise, are common manifestations of hypothyroidism and may be associated with serum muscle enzyme elevations. In one series, more than 40 percent of patients had neuromuscular complaints at the time of diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Muscle hypertrophy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diffuse muscle hypertrophy occurs infrequently in adults. When accompanied by stiffness, weakness, and painful muscle cramps, this is known as Hoffmann's syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/10\">",
"     10",
"    </a>",
"    ]. Affected patients have generalized muscular hypertrophy and variable degrees of weakness. The skin and subcutaneous tissues have a thickened, doughy appearance. Serum muscle enzymes are usually elevated. Signs of hypothyroidism are usually readily apparent and longstanding in this setting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Proximal myopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients develop a slowly progressive, symmetric proximal muscle weakness. Shoulder and hip girdle muscles are most commonly affected. A single case of camptocormia due to hypothyroid myopathy involving primarily paraspinal muscles has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/11\">",
"     11",
"    </a>",
"    ]. Deep tendon reflexes appear \"hung-up\" due to delayed muscle relaxation.",
"   </p>",
"   <p>",
"    Occasionally hypothyroid myopathy is more fulminant, with marked serum muscle enzyme elevations, and a course that clinically resembles polymyositis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/5,12-15\">",
"     5,12-15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27722?source=see_link\">",
"     \"Clinical manifestations and diagnosis of adult dermatomyositis and polymyositis\"",
"    </a>",
"    .) Coexisting clinical signs and symptoms of hypothyroidism, including delayed relaxation phase of the deep tendon reflexes, lack of fibrillation potentials on electromyogram with relatively normal appearing motor units, and the absence of inflammatory changes on muscle biopsy, all help to distinguish hypothyroid myopathy from polymyositis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Rhabdomyolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been several case reports of extremely high elevations of serum CK and rhabdomyolysis associated with hypothyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/16-20\">",
"     16-20",
"    </a>",
"    ]. In some cases, rhabdomyolysis appears to have been precipitated by vigorous exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/17\">",
"     17",
"    </a>",
"    ] or concurrent statin therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]. Renal failure may occur as a secondary complication. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rhabdomyolysis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/0/33802?source=see_link&amp;anchor=H6#H6\">",
"     \"Statin myopathy\", section on 'Rhabdomyolysis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22632?source=see_link\">",
"     \"Clinical features and diagnosis of heme pigment-induced acute kidney injury (acute renal failure)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Myoedema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myoedema (or \"mounding\") refers to a small lump rising on the surface of a muscle when it is struck with a percussion hammer. This phenomenon, which is characteristic of hypothyroid myopathy, lasts for 30 to 60 seconds, and is due to a sustained contracture associated with delayed relaxation, because of slow reaccumulation of calcium by the sarcoplasmic reticulum [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Myoedema is not specific for hypothyroidism as it can also occur in malnutrition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any of the above clinical symptoms or signs should prompt an evaluation for hypothyroidism. TSH is the most sensitive screening test; this should be followed by a thyroxine level if the TSH is elevated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26744?source=see_link\">",
"     \"Diagnosis of and screening for hypothyroidism\"",
"    </a>",
"    .) This can be sufficient to diagnose hypothyroid muscle disease.",
"   </p>",
"   <p>",
"    Electromyography (EMG) can be helpful, as clinical symptoms and signs do not always distinguish hypothyroid myopathy from inflammatory myositis. The EMG may be normal in approximately half of hypothyroid patients with proximal muscle weakness, or it may demonstrate myopathic changes with increased low-amplitude, polyphasic potentials, and rarely increased insertional activity [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/4,5,26\">",
"     4,5,26",
"    </a>",
"    ]. Myoedema elicited with muscle percussion is electrically silent, distinguishing it from myotonia.",
"   </p>",
"   <p>",
"    Muscle biopsy is not usually required. When performed, the muscle biopsy may be normal or may show a variety of nonspecific changes, including [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/3,5,6,15,27,28\">",
"     3,5,6,15,27,28",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Type II fiber atrophy",
"     </li>",
"     <li>",
"      Type I fiber hypertrophy",
"     </li>",
"     <li>",
"      Increased numbers of internal nuclei",
"     </li>",
"     <li>",
"      Core-like structures in type I fibers",
"     </li>",
"     <li>",
"      Mitochondrial inclusions",
"     </li>",
"     <li>",
"      Glycogen accumulation",
"     </li>",
"     <li>",
"      Autophagic vacuoles",
"     </li>",
"     <li>",
"      Myofibrillar disorganization",
"     </li>",
"     <li>",
"      Mild, focal necrosis and degeneration of muscle fibers",
"     </li>",
"     <li>",
"      Occasional mild inflammatory infiltrates",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pathologic changes do not correlate well with the severity of the myopathy. They can resolve with treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of hypothyroid myopathy is not understood. A variety of effects on cellular function and metabolism occurring in hypothyroidism may contribute to the development of muscle symptoms and abnormal muscle function.",
"   </p>",
"   <p>",
"    Thyroxine (T4) affects energy metabolism. T4 deficiency leads to abnormal glycogenolysis, mitochondrial oxidative metabolism, and triglyceride turnover, which in turn impair muscle function [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. These effects are reflected in selective atrophy of Type II fibers, which are more dependent on glycolysis for their energy supply. Type I hypertrophy may be a compensatory response. With severe or prolonged oxidative damage, muscle cell injury and rhabdomyolysis may occur [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. The fact that the degree of weakness often does not correlate with the biochemical severity of hypothyroidism suggests that muscle injury, rather than impaired muscle function alone, plays a prominent role in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum muscle enzyme elevations in hypothyroidism, which occur in the absence of weakness, myalgias, or structural muscle abnormalities, appear to be due to changes in muscle cell membrane permeability, although the basis for this change is unknown [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/10\">",
"     10",
"    </a>",
"    ]. Reduced clearance of CK probably also plays a role [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Animal studies have also studied the role of thyroid hormone in gene expression of several skeletal muscle proteins, including myosin ATPase, AMP-activated protein kinase, and others [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/3,32-34\">",
"     3,32-34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Treatment and prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptoms and signs of hypothyroid myopathy respond to thyroid hormone replacement. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/53/43865?source=see_link\">",
"     \"Treatment of hypothyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    CK levels fall quickly with treatment, normalizing over a few weeks, generally before TSH levels normalize [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/5,35,36\">",
"     5,35,36",
"    </a>",
"    ]. Clinical symptoms, particularly weakness, recover more slowly. In one study, muscle complaints resolved in 79 percent of patients over a median time of 5.5 months. At one year, 21 percent of patients continued to complain of weakness [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/4\">",
"     4",
"    </a>",
"    ]. Persistent weakness at six years following initiation of treatment was described in one patient with severe hypothyroid myopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29093/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Muscle disease is a frequent complication of congenital and adult-onset hypothyroidism.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Myopathic weakness in congenital hypothyroidism occurs in association with other manifestations of cretinism, is accompanied by prominent muscle hypertrophy, and responds to thyroid replacement. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Congenital hypothyroidism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In adults, the severity of muscle disease can range from asymptomatic elevation of serum creatine kinase (CK) to disabling muscle weakness. Other manifestations include myalgias, muscle hypertrophy, and myoedema. Rhabdomyolysis has been reported but occurs rarely. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The presence of typical myopathic symptoms in the setting of hypothyroidism is sufficient to make the diagnosis. Electromyography is normal or shows myopathic changes. Muscle biopsy, if performed to exclude other conditions, shows nonspecific changes and only mild, if any, inflammation. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Thyroid replacement usually leads to resolution of laboratory abnormalities and symptoms over a few to several weeks. Weakness may recover more slowly, over several months, and, in severely affected patients, may persist even longer. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Treatment and prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/1\">",
"      NAJJAR SS, NACHMAN HS. THE KOCHER-DEBR'E-S'EM'ELAIGNE SYNDROME; HYPOTHYROIDISM WITH MUSCULAR \"HYPERTROPHY\". J Pediatr 1965; 66:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/2\">",
"      Spiro AJ, Hirano A, Beilin RL, Finkelstein JW. Cretinism with muscular hypertrophy (Kocher-Debr&eacute;-S&eacute;m&eacute;laigne syndrome). Histochemical and ultrastructural study of skeletal muscle. Arch Neurol 1970; 23:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/3\">",
"      Mastaglia FL, Ojeda VJ, Sarnat HB, Kakulas BA. Myopathies associated with hypothyroidism: a review based upon 13 cases. Aust N Z J Med 1988; 18:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/4\">",
"      Duyff RF, Van den Bosch J, Laman DM, et al. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psychiatry 2000; 68:750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/5\">",
"      Madariaga MG. Polymyositis-like syndrome in hypothyroidism: review of cases reported over the past twenty-five years. Thyroid 2002; 12:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/6\">",
"      McKeran RO, Slavin G, Ward P, et al. Hypothyroid myopathy. A clinical and pathologaical study. J Pathol 1980; 132:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/7\">",
"      Giampietro O, Clerico A, Buzzigoli G, et al. Detection of hypothyroid myopathy by measurement of various serum muscle markers--myoglobin, creatine kinase, lactate dehydrogenase and their isoenzymes. Correlations with thyroid hormone levels (free and total) and clinical usefulness. Horm Res 1984; 19:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/8\">",
"      Hekimsoy Z, Oktem IK. Serum creatine kinase levels in overt and subclinical hypothyroidism. Endocr Res 2005; 31:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/9\">",
"      Doran GR. Serum enzyme disturbances in thyrotoxicosis and myxoedema. J R Soc Med 1978; 71:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/10\">",
"      Klein I, Parker M, Shebert R, et al. Hypothyroidism presenting as muscle stiffness and pseudohypertrophy: Hoffmann's syndrome. Am J Med 1981; 70:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/11\">",
"      Kim JM, Song EJ, Seo JS, et al. Polymyositis-like syndrome caused by hypothyroidism, presenting as camptocormia. Rheumatol Int 2009; 29:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/12\">",
"      Hochberg MC, Koppes GM, Edwards CQ, et al. Hypothyroidism presenting as a polymyositis-like syndrome. Report of two cases. Arthritis Rheum 1976; 19:1363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/13\">",
"      Cabili S, Pines A, Kaplinsky N, Frankl O. Hypothyroidism masquerading as polymyositis. Postgrad Med J 1982; 58:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/14\">",
"      Salvarani C, Marcello N, Macchioni P, et al. Hypothyroidism simulating polymyositis. Report of two cases. Scand J Rheumatol 1988; 17:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/15\">",
"      Ciompi ML, Zuccotti M, Bazzichi L, Puccetti L. Polymyositis-like syndrome in hypothyroidism: report of two cases. Thyroidology 1994; 6:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/16\">",
"      Halverson PB, Kozin F, Ryan LM, Sulaiman AR. Rhabdomyolysis and renal failure in hypothyroidism. Ann Intern Med 1979; 91:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/17\">",
"      Riggs JE. Acute exertional rhabdomyolysis in hypothyroidism: the result of a reversible defect in glycogenolysis? Mil Med 1990; 155:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/18\">",
"      Sekine N, Yamamoto M, Michikawa M, et al. Rhabdomyolysis and acute renal failure in a patient with hypothyroidism. Intern Med 1993; 32:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/19\">",
"      Scott KR, Simmons Z, Boyer PJ. Hypothyroid myopathy with a strikingly elevated serum creatine kinase level. Muscle Nerve 2002; 26:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/20\">",
"      Finsterer J, St&ouml;llberger C, Grossegger C, Kroiss A. Hypothyroid myopathy with unusually high serum creatine kinase values. Horm Res 1999; 52:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/21\">",
"      Kiernan TJ, Rochford M, McDermott JH. Simvastatin induced rhabdomyolysis and an important clinical link with hypothyroidism. Int J Cardiol 2007; 119:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/22\">",
"      Yeter, E, Keles, T, Durmaz, T, Bozkurt, E. Rhabdomyolysis due to the additive effect of statin therapy: a case report. J Med Case Reports 2007; 10:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/23\">",
"      Antons KA, Williams CD, Baker SK, Phillips PS. Clinical perspectives of statin-induced rhabdomyolysis. Am J Med 2006; 119:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/24\">",
"      Mizusawa H, Takagi A, Sugita H, Toyokura Y. Mounding phenomenon: an experimental study in vitro. Neurology 1983; 33:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/25\">",
"      Mizusawa H, Takagi A, Nonaka I, et al. Muscular abnormalities in experimental hypothyroidism of rats with special reference to the mounding phenomenon. Exp Neurol 1984; 85:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/26\">",
"      Horak HA, Pourmand R. Endocrine myopathies. Neurol Clin 2000; 18:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/27\">",
"      Khaleeli AA, Griffith DG, Edwards RH. The clinical presentation of hypothyroid myopathy and its relationship to abnormalities in structure and function of skeletal muscle. Clin Endocrinol (Oxf) 1983; 19:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/28\">",
"      Evans RM, Watanabe I, Singer PA. Central changes in hypothyroid myopathy: a case report. Muscle Nerve 1990; 13:952.",
"     </a>",
"    </li>",
"    <li>",
"     Kaminski, HJ, Ruff, RL. Endocrine myopathies. In: Myology, 2d ed, Engel, AG, Franzini-Armstrong, C (Eds), McGraw-Hill, New York 1994. p.1741.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/30\">",
"      Monzani F, Caraccio N, Siciliano G, et al. Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism. J Clin Endocrinol Metab 1997; 82:3315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/31\">",
"      Argov Z, Arnold DL. MR spectroscopy and imaging in metabolic myopathies. Neurol Clin 2000; 18:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/32\">",
"      Biron R, Burger A, Chinet A, et al. Thyroid hormones and the energetics of active sodium-potassium transport in mammalian skeletal muscles. J Physiol 1979; 297:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/33\">",
"      Simonides WS, van Hardeveld C. The postnatal development of sarcoplasmic reticulum Ca2+ transport activity in skeletal muscle of the rat is critically dependent on thyroid hormone. Endocrinology 1989; 124:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/34\">",
"      Winder WW, Hardie DG, Mustard KJ, et al. Long-term regulation of AMP-activated protein kinase and acetyl-CoA carboxylase in skeletal muscle. Biochem Soc Trans 2003; 31:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/35\">",
"      Klein I, Mantell P, Parker M, Levey GS. Resolution of abnormal muscle enzyme studies in hypothyroidism. Am J Med Sci 1980; 279:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/36\">",
"      Khaleeli AA, Edwards RH. Effect of treatment on skeletal muscle dysfunction in hypothyroidism. Clin Sci (Lond) 1984; 66:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29093/abstract/37\">",
"      Torres CF, Moxley RT. Hypothyroid neuropathy and myopathy: clinical and electrodiagnostic longitudinal findings. J Neurol 1990; 237:271.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4837 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-60.18.131.125-6AD27EA953-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_26_29093=[""].join("\n");
var outline_f28_26_29093=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CONGENITAL HYPOTHYROIDISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ADULT HYPOTHYROIDISM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Elevation in serum creatine kinase",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Myalgia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Muscle hypertrophy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Proximal myopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Rhabdomyolysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Myoedema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22632?source=related_link\">",
"      Clinical features and diagnosis of heme pigment-induced acute kidney injury (acute renal failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27722?source=related_link\">",
"      Clinical manifestations and diagnosis of adult dermatomyositis and polymyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=related_link\">",
"      Clinical manifestations and diagnosis of rhabdomyolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14503?source=related_link\">",
"      Clinical manifestations of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26744?source=related_link\">",
"      Diagnosis of and screening for hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39864?source=related_link\">",
"      Iodine deficiency disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/46/36585?source=related_link\">",
"      Neurologic manifestations of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/0/33802?source=related_link\">",
"      Statin myopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/53/43865?source=related_link\">",
"      Treatment of hypothyroidism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_26_29094="Diuretic-induced hyperuricemia and gout";
var content_f28_26_29094=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diuretic-induced hyperuricemia and gout",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/26/29094/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29094/contributors\">",
"     Michael A Becker, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/26/29094/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29094/contributors\">",
"     Richard H Sterns, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/26/29094/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29094/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/26/29094/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H532274\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperuricemia is a relatively common finding in patients treated with a loop or thiazide diuretic and may, over a period of time, lead to gouty arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Diuretics reduce urate excretion by both directly and indirectly increasing urate reabsorption and decreasing urate secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/2,4-6\">",
"     2,4-6",
"    </a>",
"    ]; the effect is dose dependent (",
"    <a class=\"graphic graphic_figure graphicRef69912 \" href=\"UTD.htm?37/49/38685\">",
"     figure 1",
"    </a>",
"    ). Treatment of asymptomatic hyperuricemia is not necessary. If diuretic-induced gout occurs, it is usually treated with a urate lowering drug such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=see_link\">",
"     allopurinol",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    The pathogenesis, epidemiology, and an overview of treatment of diuretic-induced hyperuricemia and gout are presented in this topic. The pathophysiology, clinical manifestations, diagnosis, and treatment of acute gouty arthritis as well as the prevention of recurrent gout are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/43/28344?source=see_link\">",
"     \"Pathophysiology of gouty arthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4890?source=see_link\">",
"     \"Clinical manifestations and diagnosis of gout\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/24/17800?source=see_link\">",
"     \"Treatment of acute gout\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/26/36266?source=see_link\">",
"     \"Prevention of recurrent gout\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The proximal tubule is the major site of urate handling; both secretion and reabsorption occur in this segment, with the net effect being reabsorption of most of the filtered urate (",
"    <a class=\"graphic graphic_figure graphicRef83925 \" href=\"UTD.htm?22/40/23182\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef83926 \" href=\"UTD.htm?32/24/33166\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/2,7-14\">",
"     2,7-14",
"    </a>",
"    ]. Urate enters the proximal tubular cell from peritubular capillary blood through organic anion transporters 1 and 3 (OAT1 and OAT3) located on the basolateral membrane, and is secreted from the cell into the tubular fluid through solute carrier (SLC) family members SLC17A1 and SLC17A3, multidrug resistance protein 4 (MRP4), and ATP-binding cassette G2 (ABCG2) located on the luminal membrane. Urate reabsorption from the tubular fluid into the cell is mediated by urate transporter 1 (URAT1), OAT4, and OAT10, located on the luminal membrane, and from the cell back to the peritubular capillary blood through glucose transporter 9 (GLUT9) located on the basolateral membrane.",
"   </p>",
"   <p>",
"    Loop and thiazide diuretics decrease urate excretion by increasing net urate reabsorption; this can occur either by enhanced reabsorption or by reduced secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. Two mechanisms have been proposed as contributing to diuretic-induced hyperuricemia [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/2,4-6\">",
"     2,4-6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A direct effect of diuretics on promoting urate reabsorption by the proximal tubule.",
"     </li>",
"     <li>",
"      An indirect effect of diuretic-induced volume depletion on increasing urate reabsorption by the proximal tubule.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The degree of urate retention caused by diuretics is dose-dependent (",
"    <a class=\"graphic graphic_figure graphicRef69912 \" href=\"UTD.htm?37/49/38685\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/15\">",
"     15",
"    </a>",
"    ]. This contrasts with the dose response relationship between diuretics and blood pressure, in which 12.5 mg of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/4/8263?source=see_link\">",
"     hydrochlorothiazide",
"    </a>",
"    (or its equivalent) is often as effective as 50 mg (",
"    <a class=\"graphic graphic_figure graphicRef61248 \" href=\"UTD.htm?18/24/18829\">",
"     figure 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/63/15350?source=see_link\">",
"     \"Use of thiazide diuretics in patients with primary hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H532627\">",
"    <span class=\"h2\">",
"     Direct effect of diuretics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thiazide diuretics selectively enhance urate reabsorption by acting as a counter-ion for urate transport [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/5\">",
"     5",
"    </a>",
"    ]. First, the thiazide enters the proximal tubule cell from the peritubular capillary blood through the anion exchanger, OAT1, on the basolateral membrane. The diuretic is then released into the tubular fluid from the cell by the urate anion exchanger, OAT4, on the luminal membrane, driving reabsorption of urate. Thiazide diuretics also upregulate the sodium-hydrogen exchanger in the proximal tubule, thereby simulating pH-dependent OAT4 activity [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/16\">",
"     16",
"    </a>",
"    ]. In addition, both thiazide and loop diuretics may inhibit MRP4 on the luminal membrane, reducing secretion of urate into the tubular fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H532634\">",
"    <span class=\"h2\">",
"     Indirect effect of diuretic-induced volume depletion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Volume depletion appears to play an important role in diuretic-induced hyperuricemia, since urate retention does not occur if the diuretic-induced fluid losses are replaced [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/17\">",
"     17",
"    </a>",
"    ]. In addition, short- and long-term salt restriction produces significant hyperuricemia, which is reversed by salt loading [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/18-23\">",
"     18-23",
"    </a>",
"    ]. In various studies, the difference in serum uric acid between salt restricted and salt loaded subjects was 1.0 to 1.4",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/19-23\">",
"     19-23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    How volume depletion or salt restriction increases net urate reabsorption is unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/2\">",
"     2",
"    </a>",
"    ]. One possible explanation is the parallel relationship between sodium and urate reabsorption in the proximal tubule [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/2,24\">",
"     2,24",
"    </a>",
"    ]. Urate entry into the cell appears to occur by a variety of anion exchangers (",
"    <a class=\"graphic graphic_figure graphicRef83926 \" href=\"UTD.htm?32/24/33166\">",
"     figure 3",
"    </a>",
"    ), including urate-hydroxyl and urate-lactate exchangers [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/24\">",
"     24",
"    </a>",
"    ]. Both of these processes are dependent upon sodium transport.",
"   </p>",
"   <p>",
"    As an example, sodium-hydrogen exchangers in the luminal membrane are responsible for most of proximal bicarbonate reabsorption. The secretion of hydrogen ions by these transporters makes the cell more alkaline than the tubular lumen. The higher hydroxyl concentration in the cell provides a favorable gradient for hydroxyl exit, which can then drive urate reabsorption. Similarly, sodium-lactate cotransporters in the luminal membrane mediate lactate entry into the cell; this lactate can then be secreted back into the lumen by urate-lactate exchange.",
"   </p>",
"   <p>",
"    This indirect relationship between sodium and urate is important clinically because hypovolemia (in part via increased generation of angiotensin II) is associated with an appropriate increase in proximal sodium reabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/25\">",
"     25",
"    </a>",
"    ]. The rise in the activity of the sodium-hydrogen exchanger in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/25\">",
"     25",
"    </a>",
"    ] can then lead to increased urate-hydroxyl exchange and therefore enhanced urate reabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/2,24\">",
"     2,24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H532422\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thiazide diuretics are widely used in treatment of hypertension and are inexpensive and efficacious. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/63/15350?source=see_link\">",
"     \"Use of thiazide diuretics in patients with primary hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Diuretic use is an independent risk factor for incident [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/3\">",
"     3",
"    </a>",
"    ] and, likely, recurrent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/26\">",
"     26",
"    </a>",
"    ] gout, although the association in the case of recurrent gout warrants confirmation [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/27\">",
"     27",
"    </a>",
"    ]. In a large prospective cohort of men, for example, approximately 4700 participants without a prior history of gout used diuretics and nearly 3 percent of these men subsequently developed gout [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/3\">",
"     3",
"    </a>",
"    ]. Compared with men who did not use diuretics, those who did had a 77 percent higher relative risk of developing gout, even after controlling for conventional risk factors for gout such as adiposity, alcohol intake, kidney function, and hypertension.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW OF TREATMENT AND BENEFITS OF ANGIOTENSIN INHIBITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of diuretic-induced asymptomatic hyperuricemia is not necessary, even though the plasma urate concentration may exceed 15",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (893",
"    <span class=\"nowrap\">",
"     &micro;mol/L)",
"    </span>",
"    with diuretic therapy (particularly in patients with reduced renal perfusion due to underlying advanced heart failure) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/1,28\">",
"     1,28",
"    </a>",
"    ]. These patients are not at risk of uric acid precipitation in the tubules (uric acid nephropathy), since the elevation in the plasma urate level is due to an initial decrease in the rate of urate excretion. Prophylactic therapy with a potentially toxic drug (such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=see_link\">",
"     allopurinol",
"    </a>",
"    ) is not warranted to prevent a benign complication [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/24/1416?source=see_link\">",
"     \"Asymptomatic hyperuricemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A diagnosis of gout is",
"    <strong>",
"     not",
"    </strong>",
"    necessarily an indication for discontinuation of the diuretic, particularly if diuretic therapy is required for management of edema. However, if blood pressure control can be effectively and affordably achieved with an appropriate alternative agent, such as an angiotensin inhibitor or a dihydropyridine calcium channel blocker, then the diuretic can be stopped. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/29/36314?source=see_link\">",
"     \"Choice of therapy in primary (essential) hypertension: Recommendations\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most patients with diuretic-induced gout are treated with a urate lowering drug such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=see_link\">",
"     allopurinol",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/24/17800?source=see_link\">",
"     \"Treatment of acute gout\"",
"    </a>",
"    .) The concomitant use of a urate lowering agent and a diuretic may require a higher dose of the former to achieve the goal range for serum urate of &lt;6.0",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"    This combination was originally thought to impart a higher risk for allopurinol hypersensitivity reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/29\">",
"     29",
"    </a>",
"    ]. However, subsequent studies suggest that carefully titrating the urate lowering drug dose to achieve the goal urate level is likely",
"    <strong>",
"     not",
"    </strong>",
"    associated with a higher risk for this serious adverse event [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=see_link\">",
"     Allopurinol",
"    </a>",
"    dose titration can begin at a dose of 100 mg daily, with increments of 100 mg every two to four weeks until goal serum urate is achieved. Finally, patients with gout who are receiving diuretics for co-morbidities should be encouraged to adhere to the prescribed diuretic dose, since many gout flares occur in the setting of changes in serum urate levels that accompany intermittent diuretic use [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Benefits of angiotensin inhibition and losartan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with hypertension, the concurrent administration of an angiotensin converting enzyme inhibitor or an angiotensin II receptor blocker can minimize the diuretic-induced rise in plasma urate concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. This has been thought to be mediated by reversal of the stimulatory effect of angiotensin II on proximal sodium and urate reabsorption. (See",
"    <a class=\"local\" href=\"#H532634\">",
"     'Indirect effect of diuretic-induced volume depletion'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In addition,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/35/26168?source=see_link\">",
"     losartan",
"    </a>",
"    may have a more direct uricosuric effect, thereby inhibiting urate reabsorption and lowering the plasma urate concentration. This hypothesis is supported by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a randomized trial, 1161 patients with mild to moderate hypertension were randomly assigned to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/35/26168?source=see_link\">",
"       losartan",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/48/38663?source=see_link\">",
"       candesartan",
"      </a>",
"      , or losartan plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/4/8263?source=see_link\">",
"       hydrochlorothiazide",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/34\">",
"       34",
"      </a>",
"      ]. At 12 weeks, serum uric acid levels had decreased, stayed the same, or increased in those administered losartan, losartan plus thiazide, and candesartan, respectively. The combination of losartan plus the thiazide also provided superior blood pressure control to monotherapy.",
"     </li>",
"     <li>",
"      In a randomized trial that compared",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/35/26168?source=see_link\">",
"       losartan",
"      </a>",
"      with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/19/8505?source=see_link\">",
"       enalapril",
"      </a>",
"      , losartan but not enalapril lowered plasma urate levels; there were no other metabolic differences between the two drugs [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a small prospective study, four weeks of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/35/26168?source=see_link\">",
"       losartan",
"      </a>",
"      decreased serum uric acid levels by 9 percent, while",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/37/21079?source=see_link\">",
"       irbesartan",
"      </a>",
"      had no effect [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/36\">",
"       36",
"      </a>",
"      ]. The effect of losartan was seen at a dose of 50 mg once daily with no further reduction at a dose of 50 mg twice daily.",
"     </li>",
"     <li>",
"      In an in vitro study,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/35/26168?source=see_link\">",
"       losartan",
"      </a>",
"      but not other ARBs, inhibited the renal urate anion exchanger (URAT1) that partially mediates urate reabsorption [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although uric acid excretion is initially increased, there appears to be little risk of uric acid nephropathy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/35/26168?source=see_link\">",
"     losartan",
"    </a>",
"    because of a concurrent elevation in urine pH due to reduced bicarbonate reabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/32\">",
"     32",
"    </a>",
"    ]. As a result, there is little or no increase in the urinary excretion of insoluble undissociated uric acid; urinary urate excretion rises but this is associated with little stone potential. A new steady state for uric acid is achieved within seven days as uric acid excretion returns to baseline levels. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/57/27541?source=see_link\">",
"     \"Uric acid renal diseases\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/35/26168?source=see_link\">",
"     losartan",
"    </a>",
"    or an ACE inhibitor with a thiazide has the added advantages of a more potent antihypertensive effect than seen with either drug alone and of minimizing other metabolic effects of the diuretic, such as hypokalemia and hyperlipidemia [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29094/abstract/15,31\">",
"     15,31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/40/25224?source=see_link\">",
"     \"Renin-angiotensin system inhibition in the treatment of hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H533507\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hyperuricemia is a relatively common finding in patients treated with a loop or thiazide diuretic and may, over a period of time, lead to gouty arthritis. The degree of urate retention caused by diuretics is dose-dependent (",
"      <a class=\"graphic graphic_figure graphicRef69912 \" href=\"UTD.htm?37/49/38685\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H532274\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Loop and thiazide diuretics decrease urate excretion by increasing net urate reabsorption; this can occur either by enhanced reabsorption or by reduced secretion. Two mechanisms have been proposed as contributing to diuretic-induced hyperuricemia (see",
"      <a class=\"local\" href=\"#H1\">",
"       'Pathogenesis'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A direct effect of diuretics on promoting urate reabsorption by the proximal tubule. (See",
"      <a class=\"local\" href=\"#H532627\">",
"       'Direct effect of diuretics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An indirect effect of diuretic-induced volume depletion on increasing urate reabsorption by the proximal tubule. (See",
"      <a class=\"local\" href=\"#H532634\">",
"       'Indirect effect of diuretic-induced volume depletion'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diuretics may increase the relative risk of gout by nearly 80 percent; the absolute incidence of gout in patients taking diuretics may be close to 3 percent. (See",
"      <a class=\"local\" href=\"#H532422\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A diagnosis of gout is not necessarily an indication for discontinuation of the diuretic. However, if blood pressure control can be effectively and affordably achieved with an appropriate alternative agent, such as an angiotensin inhibitor or a dihydropyridine calcium channel blocker, then the diuretic can be stopped. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Overview of treatment and benefits of angiotensin inhibition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most patients with diuretic-induced gout are treated with a urate lowering drug such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=see_link\">",
"       allopurinol",
"      </a>",
"      . Treatment of diuretic-induced asymptomatic hyperuricemia is not necessary. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Overview of treatment and benefits of angiotensin inhibition'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      Among patients with hypertension, the concurrent administration of an angiotensin converting enzyme inhibitor or an angiotensin II receptor blocker, particularly",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/35/26168?source=see_link\">",
"       losartan",
"      </a>",
"      , can minimize the diuretic-induced rise in plasma urate concentration. The combination of losartan or an ACE inhibitor with a thiazide has the added advantages of a more potent antihypertensive effect than seen with either drug alone and of minimizing other metabolic effects of the diuretic, such as hypokalemia and hyperlipidemia. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Benefits of angiotensin inhibition and losartan'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/1\">",
"      Langford HG, Blaufox MD, Borhani NO, et al. Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program. Arch Intern Med 1987; 147:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/2\">",
"      Kahn AM. Effect of diuretics on the renal handling of urate. Semin Nephrol 1988; 8:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/3\">",
"      Choi HK, Atkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005; 165:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/4\">",
"      Weinman EJ, Eknoyan G, Suki WN. The influence of the extracellular fluid volume on the tubular reabsorption of uric acid. J Clin Invest 1975; 55:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/5\">",
"      Hagos Y, Stein D, Ugele B, et al. Human renal organic anion transporter 4 operates as an asymmetric urate transporter. J Am Soc Nephrol 2007; 18:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/6\">",
"      El-Sheikh AA, van den Heuvel JJ, Koenderink JB, Russel FG. Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4. Br J Pharmacol 2008; 155:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/7\">",
"      Enomoto A, Kimura H, Chairoungdua A, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002; 417:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/8\">",
"      Dalbeth N, Merriman T. Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout. Rheumatology (Oxford) 2009; 48:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/9\">",
"      Hosomi A, Nakanishi T, Fujita T, Tamai I. Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2. PLoS One 2012; 7:e30456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/10\">",
"      Iharada M, Miyaji T, Fujimoto T, et al. Type 1 sodium-dependent phosphate transporter (SLC17A1 Protein) is a Cl(-)-dependent urate exporter. J Biol Chem 2010; 285:26107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/11\">",
"      Jutabha P, Anzai N, Kitamura K, et al. Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate. J Biol Chem 2010; 285:35123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/12\">",
"      Russel FG, Koenderink JB, Masereeuw R. Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. Trends Pharmacol Sci 2008; 29:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/13\">",
"      Eraly SA, Vallon V, Rieg T, et al. Multiple organic anion transporters contribute to net renal excretion of uric acid. Physiol Genomics 2008; 33:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/14\">",
"      Caulfield MJ, Munroe PB, O'Neill D, et al. SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 2008; 5:e197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/15\">",
"      Carlsen JE, K&oslash;ber L, Torp-Pedersen C, Johansen P. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ 1990; 300:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/16\">",
"      Nijenhuis T, Vallon V, van der Kemp AW, et al. Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 2005; 115:1651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/17\">",
"      Steele TH, Oppenheimer S. Factors affecting urate excretion following diuretic administration in man. Am J Med 1969; 47:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/18\">",
"      Page LB, Damon A, Moellering RC Jr. Antecedents of cardiovascular disease in six Solomon Islands societies. Circulation 1974; 49:1132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/19\">",
"      Egan BM, Lackland DT. Biochemical and metabolic effects of very-low-salt diets. Am J Med Sci 2000; 320:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/20\">",
"      Masugi F, Ogihara T, Hashizume K, et al. Changes in plasma lipids and uric acid with sodium loading and sodium depletion in patients with essential hypertension. J Hum Hypertens 1988; 1:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/21\">",
"      Del R&iacute;o A, Rodr&iacute;guez-Villamil JL. Metabolic effects of strict salt restriction in essential hypertensive patients. J Intern Med 1993; 233:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/22\">",
"      Skrabal F, Aub&ouml;ck J, H&ouml;rtnagl H. Low sodium/high potassium diet for prevention of hypertension: probable mechanisms of action. Lancet 1981; 2:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/23\">",
"      Ruppert M, Diehl J, Kolloch R, et al. Short-term dietary sodium restriction increases serum lipids and insulin in salt-sensitive and salt-resistant normotensive adults. Klin Wochenschr 1991; 69 Suppl 25:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/24\">",
"      Kahn AM. Indirect coupling between sodium and urate transport in the proximal tubule. Kidney Int 1989; 36:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/25\">",
"      Cogan MG. Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 1990; 15:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/26\">",
"      Hunter DJ, York M, Chaisson CE, et al. Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study. J Rheumatol 2006; 33:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/27\">",
"      Janssens HJ, van de Lisdonk EH, Janssen M, et al. Gout, not induced by diuretics? A case-control study from primary care. Ann Rheum Dis 2006; 65:1080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/28\">",
"      Liang MH, Fries JF. Asymptomatic hyperuricemia: the case for conservative management. Ann Intern Med 1978; 88:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/29\">",
"      Hande KR, Noone RM, Stone WJ. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Am J Med 1984; 76:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/30\">",
"      Stamp LK, O'Donnell JL, Zhang M, et al. Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment. Arthritis Rheum 2011; 63:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/31\">",
"      Weinberger MH. Influence of an angiotensin converting-enzyme inhibitor on diuretic-induced metabolic effects in hypertension. Hypertension 1983; 5:III132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/32\">",
"      Shahinfar S, Simpson RL, Carides AD, et al. Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia. Kidney Int 1999; 56:1879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/33\">",
"      Soffer BA, Wright JT Jr, Pratt JH, et al. Effects of losartan on a background of hydrochlorothiazide in patients with hypertension. Hypertension 1995; 26:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/34\">",
"      Manolis AJ, Grossman E, Jelakovic B, et al. Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension. Losartan Trial Investigators. Clin Ther 2000; 22:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/35\">",
"      Tikkanen I, Omvik P, Jensen HA. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension. J Hypertens 1995; 13:1343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29094/abstract/36\">",
"      W&uuml;rzner G, Gerster JC, Chiolero A, et al. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout. J Hypertens 2001; 19:1855.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2380 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-14.112.150.18-587BC34546-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_26_29094=[""].join("\n");
var outline_f28_26_29094=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H533507\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H532274\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H532627\">",
"      Direct effect of diuretics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H532634\">",
"      Indirect effect of diuretic-induced volume depletion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H532422\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW OF TREATMENT AND BENEFITS OF ANGIOTENSIN INHIBITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Benefits of angiotensin inhibition and losartan",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H533507\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/2380\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/2380|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/49/38685\" title=\"figure 1\">",
"      Thiazide side effects and dose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/40/23182\" title=\"figure 2\">",
"      Mechanisms for urate secretion by the proximal tubule",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/24/33166\" title=\"figure 3\">",
"      Mechanisms for urate reabsorption by the proximal tubule",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/24/18829\" title=\"figure 4\">",
"      Antihypertensive dose-response to thiazide therapy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/24/1416?source=related_link\">",
"      Asymptomatic hyperuricemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/29/36314?source=related_link\">",
"      Choice of therapy in primary (essential) hypertension: Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4890?source=related_link\">",
"      Clinical manifestations and diagnosis of gout",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/43/28344?source=related_link\">",
"      Pathophysiology of gouty arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/26/36266?source=related_link\">",
"      Prevention of recurrent gout",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/40/25224?source=related_link\">",
"      Renin-angiotensin system inhibition in the treatment of hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/24/17800?source=related_link\">",
"      Treatment of acute gout",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/57/27541?source=related_link\">",
"      Uric acid renal diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/63/15350?source=related_link\">",
"      Use of thiazide diuretics in patients with primary hypertension",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_26_29095="Cystic fibrosis: Assessment and management of pancreatic insufficiency";
var content_f28_26_29095=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cystic fibrosis: Assessment and management of pancreatic insufficiency",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/26/29095/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29095/contributors\">",
"     Julie P Katkin, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29095/contributors\">",
"     Robert D Baker, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29095/contributors\">",
"     Susan S Baker, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/26/29095/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29095/contributors\">",
"     Kathleen J Motil, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29095/contributors\">",
"     George B Mallory, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29095/contributors\">",
"     William J Klish, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/26/29095/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29095/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/26/29095/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 12, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic insufficiency is the most common gastrointestinal complication of cystic fibrosis (CF), affecting approximately 85 percent of patients at some time in their lives [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/1\">",
"     1",
"    </a>",
"    ]. The major consequences of pancreatic insufficiency are due to fat malabsorption, which is caused by decreased production of pancreatic enzymes. As a result, patients are at risk for steatorrhea, malnutrition, and fat-soluble vitamin deficiencies.",
"   </p>",
"   <p>",
"    The pathogenesis, clinical manifestations, diagnosis, and management of pancreatic insufficiency in children with CF will be discussed here. The nutritional consequences of this disorder and other gastrointestinal complications of CF are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15754?source=see_link\">",
"     \"Cystic fibrosis: Nutritional issues\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=see_link\">",
"     \"Cystic fibrosis: Overview of gastrointestinal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traditionally, patients with CF have been categorized as pancreatic sufficient (10 to 15 percent) and pancreatic insufficient (the remainder) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/2\">",
"     2",
"    </a>",
"    ]. It is now clear that pancreatic function in CF varies along a spectrum from normal to severely deficient. Patients with normal or near normal pancreatic function tend to have less severe lung disease, and their nutritional status is better than their counterparts who have more severe pancreatic dysfunction. Pancreatic function also varies with the age of the patient, tending to worsen over time.",
"   </p>",
"   <p>",
"    Pancreatic function correlates strongly with genotype in patients with cystic fibrosis. Pancreatic insufficiency generally develops within the first few months of life in patients with two class I or II Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) mutations; these classes of mutation are characterized by defective production or processing of the CFTR protein, and include delta F508, N1303K, G542X, G551D and others [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/3\">",
"     3",
"    </a>",
"    ]. The presence of at least one \"mild\" mutation (such as R117H, 3171insC, A155P2, 138insL, 296 +IG-A, E92GK, E217G, 2789 +5G-A, or 3849 +10kbC-T and others) is generally associated with pancreatic sufficiency; however, patients with one \"mild\" mutation may still develop pancreatic insufficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/11/39095?source=see_link\">",
"     \"Cystic fibrosis: Genetics and pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Defective functioning of the CFTR leads to impaired transport of chloride and sodium. As a result, water does not diffuse out of the cell into the mucus layer, leading to viscous epithelial secretions. The resultant protein-rich, viscous exocrine fluid becomes inspissated in the proximal pancreatic ducts, leading to their obstruction.",
"   </p>",
"   <p>",
"    Pancreatic duct obstruction begins as early as the mid-trimester of gestation. The functioning acinar cells are gradually replaced with adipose tissue and, later, with fibrotic tissue. Patients with pancreatic insufficiency have decreased or absent levels of pancreatic amylase, lipase, colipase, and phospholipases. However, they have increased or normal production of salivary and brush border amylases, brush border peptidases, and lingual lipases, which account for increased monosaccharide absorption, increased amino acid absorption, and some residual lipolysis, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/1\">",
"     1",
"    </a>",
"    ]. Because of the CFTR mutation, patients with CF also have decreased amounts of bicarbonate in their pancreatic secretions, which may further contribute to the enzyme deficiency since remaining enzymes may not function optimally in an acidic environment [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, patients with CF may have primary abnormalities in fatty acid metabolism, as have been noted in biopsies of CFTR-expressing tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/6\">",
"     6",
"    </a>",
"    ]. These changes, which result in increased tissue levels of arachidonic acid, are also present in the mouse model of CF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately two-thirds of infants with CF have pancreatic insufficiency at birth [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/7\">",
"     7",
"    </a>",
"    ]. If CF is not diagnosed through newborn screening, it will usually be diagnosed because of failure to thrive, protein-calorie malnutrition, or rectal prolapse, typically presenting before the age of one year [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/8\">",
"     8",
"    </a>",
"    ]. Even individuals with relatively normal pancreatic function at birth will usually develop pancreatic dysfunction and insufficiency over time, but clinically apparent protein and fat deficiencies do not occur until over 90 percent of pancreatic function is lost.",
"   </p>",
"   <p>",
"    Patients with pancreatic insufficiency characteristically have frequent, bulky, foul-smelling stools that may be oily. Older children may also report that their stools float (reflecting their high fat content). These features may not be as evident in infants since they have wide variation in stool patterns at baseline [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/7\">",
"     7",
"    </a>",
"    ]. Abdominal distention may also be present [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/9\">",
"     9",
"    </a>",
"    ]. These characteristics, all suggestive of fat malabsorption, are not specific to pancreatic insufficiency due to CF; they can also be seen in patients with small bowel mucosal disease, and other causes of pancreatic insufficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/7\">",
"     7",
"    </a>",
"    ]. Moreover, these symptoms are subjective and nonspecific, so laboratory testing should usually be performed to determine if fat malabsorption is present. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Fat malabsorption can develop at variable time points in the course of CF. As a result, patients with CF may require modification of their therapy as the disease progresses. It is imperative that the clinician inquire about signs and symptoms of pancreatic insufficiency at every visit. Patients who are considered to be pancreatic sufficient should undergo laboratory screening (eg, fecal elastase and serum levels of fat-soluble vitamins) periodically to assess fat absorption [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Individuals with cystic fibrosis involving the pancreas also may develop pancreatic endocrine insufficiency, causing CF related diabetes. Others may develop pancreatitis, which is most common among patients with pancreatic sufficiency at diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=see_link&amp;anchor=H22#H22\">",
"     \"Cystic fibrosis: Overview of gastrointestinal disease\", section on 'CF-related diabetes'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=see_link&amp;anchor=H21#H21\">",
"     \"Cystic fibrosis: Overview of gastrointestinal disease\", section on 'Pancreatitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because a variety of factors can contribute to growth failure and abdominal symptoms, we suggest an objective assessment of pancreatic insufficiency (eg, fecal elastase testing) to document the need for pancreatic enzyme replacement therapy (PERT). This approach is particularly appropriate for patients identified by newborn screening programs [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/10\">",
"     10",
"    </a>",
"    ]. Approximately 60 percent of infants with CF have pancreatic insufficiency at birth, and 90 percent have developed pancreatic insufficiency by one year of age [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients with CF and typical symptoms of pancreatic insufficiency (growth failure and symptoms of steatorrhea), or for those with two CFTR mutations known to be associated with pancreatic insufficiency, it is reasonable to begin PERT therapy prior to formal documentation of pancreatic insufficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/10\">",
"     10",
"    </a>",
"    ]&nbsp;(see",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above). In this case, pancreatic insufficiency should be confirmed after starting PERT therapy. If such patients do not respond to PERT treatment, alternate causes of abdominal symptoms, including the possibility of constipation or small intestine bacterial overgrowth, should be sought and treated.",
"   </p>",
"   <p>",
"    Individuals with normal fecal elastase or fecal fat testing and no clinical evidence of malabsorption do not require PERT. In particular, patients with one or two CFTR mutations known to be associated with pancreatic",
"    <strong>",
"     sufficiency",
"    </strong>",
"    should not be given PERT unless there is clear evidence of fat malabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/10\">",
"     10",
"    </a>",
"    ]&nbsp;(see",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above). Because pancreatic insufficiency may develop over time, these patients should be monitored with periodic measurements of fecal elastase and for clinical symptoms of fat malabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Fecal elastase",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurements of fecal elastase provide a useful index of exocrine pancreatic function [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/2,13,14\">",
"     2,13,14",
"    </a>",
"    ]. We suggest that this test be performed for each patient with CF to help determine the need for pancreatic enzyme replacement therapy (PERT). Because it is not a quantitative test, it is not valuable as a measure to monitor the effectiveness of PERT [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fecal elastase values less than 200",
"    <span class=\"nowrap\">",
"     micrograms/gram",
"    </span>",
"    indicate pancreatic insufficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/10,12\">",
"     10,12",
"    </a>",
"    ]. Fecal elastase testing has high sensitivity and specificity in detecting severe pancreatic insufficiency in children with CF. However, the test performs less well for detecting mild or moderate pancreatic insufficiency, and also displays variability with repeat testing in this type of patient [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. Thus, results of fecal elastase testing should be combined with clinical observations, including nutritional status and symptoms of steatorrhea, to determine the need for PERT.",
"   </p>",
"   <p>",
"    Determination of fecal elastase can be performed on a single stool sample that requires no special storage, and does not require discontinuation of pancreatic enzymes. Thus, it is more clinically practical than a 72-hour collection of fecal fat or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/49/28435?source=see_link\">",
"     secretin",
"    </a>",
"    stimulation tests, which are discussed below.",
"   </p>",
"   <p>",
"    The results of fecal elastase testing correlate well with the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/49/28435?source=see_link\">",
"     secretin",
"    </a>",
"    stimulation test [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/17\">",
"     17",
"    </a>",
"    ]. The sensitivity and specificity of fecal elastase in detecting severe pancreatic insufficiency in children with CF range from 89 to 100 percent and 86 to 100 percent, respectively, depending upon the cut-off values (&lt;100 versus &lt;200",
"    <span class=\"nowrap\">",
"     mcg/g",
"    </span>",
"    stool) and the gold-standard for diagnosis (eg, secretin stimulation, fecal fat collection, clinical evaluation) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/14,17-20\">",
"     14,17-20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Other tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two approaches for the diagnosis of pancreatic insufficiency, which can be categorized as direct and indirect tests. The direct tests are more accurate across the entire range of pancreatic function but are invasive and expensive [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/9,13\">",
"     9,13",
"    </a>",
"    ]. The diagnostic accuracy of these tests is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/25/34201?source=see_link\">",
"     \"Pancreatic exocrine function tests\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Direct tests involve the collection of duodenal aspirates after stimulation of the pancreas with a secretagogue, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/49/28435?source=see_link\">",
"       secretin",
"      </a>",
"      . The basis for this test is that secretin causes the secretion of bicarbonate-rich fluid from the pancreas. A peak bicarbonate concentration of less than 80",
"      <span class=\"nowrap\">",
"       mEq/L",
"      </span>",
"      is consistent with pancreatic exocrine insufficiency.",
"     </li>",
"     <li>",
"      Indirect tests are performed on stool samples to measure the concentrations of pancreatic enzymes, such as trypsin, chymotrypsin, and elastase or fat. The most commonly used indirect test is the collection of a 72-hour stool sample with a careful dietary inventory (",
"      <a class=\"graphic graphic_table graphicRef67223 \" href=\"UTD.htm?19/22/19819\">",
"       table 1",
"      </a>",
"      ). Fecal fat excretion is considered abnormal if it is more than 7 percent of the fat intake [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/8,9\">",
"       8,9",
"      </a>",
"      ]. For infants under 6 months of age, fecal fat excretion of up to 15 percent of total fat intake can be normal [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/10\">",
"       10",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/21/38232?source=see_link\">",
"       \"Clinical features and diagnosis of malabsorption\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Although measurement of 72-hour fecal fat excretion is the most commonly used indirect test, it is not ideal [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/2\">",
"       2",
"      </a>",
"      ]. The 72 hour stool collection procedure is onerous for most patients, and PERT must be discontinued during the collection period. Furthermore, the test does not distinguish between hepatobiliary, mucosal, and pancreatic causes of fat malabsorption.",
"      <br/>",
"      <br/>",
"      Because of these considerations, measurement of fecal elastase, chymotrypsin, or lipase are frequently used. These tests can be performed on single samples of stool. Fecal elastase appears to be the most sensitive of these tests [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/21,22\">",
"       21,22",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Fecal elastase'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Pancreatic enzyme replacement therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mainstay of treatment for pancreatic insufficiency in CF is pancreatic enzyme replacement therapy (PERT). Multiple formulations of pancreatic enzymes exist with different combinations of lipase, protease, and amylase (",
"    <a class=\"graphic graphic_table graphicRef57416 \" href=\"UTD.htm?14/29/14814\">",
"     table 2",
"    </a>",
"    ). Preparations with equivalent doses of enzymes may still differ in their effects. Patients should be reevaluated after any changes in the enzyme preparation or dose. The guidelines endorsed by the CF foundation do not recommend use of generic or non-proprietary preparations [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/10,23\">",
"     10,23",
"    </a>",
"    ]. Individual product contents, preparation type, and units of activity vary by country, so local product information should be consulted before using or changing products. (See",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/14/8422?source=see_link\">",
"     \"Pancrelipase: Pediatric drug information\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    Pancreatic enzymes are extracts of porcine pancreas containing varying amounts of lipase, protease, and amylase. Most enzyme preparations are in the form of granules or microspheres that are coated with a pH-sensitive material that protects the enzyme from destruction by acid in the stomach (",
"    <a class=\"graphic graphic_table graphicRef57416 \" href=\"UTD.htm?14/29/14814\">",
"     table 2",
"    </a>",
"    ). The coating dissolves in the alkaline milieu of the duodenum, releasing the enzyme [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    PERT clearly improves fecal fat absorption in most patients with pancreatic insufficiency. This was demonstrated by a double-blind placebo-controlled trial in which PERT increased the coefficient of fat absorption (CFA), decreased stool frequency, and improved stool consistency in both adult and pediatric patients with CF [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/25\">",
"     25",
"    </a>",
"    ]. The effectiveness of PERT in an individual patient may be limited by variations in the pH of the gastrointestinal tract in CF from patient to patient and also varies over time in the same patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Dosing considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most pancreatic enzyme preparations consist of capsules containing microspheres. Older children and adults generally swallow the capsule whole. For younger children and infants, enzymes are administered by opening the capsule and sprinkling the microspheres on food. The food should be soft so that it does not require chewing, and should be relatively acidic to avoid dissolving the enteric coating (eg, applesauce, gelatins, pureed apricot, bananas, or sweet potatoes).",
"   </p>",
"   <p>",
"    Dosing of pancreatic enzymes is based upon the units of lipase determined as a function of patient weight or dietary fat intake.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The weight-based method can generally be used at any age. The starting dose for children less than four years of age is 1000 lipase",
"      <span class=\"nowrap\">",
"       units/kg",
"      </span>",
"      body weight per meal, and for children older than four years of age is 500 lipase",
"      <span class=\"nowrap\">",
"       units/kg",
"      </span>",
"      body weight per meal [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/23,26,27\">",
"       23,26,27",
"      </a>",
"      ]. Smaller doses usually are offered with fat-containing snacks eaten between meals. Dosing is increased based upon symptoms of pancreatic insufficiency to a maximum of 2500 lipase",
"      <span class=\"nowrap\">",
"       units/kg",
"      </span>",
"      body weight per meal to avoid fibrosing colonopathy.",
"     </li>",
"     <li>",
"      The fat-based method is useful for infants who take a known amount of formula or in patients who receive tube feedings. The dose starts at approximately 2000 lipase",
"      <span class=\"nowrap\">",
"       units/120",
"      </span>",
"      ml of formula or per breast feeding (about 1600 lipase",
"      <span class=\"nowrap\">",
"       units/gram",
"      </span>",
"      of fat ingested per day). The dose can be adjusted up to no more than 2,500 lipase units per kg body weight per feeding, with a maximum daily dose of 10,000 lipase units per kg [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients who fail to respond to maximal doses of supplemental pancreatic enzymes may benefit from reduction of gastric acidity by addition of histamine 2 receptor antagonists, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/56/42888?source=see_link\">",
"     ranitidine",
"    </a>",
"    . The reason for this improvement is that some enzyme products require a higher pH for the entire product to be released [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/28\">",
"     28",
"    </a>",
"    ], but the practice is based on limited evidence [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adjustment of PERT doses is typically guided by patient-reported symptoms of malabsorption, such as diarrhea (foul smelling, greasy, bulky stools), bloating, gassiness, and abdominal pain. Unfortunately, symptoms do not correlate well with the efficacy of PERT in individual patients [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. Thus, if PERT dosing appears to be adequate, alternate causes of abdominal symptoms, including the possibility of constipation or small intestine bacterial overgrowth, should be sought and treated. There is no evidence that constipation is caused by higher enzyme doses.",
"   </p>",
"   <p>",
"    There are no accurate and clinically practical laboratory methods for quantifying fat malabsorption. The 72-hour fecal fat determination is currently the only clinical method of quantifying fat malabsorption (",
"    <a class=\"graphic graphic_table graphicRef67223 \" href=\"UTD.htm?19/22/19819\">",
"     table 1",
"    </a>",
"    ), but this technique is seldom used because it is tedious and unpleasant for caretakers, and results are not particularly accurate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Adverse effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prolonged contact of the enzyme supplements with oral mucosa may cause ulcers, especially with the powdered form. Thus, the microspheres should preferably be administered with food (eg, applesauce), even in infants. To further prevent this complication, the mouth should be rinsed after administration, particularly in infants [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Excessive doses of PERT can cause fibrosing colonopathy, characterized by inflammation and strictures. The risk can be reduced significantly by limiting the dose of supplemental pancreatic enzymes to less than 2500 lipase",
"    <span class=\"nowrap\">",
"     units/kg",
"    </span>",
"    body weight per meal, or less than 10,000 lipase",
"    <span class=\"nowrap\">",
"     units/kg",
"    </span>",
"    body weight per day [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/27,31\">",
"     27,31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Growth failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic insufficiency in CF may cause malabsorption of fat and other macronutrients, which is particularly problematic because the disease may also cause increased energy requirements. Thus it is imperative that growth parameters are followed closely. Weight, and length or height are measured every three months in all patients, and",
"    <span class=\"nowrap\">",
"     weight/length",
"    </span>",
"    or body mass index (BMI) is calculated; mid-arm circumference and triceps skin-fold thickness is also measured annually in children over one year of age, and head circumference is monitored every three months in those younger than two years of age (",
"    <a class=\"graphic graphic_table graphicRef76676 \" href=\"UTD.htm?24/26/25005\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15754?source=see_link&amp;anchor=H4#H4\">",
"     \"Cystic fibrosis: Nutritional issues\", section on 'Assessing and monitoring nutrition'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many patients with CF require dietary supplementation either by mouth or by tube feeds to maintain adequate nutrition [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29095/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15754?source=see_link&amp;anchor=H23#H23\">",
"     \"Cystic fibrosis: Nutritional issues\", section on 'Nutrition support'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Fat-soluble vitamin deficiencies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic insufficiency and CF-related liver disease lead to fat malabsorption that predisposes patients to deficiencies of the fat-soluble vitamins: vitamins A, D, E, and K. Requirements for these nutrients and monitoring recommendations for patients with CF are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15754?source=see_link&amp;anchor=H14#H14\">",
"     \"Cystic fibrosis: Nutritional issues\", section on 'Fat soluble vitamins'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Bone disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone disease, characterized by decreased mineral density, increased fracture rates, and kyphosis is common in patients with cystic fibrosis, even among those with pancreatic sufficiency. Important contributors to the problem include malabsorption of calcium, magnesium, and fat-soluble vitamins (vitamin D and possibly vitamin K). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15754?source=see_link&amp;anchor=H8#H8\">",
"     \"Cystic fibrosis: Nutritional issues\", section on 'Bone disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/57/20371?source=see_link\">",
"       \"Patient information: Cystic fibrosis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most patients with CF have some degree of pancreatic exocrine dysfunction. This problem tends to worsen over time, and at least 85 percent develop clinically important pancreatic insufficiency. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All patients with CF should be screened for pancreatic insufficiency; this is generally done with fecal elastase testing. Those with normal results should be retested periodically to monitor for development of pancreatic insufficiency. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with pancreatic insufficiency (as determined by fecal elastase testing or other measure) should be treated with pancreatic enzyme replacement therapy (PERT) (",
"      <a class=\"graphic graphic_table graphicRef57416 \" href=\"UTD.htm?14/29/14814\">",
"       table 2",
"      </a>",
"      ). Dosing is generally estimated by the patient's weight and adjusted depending on the patient's response and symptoms. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Dosing considerations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prolonged contact of the enzyme supplements with oral mucosa may cause ulcers and should be avoided. PERT doses should be limited to 2500 lipase",
"      <span class=\"nowrap\">",
"       units/kg",
"      </span>",
"      body weight per meal to avoid fibrosing colonopathy. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Adverse effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Even with optimal management, patients with pancreatic insufficiency are at risk for growth failure, deficiencies of fat-soluble vitamins and other micronutrients, and bone disease. Prevention and monitoring for these complications is discussed separately. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Complications'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15754?source=see_link\">",
"       \"Cystic fibrosis: Nutritional issues\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/1\">",
"      Nousia-Arvanitakis S. Cystic fibrosis and the pancreas: recent scientific advances. J Clin Gastroenterol 1999; 29:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/2\">",
"      Borowitz D, Baker SS, Duffy L, et al. Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis. J Pediatr 2004; 145:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/3\">",
"      Walkowiak J, Sands D, Nowakowska A, et al. Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations. J Pediatr Gastroenterol Nutr 2005; 40:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/4\">",
"      Walkowiak J, Herzig KH, Witt M, et al. Analysis of exocrine pancreatic function in cystic fibrosis: one mild CFTR mutation does not exclude pancreatic insufficiency. Eur J Clin Invest 2001; 31:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/5\">",
"      Kristidis P, Bozon D, Corey M, et al. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet 1992; 50:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/6\">",
"      Freedman SD, Blanco PG, Zaman MM, et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 2004; 350:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/7\">",
"      Colin AA, Wohl ME. Cystic fibrosis. Pediatr Rev 1994; 15:192.",
"     </a>",
"    </li>",
"    <li>",
"     Ferry, G, Klish, WJ, Borowitz, D, et al. Consensus Conference: Gastrointestinal Problems in Cystic Fibrosis. In: Clinical Practice Guidelines for Cystic Fibrosis, vol II, Cystic Fibrosis Foundation, Bethesda, MD, 1991.",
"    </li>",
"    <li>",
"     Taussig, LM, Landau, LI, eds. Pediatric Respiratory Medicine, Mosby, St. Louis 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/10\">",
"      Cystic Fibrosis Foundation, Borowitz D, Robinson KA, et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr 2009; 155:S73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/11\">",
"      Bronstein MN, Sokol RJ, Abman SH, et al. Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis. J Pediatr 1992; 120:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/12\">",
"      O'Sullivan BP, Baker D, Leung KG, et al. Evolution of Pancreatic Function during the First Year in Infants with Cystic Fibrosis. J Pediatr 2013; 162:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/13\">",
"      Walkowiak J. Assessment of maldigestion in cystic fibrosis. J Pediatr 2004; 145:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/14\">",
"      Cade A, Walters MP, McGinley N, et al. Evaluation of fecal pancreatic elastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis. Pediatr Pulmonol 2000; 29:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/15\">",
"      Weintraub A, Blau H, Mussaffi H, et al. Exocrine pancreatic function testing in patients with cystic fibrosis and pancreatic sufficiency: a correlation study. J Pediatr Gastroenterol Nutr 2009; 48:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/16\">",
"      Meyts I, Wuyts W, Proesmans M, De Boeck K. Variability of fecal pancreatic elastase measurements in cystic fibrosis patients. J Cyst Fibros 2002; 1:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/17\">",
"      Walkowiak J, Cichy WK, Herzig KH. Comparison of fecal elastase-1 determination with the secretin-cholecystokinin test in patients with cystic fibrosis. Scand J Gastroenterol 1999; 34:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/18\">",
"      Walkowiak J. Faecal elastase-1: clinical value in the assessment of exocrine pancreatic function in children. Eur J Pediatr 2000; 159:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/19\">",
"      Beharry S, Ellis L, Corey M, et al. How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease? J Pediatr 2002; 141:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/20\">",
"      Borowitz D, Lin R, Baker SS. Comparison of monoclonal and polyclonal ELISAs for fecal elastase in patients with cystic fibrosis and pancreatic insufficiency. J Pediatr Gastroenterol Nutr 2007; 44:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/21\">",
"      Walkowiak J, Herzig KH, Strzykala K, et al. Fecal elastase-1 is superior to fecal chymotrypsin in the assessment of pancreatic involvement in cystic fibrosis. Pediatrics 2002; 110:e7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/22\">",
"      Walkowiak J, Lisowska A, Przyslawski J, et al. Faecal elastase-1 test is superior to faecal lipase test in the assessment of exocrine pancreatic function in cystic fibrosis. Acta Paediatr 2004; 93:1042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/23\">",
"      Stallings VA, Stark LJ, Robinson KA, et al. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc 2008; 108:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/24\">",
"      Kraisinger M, Hochhaus G, Stecenko A, et al. Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations. J Clin Pharmacol 1994; 34:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/25\">",
"      Stern RC, Eisenberg JD, Wagener JS, et al. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency. Am J Gastroenterol 2000; 95:1932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/26\">",
"      Erdman SH. Nutritional imperatives in cystic fibrosis therapy. Pediatr Ann 1999; 28:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/27\">",
"      Borowitz DS, Grand RJ, Durie PR. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr 1995; 127:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/28\">",
"      Wallace CS, Hall M, Kuhn RJ. Pharmacologic management of cystic fibrosis. Clin Pharm 1993; 12:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/29\">",
"      Ng SM, Francini AJ. Drug therapies for reducing gastric acidity in people with cystic fibrosis. Cochrane Database Syst Rev 2012; 4:CD003424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/30\">",
"      Baker SS, Borowitz D, Duffy L, et al. Pancreatic enzyme therapy and clinical outcomes in patients with cystic fibrosis. J Pediatr 2005; 146:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29095/abstract/31\">",
"      Baker SS. Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis. Ther Clin Risk Manag 2008; 4:1079.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5885 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-83.177.194.223-4F5D24ED7D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_26_29095=[""].join("\n");
var outline_f28_26_29095=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Fecal elastase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Other tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Pancreatic enzyme replacement therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Dosing considerations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Growth failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Fat-soluble vitamin deficiencies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Bone disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5885\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5885|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/22/19819\" title=\"table 1\">",
"      72h fecal fat test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/29/14814\" title=\"table 2\">",
"      PERT preparations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/26/25005\" title=\"table 3\">",
"      CF nutrition monitor",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/21/38232?source=related_link\">",
"      Clinical features and diagnosis of malabsorption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/11/39095?source=related_link\">",
"      Cystic fibrosis: Genetics and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15754?source=related_link\">",
"      Cystic fibrosis: Nutritional issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=related_link\">",
"      Cystic fibrosis: Overview of gastrointestinal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/25/34201?source=related_link\">",
"      Pancreatic exocrine function tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/14/8422?source=related_link\">",
"      Pancrelipase: Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/57/20371?source=related_link\">",
"      Patient information: Cystic fibrosis (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_26_29096="Tuberculosis in pregnancy";
var content_f28_26_29096=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Tuberculosis in pregnancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/26/29096/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29096/contributors\">",
"     Lloyd N Friedman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29096/contributors\">",
"     Lynn T Tanoue, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/26/29096/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29096/contributors\">",
"     C Fordham von Reyn, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29096/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/26/29096/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29096/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/26/29096/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 8, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prenatal care presents a unique opportunity for evaluation and management of latent and active tuberculosis (TB) in pregnant women [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/1\">",
"     1",
"    </a>",
"    ]. Routine",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    (TST) screening is not indicated for all pregnant women. However, individuals with an increased risk of tuberculosis may seek medical care only during pregnancy (such as foreign born individuals within five years of immigration from TB endemic countries or individuals with HIV infection) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18649?source=see_link\">",
"     \"Epidemiology of tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The pathogenesis of tuberculosis infection and disease in pregnant women is similar to that in nonpregnant women [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. There is no firm evidence that the risk of new infection or reactivation of tuberculosis in pregnant women is significantly different from matched controls. However, tuberculosis in pregnant women can present insidiously, since symptoms of malaise and fatigue may be attributed to pregnancy rather than disease [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/5\">",
"     5",
"    </a>",
"    ]. In addition, during pregnancy it can be difficult to recognize weight loss. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22378?source=see_link\">",
"     \"Microbiology and pathogenesis of tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Since pregnancy has not been shown to increase the risk of TB, the epidemiology of TB in pregnancy is a reflection of the general incidence of disease [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/6\">",
"     6",
"    </a>",
"    ]. This also is true in HIV-infected women, as shown in a group of predominantly HIV-infected pregnant women in New York City during 1991 to 1992, where the rate of TB was 94.8 per 100,000 deliveries [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Issues related to diagnosis and treatment of latent TB infection and active TB disease in pregnant women will be reviewed here. Issues related to the management of latent and active TB in nonpregnant patients are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20648?source=see_link\">",
"     \"Diagnosis of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link\">",
"     \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/21/19802?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LATENT TB",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy has not been shown to influence the pathogenesis of TB or the likelihood of progression from latent to active disease, nor has it been shown to affect the response to treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine testing for latent tuberculosis in pregnant women is not indicated. Testing should be performed during pregnancy only if there is an indication for prompt treatment of latent tuberculosis infection (LTBI); a decision to test presupposes a decision to treat promptly if the test is positive. However, contact with the health system during pregnancy is an opportunity to identify patients at risk for LTBI who should be evaluated further following pregnancy. Appropriate groups for testing include those at high risk for progression of LTBI to active disease, especially those who are significantly immunocompromised (eg, HIV infection, immunosuppressive therapy) or those who have been infected with TB recently [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20648?source=see_link\">",
"     \"Diagnosis of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If indicated, testing for LTBI prior to pregnancy is preferred (if feasible); this allows opportunity for counseling about the risk of becoming pregnant while on therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/11\">",
"     11",
"    </a>",
"    ]. If treatment for LTBI is initiated and the patient becomes pregnant subsequently, therapy should be continued [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/12\">",
"     12",
"    </a>",
"    ]. In the absence of major risk factors for progression to active infection during pregnancy, testing and treatment for LTBI in those for whom targeted testing is indicated should be delayed until three months after delivery to minimize risk of adverse drug effects. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Toxicity and monitoring'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Diagnostic tools for latent tuberculosis include tuberculin skin testing (TST) and interferon gamma release assays (IGRAs). Tuberculin skin testing can be performed safely in pregnant women, and pregnancy does not alter the response to the TST [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/10,13\">",
"     10,13",
"    </a>",
"    ]. Definitions of positive skin tests are outlined in the Table (",
"    <a class=\"graphic graphic_table graphicRef67357 \" href=\"UTD.htm?31/0/31756\">",
"     table 1",
"    </a>",
"    ). Interferon gamma release assays are also safe in pregnancy and likely as effective for diagnosis of LTBI in pregnancy as in other circumstances; data are limited [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/14-17\">",
"     14-17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/18/37160?source=see_link\">",
"     \"Interferon-gamma release assays for diagnosis of latent tuberculosis infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with positive LTBI screening results (",
"    <a class=\"graphic graphic_table graphicRef67357 \" href=\"UTD.htm?31/0/31756\">",
"     table 1",
"    </a>",
"    ) must undergo clinical evaluation to rule out active tuberculosis. This includes evaluation for symptoms (eg, fever, cough, weight loss) and radiographic examination of the chest (with appropriate shielding). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/18/37160?source=see_link\">",
"     \"Interferon-gamma release assays for diagnosis of latent tuberculosis infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testing and treatment for latent tuberculosis infection should be pursued during pregnancy only if there is an indication for prompt management of LTBI (usually in recent infection or immunocompromised hosts); a decision to test presupposes a decision to treat promptly if the test is positive (even during the first trimester). Therefore, patients appropriately targeted for LTBI screening with positive TST results should initiate treatment during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/10\">",
"     10",
"    </a>",
"    ]. If treatment for LTBI is initiated prior to pregnancy for the usual indications noted in the CDC statement [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/10\">",
"     10",
"    </a>",
"    ], and the patient becomes pregnant subsequently, therapy should be continued [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Diagnosis'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20648?source=see_link\">",
"     \"Diagnosis of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, if a skin test has been performed in the absence of an indication for prompt LTBI management and is positive, a chest radiograph should be performed. Delaying therapy is appropriate for patients with positive TST in the absence of a major risk factor for progression to active disease, ie, recent infection or immunosuppression. Therapy may be initiated three months after delivery to minimize concern for hepatitis in the postpartum period. If treatment for LTBI is deferred until after delivery, repeat evaluation for active disease, including chest x-ray, should be performed to confirm that active tuberculosis did not develop in the intervening time between diagnosis and treatment. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Toxicity and monitoring'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Adherence may suffer when patients identified with LTBI during pregnancy delay treatment. In a study evaluating 393 women with LTBI during pregnancy who delayed treatment until the postpartum period, only 42 percent attended a follow up visit in the TB clinic, and only 18 percent completed treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/18\">",
"     18",
"    </a>",
"    ]. Therefore, close follow-up is required.",
"   </p>",
"   <p>",
"    The regimen of choice for treatment of LTBI is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    (5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    up to 300 mg daily) for nine months (",
"    <a class=\"graphic graphic_table graphicRef73637 \" href=\"UTD.htm?18/49/19227\">",
"     table 2",
"    </a>",
"    ). This should be combined with pyridoxine supplementation (25 mg daily) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/10\">",
"     10",
"    </a>",
"    ]. Minor interruptions in therapy are acceptable, so long as 270 doses are completed within 12 months. A six month regimen of daily isoniazid also provides protection but is less desirable, although in the setting of difficulty with adherence, providers may prefer to concentrate efforts in ensuring six months of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another choice for treatment of LTBI is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    (daily for four months) (",
"    <a class=\"graphic graphic_table graphicRef73637 \" href=\"UTD.htm?18/49/19227\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/10\">",
"     10",
"    </a>",
"    ]. Rifampin should be used for patients who are intolerant of INH or who are presumed to have infection with INH-resistant, rifampin-sensitive strains of TB. It may also be useful in the setting of difficulty with adherence. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20648?source=see_link\">",
"     \"Diagnosis of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Toxicity and monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy and the early postpartum period may confer increased risk for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    hepatotoxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/19-22\">",
"     19-22",
"    </a>",
"    ]. Among 3681 pregnant and postpartum women with LTBI, isoniazid was associated with a 2.5-fold increase in fulminant hepatitis and a fourfold increase in mortality compared with nonpregnant women, although these data did not reach statistical significance [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pregnant and postpartum women should have pre-treatment liver transaminases and bilirubin function tests and, if normal,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    can be started with follow up symptom evaluations, and exams every month. Initially LFTs should be obtained every month for at least two months until shown to remain within normal limits. The evaluation of pregnant and postpartum women receiving LTBI treatment (either isoniazid or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    ) also should include testing for HIV, hepatitis B and C, and a general evaluation for chronic liver disease, alcohol use, and exposure to other hepatotoxins. If there is a mild elevation of transaminases, more frequent monitoring may be necessary until stability is established.",
"   </p>",
"   <p>",
"    Patients should receive explicit instructions to stop therapy immediately and contact their healthcare provider upon the development of any symptoms that are consistent with hepatitis.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"     Isoniazid",
"    </a>",
"    should be discontinued if the patient is symptomatic and the ALT is more than three times the upper limit of normal [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/23\">",
"     23",
"    </a>",
"    ]. It should be discontinued in asymptomatic patients when the ALT is more than five times the upper limit of normal [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other side effects of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    include rashes, neuropsychiatric disturbances including depression, mania, and memory loss, pellagra, peripheral neuritis, and seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adverse effects due to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    include hepatitis, thrombocytopenia, hemolytic anemia, and fever and rash. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/26/24998?source=see_link\">",
"     \"Rifampin and other rifamycins\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H10\">",
"     'First line drugs'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     ACTIVE TB",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy has not been shown to influence the pathogenesis of TB or the likelihood of progression from latent infection to active disease, nor has it been shown to affect the response to treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Active maternal infection can lead to congenital infection by hematogenous dissemination via the placenta, although congenital infection is very rare. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Congenital and neonatal TB'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant patients with pulmonary tuberculosis typically have the same clinical manifestations as nonpregnant patients. However, tuberculosis in pregnant women can present insidiously, since malaise and fatigue may be attributed to pregnancy rather than disease [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/22\">",
"     22",
"    </a>",
"    ]. In addition, during pregnancy it can be difficult to recognize weight loss. In the setting of extrapulmonary disease symptoms may be especially vague and the diagnosis can be significantly delayed [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/47/39673?source=see_link\">",
"     \"Clinical manifestations and evaluation of pulmonary tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation for active tuberculosis in pregnant women should proceed as in nonpregnant individuals, including chest X-ray, with appropriate protection of the fetus [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/28\">",
"     28",
"    </a>",
"    ]. Evaluation for extrapulmonary disease should be guided by clinical symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radiographic findings. Diagnosis of TB also should prompt evaluation for HIV infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link\">",
"     \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22808?source=see_link\">",
"     \"Acute and early HIV infection: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TREATMENT OF ACTIVE TB",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of tuberculosis in the setting of pregnancy should be initiated if the suspicion of active disease is moderate to high (such as a persistent upper lobe infiltrate and cough in a high-risk individual",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a positive AFB smear or nucleic acid amplification test), since untreated disease represents a greater hazard to the mother and fetus than antituberculous therapy. The principles of treatment of active tuberculosis in HIV-seronegative pregnant patients are the same as for nonpregnant patients, except for the exclusion of certain medications [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/29\">",
"     29",
"    </a>",
"    ]. HIV-positive patients are discussed in detail separately, and decisions about therapy in these individuals should be made in consultation with an expert. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/21/19802?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19002?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in the HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The approach to treatment also includes consideration of issues related to transmission, including separation of mother from newborn in certain circumstances. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Controlling transmission'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     First line drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial treatment regimen (for presumed drug sensitive disease) for active TB during pregnancy in the United States typically consists of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/7/12406?source=see_link\">",
"     ethambutol",
"    </a>",
"    administered for two months followed by isoniazid and rifampin for seven months, for a total of nine months [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/4,8,15,29,30\">",
"     4,8,15,29,30",
"    </a>",
"    ]. If the results of drug sensitivity studies are available and the organism is known to be susceptible to isoniazid and rifampin, then ethambutol may be discontinued after one month.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/34/31269?source=see_link\">",
"     Pyrazinamide",
"    </a>",
"    is not absolutely necessary as part of a first line regimen, and because of limited safety data, it is not used routinely for pregnant women in the United States. However, pyrazinamide is recommended by the World Health Organizations as part of a standard regimen for treatment of TB in pregnant women [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. In circumstances such as HIV coinfection, tuberculous meningitis, very extensive disease, and any form of drug resistance, it would be prudent to consider the use of pyrazinamide [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/15,33\">",
"     15,33",
"    </a>",
"    ]. The absence of pyrazinamide from the treatment regimen results in a treatment duration of nine months instead of six months.",
"   </p>",
"   <p>",
"    Steroids for manifestations such as meningitis and pericarditis should be used as discussed separately [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28713?source=see_link\">",
"     \"Central nervous system tuberculosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/36/2633?source=see_link\">",
"     \"Tuberculous pericarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"       Isoniazid",
"      </a>",
"      is considered acceptable for use in pregnancy and is not considered to be a human teratogen, although the risk of hepatitis and peripheral neurotoxicity may be increased in the peripartum period [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/29,30,34,35\">",
"       29,30,34,35",
"      </a>",
"      ]. In general, the benefit of isoniazid (given its importance for treatment of active TB) justifies the potential risk to the fetus. Pyridoxine (25",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      should be administered to pregnant women receiving isoniazid (and to their breastfeeding infants, even if the infant is not receiving isoniazid therapy) [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/10,29\">",
"       10,29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       Rifampin",
"      </a>",
"      is considered acceptable for use in pregnancy; rare cases of fetal abnormalities and hemorrhagic disease have been reported [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/10,12,29,35,36\">",
"       10,12,29,35,36",
"      </a>",
"      ].",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/63/32760?source=see_link\">",
"       Rifabutin",
"      </a>",
"      often is used as an alternative to rifampin in patients with HIV infection on antiretroviral medications. There is insufficient safety information relating to the use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/51/15160?source=see_link\">",
"       rifapentine",
"      </a>",
"      in pregnancy (category C). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19002?source=see_link\">",
"       \"Treatment of pulmonary tuberculosis in the HIV-infected patient\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/7/12406?source=see_link\">",
"       Ethambutol",
"      </a>",
"      is considered acceptable for use in pregnancy [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/29,34,35\">",
"       29,34,35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/34/31269?source=see_link\">",
"       Pyrazinamide",
"      </a>",
"      is not universally considered acceptable for use in pregnancy; the adverse effects of pyrazinamide in pregnancy are not certain. Because detailed teratogenicity data are not available for this agent, it is not used routinely for pregnant women in the United States since it is not absolutely necessary as part of a first line regimen [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/9,29\">",
"       9,29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Dosing regimens for treatment of tuberculosis are outlined separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/21/19802?source=see_link\">",
"     \"Treatment of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Second line drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant women with drug resistant tuberculosis or who have difficulty taking first line drugs should be managed in consultation with an expert in treating tuberculosis. In the setting of monoresistance it may be acceptable to treat with first line drugs during pregnancy, especially if a determination is made that it is acceptable to use",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/34/31269?source=see_link\">",
"     pyrazinamide",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    In the setting of resistance to multiple agents, there may be no choice but to use a regimen with some potential toxicity to the fetus; women should be counseled accordingly. There have been multiple cases in which mothers with MDR-TB have been treated with second line agents and delivered at term; most of these babies were delivered without evidence of adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/37-40\">",
"     37-40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Agents to avoid",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     Streptomycin",
"    </a>",
"    (category D) is a known teratogen; it interferes with inner ear development and may cause congenital deafness [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/35\">",
"     35",
"    </a>",
"    ]. Among 40 pregnant women treated with streptomycin, 17 percent of the babies had eighth nerve damage with deficits ranging from mild hearing loss to bilateral deafness [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/41\">",
"     41",
"    </a>",
"    ]. Given this risk and the availability of effective and less toxic alternatives, streptomycin should NOT be used for treatment of TB in pregnancy.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/10/40102?source=see_link\">",
"     Kanamycin",
"    </a>",
"    (category D) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/16/34056?source=see_link\">",
"     amikacin",
"    </a>",
"    (category D) presumably share this potential for toxicity and should NOT be administered in pregnancy, although there is little specific information on the fetal effects of these drugs.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/59/11189?source=see_link\">",
"     Capreomycin",
"    </a>",
"    (category C), which is assumed to have eighth nerve and renal toxicity in fetuses, also should be avoided.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Agents to consider",
"    </span>",
"    &nbsp;&mdash;&nbsp;These agents should be used in pregnancy only when there are no suitable alternatives for treatment (eg, due to drug resistance or adverse effects of safer agents) and only in consultation with an expert in the treatment of tuberculosis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The adverse effects of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/30/43492?source=see_link\">",
"       cycloserine",
"      </a>",
"      (category C) in pregnancy are unproven. This agent crosses the placenta and should be used for pregnant women only where there are no suitable alternatives [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The adverse effects of PAS (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15141?source=see_link\">",
"       para-aminosalicylic acid",
"      </a>",
"      ) (category C) in pregnancy are not certain. There appears to be no evidence for teratogenicity among babies whose mothers received",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"       isoniazid",
"      </a>",
"      with PAS [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/30,35\">",
"       30,35",
"      </a>",
"      ]. PAS should be used in pregnancy only where there are no suitable alternatives.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/16/42244?source=see_link\">",
"       Ethionamide",
"      </a>",
"      (category C) crosses the placenta and is teratogenic in laboratory animals [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/35\">",
"       35",
"      </a>",
"      ]. It should be used in pregnancy only when there are no suitable alternatives.",
"     </li>",
"     <li>",
"      The fluoroquinolones (category C) have been associated with arthropathies and should be used in pregnancy only where there are no suitable alternatives [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Follow up",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment should be administered by directly observed therapy (DOT). To improve adherence and to evaluate for drug toxicity, patients should be seen and examined every month. An expert in tuberculosis should be consulted for interruptions longer than two weeks or for sporadic adherence, especially within the first two months of treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10341?source=see_link\">",
"     \"Adherence to tuberculosis treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As noted above, careful clinical monitoring for hepatitis is especially important for pregnant and postpartum women; pre-treatment liver transaminases and bilirubin function tests followed by monthly liver enzyme testing should be obtained, and patients should be instructed to call immediately if any symptoms or signs of hepatitis occur. In general,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    should be discontinued for the same indications as for treatment of LTBI. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Toxicity and monitoring'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     BREAST FEEDING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breast feeding is not contraindicated if the mother is being treated for active TB or LTBI with usual first line agents, since the small concentrations of these drugs in breast milk do not produce toxic effects in the nursing infant (ie, approximately 20 percent or less of a normal newborn infant dose) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/10,29,35,42\">",
"     10,29,35,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    All infants receiving",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    (either via breast milk or as directed therapy) should receive supplemental pyridoxine. If the infant already is receiving isoniazid therapy, then breast feeding will increase the infant's total daily exposure to INH. There are no specific recommendations concerning this or other antituberculous drugs, and it would be difficult to make accurate adjustments of the daily dose to compensate for the amount received in the breast milk.",
"   </p>",
"   <p>",
"    Breast feeding in the setting of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/63/32760?source=see_link\">",
"     rifabutin",
"    </a>",
"    or fluoroquinolones is not recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/29,35\">",
"     29,35",
"    </a>",
"    ]. Decisions about breast feeding with other second-line agents should be made in consultation with an expert. Decisions regarding choice of these agents should be individualized in consultation with an expert [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     CONGENITAL AND NEONATAL TB",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital TB is very rare; a 1980 review noted that only 24 cases had been described in the literature since the introduction of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"     isoniazid",
"    </a>",
"    in 1952 [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/43\">",
"     43",
"    </a>",
"    ]. Congenital TB is associated with maternal HIV infection, tuberculous endometritis and miliary tuberculosis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/29\">",
"     29",
"    </a>",
"    ]. The index of suspicion should be increased in regions with high prevalence of both maternal HIV and tuberculosis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/44\">",
"     44",
"    </a>",
"    ]. It can occur hematogenously via the placenta and umbilical vein or by fetal aspiration (or ingestion) of infected amniotic fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/8\">",
"     8",
"    </a>",
"    ]. Clinical manifestations of congenital TB include respiratory distress, fever, hepatomegaly, splenomegaly, poor feeding, lethargy, irritability, low birth weight, and low APGAR scores [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/43,45\">",
"     43,45",
"    </a>",
"    ]. Clinical evaluation of the infant in the setting of suspected congenital TB should include routine evaluation in addition to lumbar puncture and evaluation of the placenta with histologic examination (including acid fast bacillus [AFB] staining) and AFB culture [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/34\">",
"     34",
"    </a>",
"    ]. The",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    in the infant most often is negative.",
"   </p>",
"   <p>",
"    Neonatal TB develops following exposure of an infant to his or her mother's aerosolized respiratory secretions. This is more common than congenital TB, and diagnosis of neonatal TB can lead to identification of previously unrecognized diagnosis of TB in the mother [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/46\">",
"     46",
"    </a>",
"    ]. Clinical evaluation of the infant and the mother should be pursued as outlined in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link\">",
"     \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The mortality in the setting of congenital and neonatal TB is about 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/8,43\">",
"     8,43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     CONTROLLING TRANSMISSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a mother has established or suspected active pulmonary TB at the time of delivery, she and the infant should be separated until both have been fully evaluated [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29096/abstract/34\">",
"     34",
"    </a>",
"    ]. The same is true for household contacts of the infant.",
"   </p>",
"   <p>",
"    If both the mother (or household contact) and infant are found to have active TB and both are started on treatment, separation is not necessary as long as both adhere to treatment. The mother (or household contact) should wear a mask until no longer infectious.",
"   </p>",
"   <p>",
"    If the mother (or household contact) has active TB disease, and the infant has a positive skin test (in the absence of evidence for active disease), the mother should be treated for active disease and the infant should be treated for latent TB infection. Separation is not necessary as long as both adhere to treatment. The mother (or household contact) should wear a mask until no longer infectious.",
"   </p>",
"   <p>",
"    If the mother (or household contact) has TB but the infant does not have active TB or a positive skin test, the mother should be treated for active disease and the infant should be treated for LTBI for three to four months, at which time a skin test should be repeated. If the repeat skin test is positive, the infant should be reevaluated for active TB, and a full course of treatment for either latent or active TB should ensue, based on the result of the reevaluation. If the repeat skin test is negative, and the mother is no longer contagious, the infant's LTBI treatment may be discontinued. Separation is not necessary as long as both adhere to treatment; the mother (or household contact) should wear a mask until she is no longer infectious.",
"   </p>",
"   <p>",
"    If the mother has known or suspected pulmonary drug resistant TB and the newborn does not have evidence of active or latent infection, they should remain separated until the mother is not infectious. Routine BCG vaccination at birth is warranted in countries where tuberculosis is endemic [special considerations apply for children born to HIV infected mothers as discussed separately; (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40136?source=see_link\">",
"     \"BCG vaccination\"",
"    </a>",
"    )]. In countries where BCG administration is not routine, BCG immunization should be considered for the infant of a mother with tuberculosis in consultation with an expert in TB. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40136?source=see_link\">",
"     \"BCG vaccination\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    BCG vaccination should not be administered during pregnancy for prevention of tuberculosis since it is a live vaccine. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40136?source=see_link\">",
"     \"BCG vaccination\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pregnancy is not a risk factor for TB and has not been shown to influence the pathogenesis of TB or the likelihood of progression from latent infection to active disease. However, maternal infection can lead to congenital infection or neonatal infection. In addition, TB in pregnant women can present insidiously since symptoms of malaise and fatigue may be attributed to pregnancy rather than infection. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Screening for latent TB infection (LTBI) should be performed during pregnancy only for those women at high risk for progression from latent to active disease (eg, women who have been infected recently and those who have HIV or are otherwise significantly immunocompromised) (",
"      <a class=\"graphic graphic_table graphicRef67357 \" href=\"UTD.htm?31/0/31756\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Latent TB'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20648?source=see_link\">",
"       \"Diagnosis of latent tuberculosis infection in HIV-negative adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Treatment of LTBI is reserved for pregnant women at high risk for progression of LTBI to active disease, such as recent infection, HIV infection, or immunosuppression. In these circumstances, we recommend",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"       isoniazid",
"      </a>",
"      for treatment of LTBI (",
"      <a class=\"graphic graphic_table graphicRef73637 \" href=\"UTD.htm?18/49/19227\">",
"       table 2",
"      </a>",
"      )&nbsp;(",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). We use daily therapy for nine months; for patients with difficulties related to adherence, six months duration",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      twice weekly directly observed therapy are alternatives. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Latent TB'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that the initial treatment regimen for active TB in pregnancy (for presumed drug susceptible disease) consist of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"       isoniazid",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/7/12406?source=see_link\">",
"       ethambutol",
"      </a>",
"      administered for two months, followed by isoniazid and rifampin for seven months for a total of nine months (",
"      <a class=\"graphic graphic_table graphicRef73637 \" href=\"UTD.htm?18/49/19227\">",
"       table 2",
"      </a>",
"      )&nbsp;(",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ).",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/34/31269?source=see_link\">",
"       Pyrazinamide",
"      </a>",
"      is not absolutely necessary as part of a first line regimen, and because of limited safety data, it is not used routinely for pregnant women in the United States. However, pyrazinamide is recommended by the World Health Organizations as part of a standard regimen for treatment of TB in pregnant women. It may be important to consider in the setting of HIV coinfection, tuberculous meningitis, extensive disease, and drug resistance. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Treatment of active TB'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend NOT using",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"       streptomycin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/10/40102?source=see_link\">",
"       kanamycin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/16/34056?source=see_link\">",
"       amikacin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/59/11189?source=see_link\">",
"       capreomycin",
"      </a>",
"      for treatment of TB in pregnancy (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Streptomycin is a known teratogen that interferes with eighth nerve development and may cause congenital deafness. Kanamycin and amikacin presumably share this potential for toxicity, and although they are also aminoglycosides, there is little specific information on the fetal effects of these drugs. Capreomycin is assumed to have eighth nerve and renal toxicity. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Agents to avoid'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The following agents may be useful when there are no suitable alternatives, but should be considered in consultation with an expert in treating TB:",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/63/32760?source=see_link\">",
"       rifabutin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/30/43492?source=see_link\">",
"       cycloserine",
"      </a>",
"      , PAS (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15141?source=see_link\">",
"       para-aminosalicylic acid",
"      </a>",
"      ),",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/16/42244?source=see_link\">",
"       ethionamide",
"      </a>",
"      and fluoroquinolones. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Agents to consider'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Breast feeding is not contraindicated in mothers being treated for active TB or LTBI with standard first line agents, since the small concentrations of these drugs in breast milk do not produce toxic effects in the nursing infant. Supplemental pyridoxine should be administered to breastfeeding mothers receiving",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40279?source=see_link\">",
"       isoniazid",
"      </a>",
"      as well as to their infants, even if the infant is not taking isoniazid therapy. Patients receiving treatment for drug resistant TB with second line agents should not breast feed. &nbsp;(See",
"      <a class=\"local\" href=\"#H15\">",
"       'Breast feeding'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Congenital TB is very rare and most often associated with maternal HIV infection or maternal miliary or uterine TB. Neonatal TB is more common than congenital tuberculosis, and diagnosis can lead to identification of a previously unrecognized diagnosis of TB in the mother. The mortality of untreated congenital and neonatal TB is about 50 percent. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Congenital and neonatal TB'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Issues related to separation of mother and infant for controlling transmission are as outlined above. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Controlling transmission'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/1\">",
"      Carter EJ, Mates S. Tuberculosis during pregnancy. The Rhode Island experience, 1987 to 1991. Chest 1994; 106:1466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/2\">",
"      Mathad JS, Gupta A. Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps. Clin Infect Dis 2012; 55:1532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/3\">",
"      Snider D. Pregnancy and tuberculosis. Chest 1984; 86:10S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/4\">",
"      Hamadeh MA, Glassroth J. Tuberculosis and pregnancy. Chest 1992; 101:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/5\">",
"      Ormerod P. Tuberculosis in pregnancy and the puerperium. Thorax 2001; 56:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/6\">",
"      Schaefer G, Zervoudakis IA, Fuchs FF, David S. Pregnancy and pulmonary tuberculosis. Obstet Gynecol 1975; 46:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/7\">",
"      Centers for Disease Control and Prevention (CDC). Tuberculosis among pregnant women--New York City, 1985-1992. MMWR Morb Mortal Wkly Rep 1993; 42:605, 611.",
"     </a>",
"    </li>",
"    <li>",
"     Starke, JR. Tuberculosis in childhood and pregnancy. In: Tuberculosis: Current concepts and treatment, 2nd ed, Friedman, LN (Ed), CRC Press, Boca Raton 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/9\">",
"      Davidson PT. Managing tuberculosis during pregnancy. Lancet 1995; 346:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/10\">",
"      Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000; 49:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/11\">",
"      Boggess KA, Myers ER, Hamilton CD. Antepartum or postpartum isoniazid treatment of latent tuberculosis infection. Obstet Gynecol 2000; 96:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/12\">",
"      Bothamley G. Drug treatment for tuberculosis during pregnancy: safety considerations. Drug Saf 2001; 24:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/13\">",
"      Present PA, Comstock GW. Tuberculin sensitivity in pregnancy. Am Rev Respir Dis 1975; 112:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/14\">",
"      Mazurek GH, Jereb J, Lobue P, et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54:49.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.cdc.gov/tb/pubs/tbfactsheets/pregnancy.htm (Accessed April 3, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/16\">",
"      Lighter-Fisher J, Surette AM. Performance of an interferon-gamma release assay to diagnose latent tuberculosis infection during pregnancy. Obstet Gynecol 2012; 119:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/17\">",
"      Worjoloh A, Kato-Maeda M, Osmond D, et al. Interferon gamma release assay compared with the tuberculin skin test for latent tuberculosis detection in pregnancy. Obstet Gynecol 2011; 118:1363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/18\">",
"      Cruz CA, Caughey AB, Jasmer R. Postpartum follow-up of a positive purified protein derivative (PPD) among an indigent population. Am J Obstet Gynecol 2005; 192:1455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/19\">",
"      Franks AL, Binkin NJ, Snider DE Jr, et al. Isoniazid hepatitis among pregnant and postpartum Hispanic patients. Public Health Rep 1989; 104:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/20\">",
"      Moulding TS, Redeker AG, Kanel GC. Twenty isoniazid-associated deaths in one state. Am Rev Respir Dis 1989; 140:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/21\">",
"      Snider DE Jr, Caras GJ. Isoniazid-associated hepatitis deaths: a review of available information. Am Rev Respir Dis 1992; 145:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/22\">",
"      Knight M, Kurinczuk JJ, Nelson-Piercy C, et al. Tuberculosis in pregnancy in the UK. BJOG 2009; 116:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/23\">",
"      Saukkonen JJ, Cohn DL, Jasmer RM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med 2006; 174:935.",
"     </a>",
"    </li>",
"    <li>",
"     Friedman, LN. Mycobacterium tuberculosis. In: Pulmonary and Critical Care Medicine, Bone, R, Dantzker, D, George, R, et al (Eds), Mosby-Year Book, Chicago 1992. Revised, 1994.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/25\">",
"      Kothari A, Mahadevan N, Girling J. Tuberculosis and pregnancy--Results of a study in a high prevalence area in London. Eur J Obstet Gynecol Reprod Biol 2006; 126:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/26\">",
"      Wilson EA, Thelin TJ, Dilts PV Jr. Tuberculosis complicated by pregnancy. Am J Obstet Gynecol 1973; 115:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/27\">",
"      Llewelyn M, Cropley I, Wilkinson RJ, Davidson RN. Tuberculosis diagnosed during pregnancy: a prospective study from London. Thorax 2000; 55:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/28\">",
"      Good JT Jr, Iseman MD, Davidson PT, et al. Tuberculosis in association with pregnancy. Am J Obstet Gynecol 1981; 140:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/29\">",
"      American Thoracic Society, CDC, Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep 2003; 52:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/30\">",
"      Snider DE Jr, Layde PM, Johnson MW, Lyle MA. Treatment of tuberculosis during pregnancy. Am Rev Respir Dis 1980; 122:65.",
"     </a>",
"    </li>",
"    <li>",
"     Enarson, DA, Rieder, HL, Arnodottir, T, Trebucq, A. Management of tuberculosis: A guide for low income countries, 5th ed, International Union Against Tuberculosis and Lung Disease, Paris, France 2000.",
"    </li>",
"    <li>",
"     World Health Organization. Treatment of tuberculosis: Guidelines for national programmes, 3rd ed. WHO/CDS/TB/2003.313. World Health Organization, Geneva, Switzerland 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/33\">",
"      Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47:1.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Tuberculosis. In: Red Book: 2009 Report of the Committee on Infectious Diseases, 28th ed, Pickering, LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2009. p.680.",
"    </li>",
"    <li>",
"     Briggs, GG, Freeman, RK, Yaffe, SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk, 7th ed, Lippincott Williams &amp; Wilkins, Philadelphia, PA 2005.",
"    </li>",
"    <li>",
"     file://www.fda.gov/medwatch/SAFETY/2004/aug_PI/Rifadin_PI.pdf (Accessed April 3, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/37\">",
"      Nitta AT, Milligan D. Management of four pregnant women with multidrug-resistant tuberculosis. Clin Infect Dis 1999; 28:1298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/38\">",
"      Shin S, Guerra D, Rich M, et al. Treatment of multidrug-resistant tuberculosis during pregnancy: a report of 7 cases. Clin Infect Dis 2003; 36:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/39\">",
"      Drobac PC, del Castillo H, Sweetland A, et al. Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of 6 children with intrauterine exposure to second-line agents. Clin Infect Dis 2005; 40:1689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/40\">",
"      Palacios E, Dallman R, Mu&ntilde;oz M, et al. Drug-resistant tuberculosis and pregnancy: treatment outcomes of 38 cases in Lima, Peru. Clin Infect Dis 2009; 48:1413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/41\">",
"      Varpela E, Hietalahti J, Aro MJ. Streptomycin and dihydrostreptomycin medication during pregnancy and their effect on the child's inner ear. Scand J Respir Dis 1969; 50:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/42\">",
"      Snider DE Jr, Powell KE. Should women taking antituberculosis drugs breast-feed? Arch Intern Med 1984; 144:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/43\">",
"      Hageman J, Shulman S, Schreiber M, et al. Congenital tuberculosis: critical reappraisal of clinical findings and diagnostic procedures. Pediatrics 1980; 66:980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/44\">",
"      Manji KP, Msemo G, Tamim B, Thomas E. Tuberculosis (presumed congenital) in a neonatal unit in Dar-es-Salaam, Tanzania. J Trop Pediatr 2001; 47:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/45\">",
"      Jana N, Vasishta K, Saha SC, Ghosh K. Obstetrical outcomes among women with extrapulmonary tuberculosis. N Engl J Med 1999; 341:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29096/abstract/46\">",
"      Laibl VR, Sheffield JS. Tuberculosis in pregnancy. Clin Perinatol 2005; 32:739.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8014 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-222.190.118.195-4B2100FB5C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_26_29096=[""].join("\n");
var outline_f28_26_29096=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LATENT TB",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Toxicity and monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      ACTIVE TB",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TREATMENT OF ACTIVE TB",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      First line drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Second line drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Agents to avoid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Agents to consider",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Follow up",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      BREAST FEEDING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      CONGENITAL AND NEONATAL TB",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      CONTROLLING TRANSMISSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/8014\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8014|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/0/31756\" title=\"table 1\">",
"      Tuberculin skin test interpretation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/49/19227\" title=\"table 2\">",
"      Treatment of latent TB infection in pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22808?source=related_link\">",
"      Acute and early HIV infection: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10341?source=related_link\">",
"      Adherence to tuberculosis treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40136?source=related_link\">",
"      BCG vaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28713?source=related_link\">",
"      Central nervous system tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/47/39673?source=related_link\">",
"      Clinical manifestations and evaluation of pulmonary tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20648?source=related_link\">",
"      Diagnosis of latent tuberculosis infection in HIV-negative adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=related_link\">",
"      Diagnosis of pulmonary tuberculosis in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18649?source=related_link\">",
"      Epidemiology of tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/18/37160?source=related_link\">",
"      Interferon-gamma release assays for diagnosis of latent tuberculosis infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22378?source=related_link\">",
"      Microbiology and pathogenesis of tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/26/24998?source=related_link\">",
"      Rifampin and other rifamycins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/21/19802?source=related_link\">",
"      Treatment of pulmonary tuberculosis in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/35/19002?source=related_link\">",
"      Treatment of pulmonary tuberculosis in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/36/2633?source=related_link\">",
"      Tuberculous pericarditis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_26_29097="Acquired heart disease and pregnancy";
var content_f28_26_29097=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acquired heart disease and pregnancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/26/29097/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29097/contributors\">",
"     Carol A Waksmonski, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29097/contributors\">",
"     Anita LaSala, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29097/contributors\">",
"     Michael R Foley, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/26/29097/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29097/contributors\">",
"     Catherine M Otto, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29097/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/26/29097/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29097/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/26/29097/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although cardiac disease complicates a small percentage of all pregnancies in developed countries (eg, only 1 to 4 percent of pregnancies in the United States), maternal cardiac disease is a major cause of non-obstetric maternal morbidity and mortality (",
"    <a class=\"graphic graphic_figure graphicRef69833 \" href=\"UTD.htm?13/12/13519\">",
"     figure 1",
"    </a>",
"    ). Care of the high-risk patients requires a team approach including a maternal-fetal medicine specialist, cardiologist, and obstetrical anesthesiologist.",
"   </p>",
"   <p>",
"    In the past, rheumatic heart disease was the most common form of cardiac disease in pregnant women; it still predominates in developing countries and in immigrant populations in the United States. Congenital heart disease is now the most common form of heart disease complicating pregnancy in the United States, in part because advances in the treatment of congenital heart disease have made it possible for more affected children to reach adulthood and attempt pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/7/29818?source=see_link\">",
"     \"Pregnancy in women with congenital heart disease: General principles\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/50/20262?source=see_link\">",
"     \"Pregnancy and Marfan syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, many women are postponing childbearing until the fourth and fifth decades of life [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]; with advancing maternal age, underlying medical conditions such as hypertension, diabetes, and hypercholesterolemia become more common and increase the incidence of acquired heart disease complicating pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHYSIOLOGY OF NORMAL PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy is associated with several cardiocirculatory changes that can significantly impact underlying cardiac disease. These changes begin early in pregnancy (within the first five to eight weeks), reach their peak during the late second trimester, and then remain relatively constant until delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/3\">",
"     3",
"    </a>",
"    ]. Knowledge of these cardiovascular adaptations is required to correctly interpret hemodynamic and cardiovascular tests in the gravida, to predict the effects of pregnancy on the woman with underlying cardiac disease, and to understand how the fetus will be affected by maternal cardiac disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20105?source=see_link\">",
"     \"Maternal cardiovascular and hemodynamic adaptations to pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Antepartum hemodynamic changes",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cardiac output &mdash; The cardiac output rises 30 to 50 percent above baseline during normal pregnancy [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/4,5\">",
"       4,5",
"      </a>",
"      ]. The degree of change is acutely influenced by posture, as the cardiac output is higher when the pregnant woman is in the left lateral decubitus position, particularly in the latter part of pregnancy [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/6,7\">",
"       6,7",
"      </a>",
"      ]. In comparison, assumption of the supine position can lower the output by as much as 25 to 30 percent due to compression of the inferior cava by the gravid uterus, leading to a substantial reduction in venous return to the heart.",
"      <br/>",
"      <br/>",
"      The increased cardiac output is the result of changes in three important factors that determine cardiac performance: preload is increased due to the associated rise in blood volume; afterload is reduced due to the decline in systemic vascular resistance; and the maternal heart rate rises by 15 to 20",
"      <span class=\"nowrap\">",
"       beats/min",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/4\">",
"       4",
"      </a>",
"      ]. The direct effect of pregnancy on left ventricular contractility remains controversial [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/8\">",
"       8",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Regardless of the mechanism, the stress induced by the increase in cardiac output can cause patients with underlying and often asymptomatic heart disease to decompensate during the latter half of pregnancy. This was illustrated in a series of 51 pregnant or postpartum women who developed acute pulmonary edema: 13 (25 percent) had cardiac disease and 6 of the 13 had occult structural lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/9\">",
"       9",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/34/1577?source=see_link\">",
"       \"Management of heart failure in pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Blood pressure &mdash; The blood pressure typically falls early in gestation and is usually 10 mmHg below baseline in the second trimester, declining to a mean of",
"      <span class=\"nowrap\">",
"       105/60",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]. This response is induced by a reduction in systemic vascular resistance, which appears to parallel changes in afterload [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/12\">",
"       12",
"      </a>",
"      ]. Both creation of a low-resistance circuit in the uteroplacental circulation and vasodilatation contribute to the decline in vascular resistance [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/13\">",
"       13",
"      </a>",
"      ]. The factors responsible for the vasodilatation are incompletely understood, but one of the major findings is decreased vascular responsiveness to the pressor effects of angiotensin II and norepinephrine [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/14\">",
"       14",
"      </a>",
"      ]. The possible role of humoral agents, such as vasodilator prostaglandins, estrogens, progesterone, and prolactin, in mediating the vasodilation remains to be established [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal physical findings may include distended neck veins, basilar rales, a prominent left and right ventricular apical impulse, exaggerated heart sounds, and a \"new\" systolic ejection murmur best heard over the mid or lower left sternal border. Preexisting murmurs will be louder. A physiologic S3 gallop may be appreciated. Peripheral edema will be present in the last trimester. One of the challenges for the clinician is how to distinguish between these normal symptoms and signs of pregnancy and similar symptoms that may indicate underlying heart disease in the mother. The maternal cardiac evaluation is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20105?source=see_link\">",
"     \"Maternal cardiovascular and hemodynamic adaptations to pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Electrocardiographic changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The surface electrocardiogram may exhibit subtle changes during normal pregnancy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Shortening of the PR and QT intervals may accompany the increase in heart rate.",
"     </li>",
"     <li>",
"      Frontal lead axis changes are rare despite significant elevation of the diaphragm; when seen, slight leftward shifts (15 to 20 degrees left axis deviation) are more common than rightward deviations [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Nonspecific abnormalities of the ST segments and T waves appear in 4 to 14 percent of pregnancies [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/17,18\">",
"       17,18",
"      </a>",
"      ]. These changes predominate in left precordial leads and resolve in the majority of patients after delivery, but may recur during subsequent pregnancies.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Hemodynamic changes during labor and delivery",
"    </span>",
"    &nbsp;&mdash;&nbsp;During normal labor and delivery marked fluctuations in cardiac output occur, with increases up to 80 percent above third trimester levels in some cases. These hemodynamic changes are the result of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Uterine contractions are associated with an increase in cardiac output, attributed to an increase in blood volume from \"autotransfusion\" of intramyometrial blood with each contraction and from an elevation in blood pressure and heart rate because of increased sympathetic tone due to pain and anxiety.",
"     </li>",
"     <li>",
"      The type of anesthesia used will have an important impact on the hemodynamic changes observed. As an example, epidural anesthesia provides adequate pain relief, but is associated with significant peripheral vasodilatation and a fall in blood pressure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/46/38633?source=see_link\">",
"       \"Pharmacologic management of pain during labor and delivery\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In spite of the obligatory blood loss that occurs with vaginal delivery, cardiac output increases after delivery because of autotransfusion from the uterus and relief of vena caval obstruction.",
"     </li>",
"     <li>",
"      Significant hemodynamic change can occur with cesarean delivery because of the type of anesthesia required and a greater obligatory blood loss than that which occurs with vaginal delivery. Vaginal delivery is generally preferred, if possible, for cardiac patients. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Management of labor and delivery'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Minimizing hemodynamic effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the cardiac reserve of the pregnant woman with heart disease is reduced, factors that encroach on cardiac reserve and aggravate maternal heart disease can be minimized. This involves encouraging the gravida to get adequate rest and avoid undue exertion, avoidance of significant anemia, minimizing anxiety and pain, and treating infection early. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/7/29818?source=see_link&amp;anchor=H4#H4\">",
"     \"Pregnancy in women with congenital heart disease: General principles\", section on 'Management guidelines'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ASSESSING RISK",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H92292510\">",
"    <span class=\"h2\">",
"     Predictors of cardiac events",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with acquired heart disease may have cardiac complications during pregnancy. Their risk can be assessed by evaluating the severity of their valve lesions and the degree of ventricular dysfunction. The history, physical examination, echocardiogram, and electrocardiogram form the foundation of cardiac evaluation in all patients. To determine the risks and predictors of pregnancy-related cardiac complications in women with heart disease, a retrospective study analyzed outcomes of 221 women with heart disease who underwent 252 pregnancies (excluding miscarriages) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/19\">",
"     19",
"    </a>",
"    ]. The findings were then applied in a prospective study of 562 women with congenital or acquired cardiac disease or arrhythmias who had 617 pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/20\">",
"     20",
"    </a>",
"    ]. The four predictors of cardiac events identified were:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Poor functional class (New York Heart Association [NYHA] class II to IV) or cyanosis (",
"      <a class=\"graphic graphic_table graphicRef52683 \" href=\"UTD.htm?3/2/3117\">",
"       table 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Previous cardiac event (eg, heart failure, transient ischemic attack, stroke) or arrhythmia",
"     </li>",
"     <li>",
"      Left heart obstruction (mitral valve area of &lt;2 cm2, aortic valve area of &lt;1.5 cm2, peak left ventricular outflow gradient &gt;30 mmHg)",
"     </li>",
"     <li>",
"      Left ventricular systolic dysfunction (left ventricular ejection fraction &lt;40 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    One point was assigned for each finding. The actual rate of primary cardiac events (pulmonary edema, arrhythmia requiring treatment, stroke, cardiac arrest or death) was 13 percent overall, with 55 percent occurring antepartum. There was excellent agreement between the rates that were predicted and observed by risk score: 0 point (5 versus 4 percent), 1 point (27 versus 26 percent), and more than 1 point (75 versus 62 percent). Women with scores of 0 and no lesion specific risk issues are at low cardiac risk and can often deliver safely in a community hospital setting.",
"   </p>",
"   <p>",
"    Neonatal outcome also correlates with the maternal risk score. Neonatal complications occurred in one-third of women under age 20 or over age 35 who had obstetric risk factors, smoked, or received anticoagulants and had a risk score of 1 or more; whereas the rate in matched controls without heart disease was 11 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Women with acquired heart disease who present for prepregnancy or early pregnancy consultation should undergo a complete evaluation that includes an echocardiogram. Those individuals with risk scores of 1 or greater will require more frequent evaluations and close collaboration between the patient's cardiologist and obstetrician. Those individuals at greatest risk should be referred to a maternal-fetal medicine specialist (high-risk obstetrician) for management of their pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H92292543\">",
"    <span class=\"h2\">",
"     Measurement of BNP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of serial BNP levels may be helpful in following patients at risk for developing heart failure during pregnancy. BNP levels in healthy women increase approximately two-fold during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/22\">",
"     22",
"    </a>",
"    ] but are lower than the levels observed in patients with heart failure. A prospective study from Toronto evaluated BNP levels during pregnancy in 66 women with heart disease and 12 healthy women; those with heart disease had significantly higher BNP levels than those without heart disease (median 79 versus 35",
"    <span class=\"nowrap\">",
"     pg/ml)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/23\">",
"     23",
"    </a>",
"    ]. A BNP &gt;100",
"    <span class=\"nowrap\">",
"     pg/ml",
"    </span>",
"    was measured in all eight women with an adverse maternal cardiac event during pregnancy; in seven of these women the BNP &gt;100",
"    <span class=\"nowrap\">",
"     pg/ml",
"    </span>",
"    measurement was obtained prior to or at the time of decompensation. However, a BNP &gt;100",
"    <span class=\"nowrap\">",
"     pg/ml",
"    </span>",
"    was also observed in 16 of 55 women with heart disease without clinical events.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     VALVULAR HEART DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Valvular heart disease is comprised of lesions that are the sequelae of congenital abnormalities, acquired lesions (such as rheumatic fever and degenerative aortic stenosis), and mitral valve prolapse secondary to myxomatous leaflet degeneration. Some disorders may involve more than one valve. Occasional patients present after surgical valvular repair or replacement.",
"   </p>",
"   <p>",
"    Mitral stenosis is the most common valvular lesion of rheumatic origin found in women of child-bearing age, followed by mitral regurgitation; aortic stenosis and regurgitation account for the remainder of cases. In a study of pregnancy complicated by rheumatic heart disease, mitral stenosis, mitral regurgitation, and aortic regurgitation accounted for 61, 33, and 6 percent of cases, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/17/14617?source=see_link\">",
"     \"Natural history, screening, and management of rheumatic heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Risk according to valve lesion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both the maternal and fetal risks associated with pregnancy in patients with valvular heart disease are related to the type and severity of the valve lesion and the resulting abnormalities of functional capacity, left ventricular function, and pulmonary artery pressure. In a series of 64 women with valvular heart disease, most adverse maternal cardiac events occurred in those with moderate to severe mitral or aortic stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The 2008 focused update of the",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    2006 valvular guidelines and the 2007 European Society of Cardiology guidelines classified specific valve lesions and clinical settings as high or low maternal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fetal risk during pregnancy according to the severity of the valve lesion and the presence or absence of symptoms, using the New York Heart Association (NYHA) classification (",
"    <a class=\"graphic graphic_table graphicRef52683 \" href=\"UTD.htm?3/2/3117\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Assessing risk'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The following settings were considered to be associated with high maternal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fetal risk:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Severe aortic stenosis with or without symptoms (",
"      <a class=\"graphic graphic_table graphicRef65280 \" href=\"UTD.htm?17/33/17948\">",
"       table 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Symptomatic mitral stenosis (NYHA class II to IV)",
"     </li>",
"     <li>",
"      Aortic or mitral regurgitation with NYHA class III to IV symptoms",
"     </li>",
"     <li>",
"      Aortic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      mitral valve disease with severe left ventricular dysfunction (defined as an LVEF less than 40 percent) or severe pulmonary hypertension (defined as pulmonary artery pressure &gt;75 percent of systemic pressure)",
"     </li>",
"     <li>",
"      Marfan syndrome with or without aortic regurgitation (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/50/20262?source=see_link\">",
"       \"Pregnancy and Marfan syndrome\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Mechanical prosthetic valve requiring anticoagulation (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/53/1882?source=see_link&amp;anchor=H10#H10\">",
"       \"Management of pregnant women with prosthetic heart valves\", section on 'Anticoagulation during pregnancy for women with mechanical heart valves'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following settings were considered to be associated with low maternal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fetal risk:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Asymptomatic aortic stenosis with an LVEF &gt;50 percent and a mean gradient less than 25 mmHg",
"     </li>",
"     <li>",
"      Aortic or mitral regurgitation with no or mild symptoms (NYHA class I to II)",
"     </li>",
"     <li>",
"      Mitral valve prolapse with either no mitral regurgitation or mild to moderate mitral regurgitation associated with an LVEF &gt;50 percent",
"     </li>",
"     <li>",
"      Mild mitral stenosis (defined as a mitral valve area &gt;1.5 cm2 and a mean gradient less the 5 mmHg) without severe pulmonary hypertension (defined as pulmonary artery pressure &gt;75 percent of systemic pressure)",
"     </li>",
"     <li>",
"      Mild to moderate pulmonary valve stenosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Clinical course and management of valve disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of pregnant women with the individual valvular lesions is discussed separately on the appropriate topic reviews. The incidence of maternal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fetal complications is directly related to the severity of the lesion.",
"   </p>",
"   <p>",
"    Cardiac surgery should be avoided, if possible, during pregnancy. The maternal risks are about the same as those in nonpregnant women, but cardiopulmonary bypass during pregnancy poses significant risk for the fetus. These issues are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/7/29818?source=see_link&amp;anchor=H13#H13\">",
"     \"Pregnancy in women with congenital heart disease: General principles\", section on 'Cardiac surgery during pregnancy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If a woman presents early in pregnancy with one of the high risk valve lesions described above, termination of pregnancy followed by corrective surgery before another attempt at pregnancy is recommended. If the mother declines termination, the patient should be managed medically and, as recommended by the",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines, operated on only for refractory NYHA class III or IV symptoms (",
"    <a class=\"graphic graphic_table graphicRef52683 \" href=\"UTD.htm?3/2/3117\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It may be preferable to delay surgery, if possible, until the fetus is viable; a cesarean delivery can then be performed as part of a combined procedure. If surgery is necessary during pregnancy, the second trimester is the best time since the potential risks of teratogenicity from medication and x-ray exposure as well as iatrogenic, premature delivery are low.",
"   </p>",
"   <p>",
"    Clinical course and management varies among the various valve lesions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mitral stenosis &mdash; The increase in heart rate and cardiac output during pregnancy can substantially increase the resting transmitral gradient in women with mitral stenosis, which can lead to symptoms in a previously asymptomatic (and perhaps undiagnosed) patient or an exacerbation of symptoms in an already symptomatic patient.",
"      <br/>",
"      <br/>",
"      Medical management and, if this fails, percutaneous mitral balloon valvotomy are the mainstays of therapy of mitral stenosis during pregnancy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29447?source=see_link\">",
"       \"Pregnancy in women with mitral stenosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33497?source=see_link&amp;anchor=H17#H17\">",
"       \"Percutaneous mitral balloon valvotomy for mitral stenosis\", section on 'Pregnancy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mitral regurgitation &mdash; Mitral valve prolapse is the most common cause of mitral regurgitation in pregnant women. Mitral regurgitation is usually well tolerated during pregnancy, particularly in patients with no or mild symptoms (NYHA class I or II) (",
"      <a class=\"graphic graphic_table graphicRef52683 \" href=\"UTD.htm?3/2/3117\">",
"       table 1",
"      </a>",
"      ). The normal fall in systemic vascular resistance during pregnancy improves the cardiac output, unless the regurgitation is severe. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/31/6649?source=see_link&amp;anchor=H12#H12\">",
"       \"Natural history of chronic mitral regurgitation in mitral valve prolapse and flail mitral leaflet\", section on 'Effect of pregnancy'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Chronic mitral regurgitation is also of concern when left atrial enlargement is present, since atrial fibrillation and atrial thrombi may develop with the associated need for anticoagulation and its attendant risks during pregnancy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/46/18153?source=see_link\">",
"       \"Anticoagulation during pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Aortic stenosis &mdash; In developed countries, aortic stenosis in women of child-bearing age is, primarily due to a congenital bicuspid aortic valve and acquired disease (eg, rheumatic heart disease) is now a rare cause. Management of pregnancy in women with bicuspid aortic valve is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/21/35159?source=see_link&amp;anchor=H17#H17\">",
"       \"Pregnancy in women with congenital heart disease: Specific lesions\", section on 'Bicuspid aortic valve'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Aortic regurgitation &mdash; Aortic regurgitation is usually well tolerated during pregnancy. As with mitral regurgitation, the normal fall in systemic vascular resistance improves the cardiac output in valvular insufficiency, unless the regurgitation is severe. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/29/25050?source=see_link&amp;anchor=H19#H19\">",
"       \"Course and management of chronic aortic regurgitation in adults\", section on 'Pregnancy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Tricuspid regurgitation &mdash; Isolated acquired tricuspid regurgitation, due for example to endocarditis or carcinoid syndrome, should be well tolerated during pregnancy [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/25\">",
"       25",
"      </a>",
"      ]. The risk of diuretic-induced hypoperfusion may be increased. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/9/149?source=see_link\">",
"       \"Etiology, clinical features, and evaluation of tricuspid regurgitation\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Valve replacement in women of childbearing age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with biologic prosthetic heart valves who are hemodynamically stable and do not require anticoagulation generally tolerate pregnancy well. The risk of pregnancy is high for both the mother and fetus when a mechanical valve is present, mainly due to the need for anticoagulation to prevent valve thrombosis.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     Warfarin",
"    </a>",
"    , which is the most reliable anticoagulant for such women, is associated with a risk of specific fetal defects (warfarin embryopathy) when administered between the sixth and twelfth weeks of gestation. On the other hand,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    and low molecular weight heparin are associated with an increased incidence of valve thrombosis. Other potential complications include bleeding secondary to anticoagulation, structural failure, and infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/53/1882?source=see_link&amp;anchor=H10#H10\">",
"     \"Management of pregnant women with prosthetic heart valves\", section on 'Anticoagulation during pregnancy for women with mechanical heart valves'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because of these risks, it is preferable that women with moderate valvular disease and those who have undergone reparative surgery not delay pregnancy. In addition, prosthetic valve replacement should be avoided, if possible, when intervention is required. The alternative approaches vary with the valve lesion:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Balloon valvotomy is preferred for patients with mitral stenosis; however, open commissurotomy is required if valve morphology is not favorable or the patient has left atrial thrombus or moderate to severe mitral regurgitation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33497?source=see_link\">",
"       \"Percutaneous mitral balloon valvotomy for mitral stenosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Valve repair is the preferred procedure in patients with mitral regurgitation [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/25\">",
"       25",
"      </a>",
"      ]. If valve replacement is necessary, a bioprosthetic valve should be used when possible because long-term anticoagulation is not required (in the absence of atrial fibrillation). However, degeneration of bioprosthetic valves occurs after 10 to 15 years (depending upon the valve location); as a result, valve replacement will be needed. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/53/36697?source=see_link\">",
"       \"Surgical procedures for severe chronic mitral regurgitation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Aortic stenosis in young women is, in developed countries, almost always due to congenital rather than acquired disease. Some women can be treated with percutaneous aortic balloon valvotomy rather than aortic valve replacement. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/58/7078?source=see_link&amp;anchor=H9#H9\">",
"       \"Treatment of bicuspid aortic valve stenosis in adults\", section on 'Balloon valvotomy in young adults'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/21/35159?source=see_link&amp;anchor=H17#H17\">",
"       \"Pregnancy in women with congenital heart disease: Specific lesions\", section on 'Bicuspid aortic valve'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Infective endocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infective endocarditis (IE) is a rare and potentially life-threatening complication of pregnancy although rates have not been well defined. In a 2003 review of the literature, 68 cases were identified [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/27\">",
"     27",
"    </a>",
"    ]. Eighteen of the cases (27 percent) occurred postpartum. Underlying heart disease was present in 31 percent, recent dental work in 7 percent, and intravenous drug use in 4 percent. The maternal and fetal mortality rates were 22 and 15 percent, respectively. However, most of the data came from individual case reports and are subject to publication bias.",
"   </p>",
"   <p>",
"    The role of antibiotic prophylaxis for delivery is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=see_link&amp;anchor=H15#H15\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\", section on 'Vaginal or cesarean delivery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     CARDIOMYOPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women in their childbearing years may present with ventricular dysfunction from a number of etiologies: prior viral infection, HIV infection, peripartum cardiomyopathy, or drug-induced cardiomyopathy (eg, cocaine,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    ). In one study, heart failure, arrhythmias, and stroke were more common in women whose left ventricular ejection fraction was less than 40 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/0/19465?source=see_link\">",
"     \"Causes of dilated cardiomyopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/62/18410?source=see_link\">",
"     \"Peripartum cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is insufficient information to determine whether pregnancy might be better tolerated in some groups than in others based upon the etiology of the cardiomyopathy. A study of 26 women from Brazil suggested that cardiac complications were higher in the idiopathic group than in the group with peripartum cardiomyopathy and persistent left ventricular dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/28\">",
"     28",
"    </a>",
"    ]. In contrast, a study of 31 women from the United States came to the opposite conclusion; maternal outcomes were worse in the peripartum group than in the idiopathic group [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/29\">",
"     29",
"    </a>",
"    ]. A study from Haiti identified 99 women with peripartum cardiomyopathy, 15 of whom had subsequent pregnancies. Half of these women experienced worsening heart failure and long-term systolic dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A study from Toronto evaluated rates of maternal cardiac events and adverse fetal and neonatal events in 36 pregnancies in 32 women with dilated cardiomyopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/31\">",
"     31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      14 (39 percent) pregnancies were complicated by at least one maternal cardiac event. All maternal cardiac events occurred in women with moderate or severe LV systolic dysfunction (defined as left ventricular ejection fraction [LVEF] &lt;45 percent)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      NYHA functional class III or IV",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a prior cardiac event. The presence of any one of these three risk factors was associated with a 64 percent risk of an adverse cardiac event.",
"     </li>",
"     <li>",
"      The 16 month event-free survival for a subset of 18 pregnant women with LVEF &lt;45 percent was significantly worse compared to 18 age and LVEF-matched nonpregnant women with dilated cardiomyopathy (28 versus 83 percent).",
"     </li>",
"     <li>",
"      Seven of 35 (20 percent) pregnancies (excluding one pregnancy ending in induced abortion) were complicated by an adverse fetal",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      neonatal event. The adverse neonatal event rate was highest among women with both obstetric and cardiac risk factors.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with known or suspected left ventricular dysfunction should have an echocardiogram before conception, or as soon as possible after pregnancy is confirmed, to determine baseline ventricular function. Pregnancy should be discouraged if there is a significant reduction in ventricular function (ejection fraction &lt;45 percent). Of concern, women with prior peripartum cardiomyopathy in whom left ventricular function has returned to normal (&ge; 50 percent) still remain at significant risk for morbidity during subsequent pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/62/18410?source=see_link&amp;anchor=H31#H31\">",
"     \"Peripartum cardiomyopathy\", section on 'Subsequent pregnancy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with reduced ventricular function may require restriction of activity, medication (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29113?source=see_link\">",
"     digoxin",
"    </a>",
"    , diuretics, vasodilators), and close monitoring during labor and delivery to avoid significant volume shifts. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/34/1577?source=see_link\">",
"     \"Management of heart failure in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pregnancy is generally well tolerated in women with hypertrophic cardiomyopathy (HCM) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]. A study from Italy showed that the risk of death in patients with hypertrophic cardiomyopathy is increased over that of the general population, although the absolute mortality is low [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/35\">",
"     35",
"    </a>",
"    ]. Clinical deterioration with development of congestive heart failure occurred in 15 percent of the cohort and was related to their functional status prior to pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/10/22696?source=see_link&amp;anchor=H7#H7\">",
"     \"Overview of hypertrophic cardiomyopathy management including treatment of special problems\", section on 'Pregnancy and delivery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16632464\">",
"    <span class=\"h1\">",
"     CORONARY ARTERY DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with a history of prior myocardial infarction, percutaneous coronary interventions, coronary artery bypass surgery, or coronary artery disease from a systemic process such as vasculitis may contemplate pregnancy. Prior to pregnancy, baseline LV function should be determined and stress testing is beneficial to rule out active ischemia. Medications including lipid-lowering therapies, angiotensin converting enzyme inhibitors, and anti-platelet agents such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"     clopidogrel",
"    </a>",
"    should be discontinued. However, cessation of medications might impact unfavorably on prior coronary interventions and on lipid profiles during pregnancy, especially in young women with familial lipid problems.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4171842\">",
"    <span class=\"h1\">",
"     MYOCARDIAL INFARCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute myocardial infarction is a rare event in pregnancy and some women with a prior infarction become pregnant. The management of these patients is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/14/30950?source=see_link\">",
"     \"Acute coronary syndromes in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     HEART TRANSPLANT RECIPIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Successful pregnancies have been reported in heart transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/36-38\">",
"     36-38",
"    </a>",
"    ]. The management of medications such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    and antihypertensive drugs requires the expertise of a transplant service. This issue is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20487?source=see_link\">",
"     \"Pregnancy after cardiac transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     ARRHYTHMIAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arrhythmias and conduction disturbances can antedate or originate during pregnancy and may be exacerbated by it. Potential factors in pregnancy that can promote arrhythmogenesis include the hyperdynamic state (high cardiac output, increased contractility), the altered hormonal milieu, and underlying heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A study showed that recurrence of arrhythmias in women with preexisting rhythm disorders is common and that recurrence of arrhythmias increases the risk of adverse fetal complications [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/1/14362?source=see_link\">",
"     \"Supraventricular arrhythmias during pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/31/7674?source=see_link\">",
"     \"Ventricular arrhythmias during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF LABOR AND DELIVERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Virtually all gravidas with cardiac disease can expect to attempt vaginal delivery because it poses less cardiac risk than cesarean delivery (see",
"    <a class=\"local\" href=\"#H21\">",
"     'Mode of delivery'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Pregnant women with acquired cardiac disease who are considered functionally normal should be allowed to go into labor spontaneously. However, if there are any concerns about the functional adequacy of the heart and circulation, labor should be induced under controlled conditions. The timing of induction is individualized, taking into account the gravida's cardiac status, inducibility of the cervix, and fetal lung maturity. A long induction in a woman with an unfavorable cervix should be avoided. From a practical point of view, it may be useful to plan the induction so that delivery occurs during the working day when all hospital services are readily available.",
"   </p>",
"   <p>",
"    Induction of labor in a gravida with a favorable cervix usually requires only",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/0/5125?source=see_link\">",
"     oxytocin",
"    </a>",
"    administration and artificial rupture of the membranes. An unfavorable cervix should be ripened with a prostaglandin E analogue. The softened, dilated cervix is more responsive to subsequent induction of labor and permits the normal physiologic sequence of softening and dilatation before the onset of uterine contractions. Prostaglandin analogues are absorbed into the systemic circulation and can lower systemic vascular resistance, lower systemic pressure, and increase heart rate [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/41\">",
"     41",
"    </a>",
"    ]. These effects are more frequent with E2 than E1 and when the drugs are used in the higher dosages required for termination of pregnancy. Laminaria or a Foley catheter balloon can also be used for cervical ripening. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/37/31322?source=see_link\">",
"     \"Principles of labor induction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Anesthesia/analgesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intramuscular or intravenous opiates may be used to relieve pain and apprehension, but are not highly effective. Lumbar epidural anesthesia is highly effective for controlling labor pain and is recommended because it lowers pain-induced elevations of sympathetic activity, reduces the urge to push, and provides excellent anesthesia for operative procedures. The epidural should be dosed slowly with local anesthetics to maintain stable hemodynamics and adequate uteroplacental blood flow since venous return can be reduced by the anesthetic. Intravenous fluid administration must be monitored carefully to avoid over or under hydration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/36/3657?source=see_link\">",
"     \"Obstetric anesthetic management of women with acquired or congenital heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Hemodynamic monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic arterial pressure and heart rate are routinely monitored during labor; pulse oximetry and continuous ECG monitoring are utilized as required by the patient's condition. A Swan-Ganz catheter for hemodynamic monitoring should not be routinely employed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/31/27128?source=see_link\">",
"     \"Pulmonary artery catheterization: Indications and complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Mode of delivery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cesarean delivery should be reserved for obstetric indications such as failure to progress in labor, placenta previa, or fetal intolerance to labor. The concerns about cesarean delivery include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      General anesthesia, if required, incurs the risk of hemodynamic instability associated with intubation and the anesthetic agent.",
"     </li>",
"     <li>",
"      Cesarean delivery is accompanied by blood loss that is about twice as great as with vaginal delivery.",
"     </li>",
"     <li>",
"      There are increased risks of wound and uterine infection.",
"     </li>",
"     <li>",
"      Postoperative thrombophlebitis is more common after cesarean delivery.",
"     </li>",
"     <li>",
"      The risk of postoperative incisional bleeding is high in patients requiring anticoagulants.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For patients with known cardiac disease, consultation among the patient's obstetrician, the obstetrical anesthesiologist, and the patient's cardiologist is recommended prior to delivery. Once in labor, the woman should be placed in a lateral decubitus position to attenuate the hemodynamic fluctuations associated with major uterine contractions and the supine position. The obstetrician should allow the forces of labor to descend the fetal head to the perineum, unassisted by maternal pushing, to avoid the undesirable circulatory effects of the Valsalva maneuver. Delivery may then be assisted by low forceps or vacuum extraction, as needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Fetal monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;A reduction in uterine blood flow and placental oxygen delivery typically occurs during uterine contractions; however, the fetus is adapted to extract enough oxygen to maintain fetal health. Complications of labor (eg, abruption, cord compression) or maternal hemodynamic instability may subject the fetus to decreased oxygenation and lead to fetal acidosis or death. The growth restricted fetus is especially vulnerable to hypoxia during labor. For this reason, continuous electronic fetal heart rate monitoring is recommended to assess fetal well-being during labor and allow timely intervention if nonreassuring fetal heart rate patterns occur [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/11/2232?source=see_link\">",
"     \"Antepartum fetal heart rate assessment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Antibiotic prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of antibiotic prophylaxis for endocarditis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=see_link&amp;anchor=H15#H15\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\", section on 'Vaginal or cesarean delivery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Postpartum care",
"    </span>",
"    &nbsp;&mdash;&nbsp;After expulsion of the placenta, bleeding is reduced by uterine massage and intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/0/5125?source=see_link\">",
"     oxytocin",
"    </a>",
"    administration. Oxytocin should be infused slowly (less than 2",
"    <span class=\"nowrap\">",
"     units/min)",
"    </span>",
"    to avoid hypotensive effects. Prostaglandin F analogues are a good choice in the event of postpartum hemorrhage, unless an increase in pulmonary artery pressure is undesirable [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/41,43\">",
"     41,43",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/50/32549?source=see_link\">",
"     Methylergonovine",
"    </a>",
"    should be avoided in most patients because of the high rate (&gt;10 percent) of vasoconstriction and elevation of systemic pressure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/38/42600?source=see_link\">",
"     \"Overview of postpartum hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Delivery is associated with hemodynamic changes that can lead to heart failure in women with preexisting cardiovascular disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20105?source=see_link\">",
"     \"Maternal cardiovascular and hemodynamic adaptations to pregnancy\"",
"    </a>",
"    .) As a result, hemodynamic monitoring of the mother is warranted for 12 to 24 hours after delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29097/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients requiring prolonged bed rest, meticulous leg care, elastic support stockings, and early ambulation are important preventive measures that reduce the risk of thromboembolism postpartum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6966171\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although cardiac disease complicates only 1 to 4 percent of all pregnancies in the United States, maternal cardiac disease is a major cause of non-obstetric maternal morbidity and mortality. Care of the high-risk patients requires a team approach including a maternal-fetal medicine specialist, cardiologist, and obstetrical anesthesiologist. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pregnancy is associated with several cardiocirculatory changes that can significantly impact underlying cardiac disease. Knowledge of these cardiovascular adaptations is required to correctly interpret hemodynamic and cardiovascular tests in the gravida, to predict the effects of pregnancy on the woman with underlying cardiac disease, and to understand how the fetus will be affected by maternal cardiac disorders. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Physiology of normal pregnancy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      During normal labor and delivery, marked fluctuations in cardiac output occur, with increases up to 80 percent above third trimester levels in some cases. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Hemodynamic changes during labor and delivery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women with acquired heart disease may have cardiac complications during pregnancy, and their risk can be assessed by evaluating the severity of their valve lesions and the degree of ventricular dysfunction. The history, physical examination, echocardiogram, and electrocardiogram form the foundation of cardiac evaluation in all patients. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Assessing risk'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common valvular lesion of rheumatic origin found in women of child-bearing age is mitral stenosis, followed by mitral regurgitation; aortic stenosis and regurgitation account for the remainder of rheumatic heart disease cases. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Valvular heart disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with severe mitral stenosis can be successfully treated with balloon valvuloplasty during pregnancy. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Clinical course and management of valve disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cardiac surgery should be avoided, if possible, during pregnancy. The maternal risks are about the same as those in nonpregnant women, but cardiopulmonary bypass during pregnancy poses significant risk for the fetus. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Clinical course and management of valve disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women with biologic prosthetic heart valves who are hemodynamically stable and do not require anticoagulation generally tolerate pregnancy well. The risk of pregnancy is high for both the mother and fetus when a mechanical valve is present, mainly due to the need for anticoagulation to prevent valve thrombosis.",
"     </li>",
"     <li>",
"      Measurement of serial BNP levels may be helpful in following patients at risk for developing heart failure during pregnancy. (See",
"      <a class=\"local\" href=\"#H92292543\">",
"       'Measurement of BNP'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women in their childbearing years may present with ventricular dysfunction from a number of etiologies: prior viral infection, HIV infection, peripartum cardiomyopathy, or drug-induced cardiomyopathy (eg, cocaine,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"       doxorubicin",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Cardiomyopathy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women with prior peripartum cardiomyopathy in whom left ventricular function has returned to normal still remain at significant risk for morbidity during subsequent pregnancies. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Cardiomyopathy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Epidural anesthesia should be dosed slowly with local anesthetics to maintain stable hemodynamics and adequate uteroplacental blood flow since venous return can be reduced by the anesthetic. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Anesthesia/analgesia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Virtually all gravidas with cardiac disease can expect to attempt vaginal delivery because it poses less cardiac risk than cesarean delivery. Cesarean delivery should be reserved for standard obstetric indications such as failure to progress in labor, placenta previa, or fetal intolerance to labor. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Mode of delivery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Continuous electronic fetal heart rate monitoring is recommended to assess fetal well-being during labor and allow timely intervention if nonreassuring fetal heart rate patterns occur. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Fetal monitoring'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/1\">",
"      Fretts RC, Schmittdiel J, McLean FH, et al. Increased maternal age and the risk of fetal death. N Engl J Med 1995; 333:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/2\">",
"      Cunningham FG, Leveno KJ. Childbearing among older women--the message is cautiously optimistic. N Engl J Med 1995; 333:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/3\">",
"      Chapman AB, Abraham WT, Zamudio S, et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 1998; 54:2056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/4\">",
"      Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 1989; 256:H1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/5\">",
"      Robson SC, Hunter S, Moore M, Dunlop W. Haemodynamic changes during the puerperium: a Doppler and M-mode echocardiographic study. Br J Obstet Gynaecol 1987; 94:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/6\">",
"      Metcalfe J, Ueland K. Maternal cardiovascular adjustments to pregnancy. Prog Cardiovasc Dis 1974; 16:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/7\">",
"      KERR MG. THE MECHANICAL EFFECTS OF THE GRAVID UTERUS IN LATE PREGNANCY. J Obstet Gynaecol Br Commonw 1965; 72:513.",
"     </a>",
"    </li>",
"    <li>",
"     Lang RM, Borow KM. Heart disease. In: Medical Disorders During Pregnancy, Barron WM, Lindheimer MD (Eds), Mosby Year Book, St. Louis 1991. p.184.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/9\">",
"      Sciscione AC, Ivester T, Largoza M, et al. Acute pulmonary edema in pregnancy. Obstet Gynecol 2003; 101:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/10\">",
"      Pitkin RM, Perloff JK, Koos BJ, Beall MH. Pregnancy and congenital heart disease. Ann Intern Med 1990; 112:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/11\">",
"      Weiss BM, Atanassoff PG. Cyanotic congenital heart disease and pregnancy: natural selection, pulmonary hypertension, and anesthesia. J Clin Anesth 1993; 5:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/12\">",
"      Willcourt RJ, King JC, Queenan JT. Maternal oxygenation administration and the fetal transcutaneous PO2. Am J Obstet Gynecol 1983; 146:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/13\">",
"      Shime J, Mocarski EJ, Hastings D, et al. Congenital heart disease in pregnancy: short- and long-term implications. Am J Obstet Gynecol 1987; 156:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/14\">",
"      McFaul PB, Dornan JC, Lamki H, Boyle D. Pregnancy complicated by maternal heart disease. A review of 519 women. Br J Obstet Gynaecol 1988; 95:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/15\">",
"      Selzer A. Risks of pregnancy in women with cardiac disease. JAMA 1977; 238:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/16\">",
"      Schwartz DB, Schamroth L. The effect of pregnancy on the frontal plane QRS axis. J Electrocardiol 1979; 12:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/17\">",
"      Boyle DM, Lloyd-Jones RL. The electrocardiographic ST segment in pregnancy. J Obstet Gynaecol Br Commonw 1966; 73:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/18\">",
"      ORAM S, HOLT M. Innocent depression of the S-T segment and flattening of the T-wave during pregnancy. J Obstet Gynaecol Br Emp 1961; 68:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/19\">",
"      Siu SC, Sermer M, Harrison DA, et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 1997; 96:2789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/20\">",
"      Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001; 104:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/21\">",
"      Siu SC, Colman JM, Sorensen S, et al. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 2002; 105:2179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/22\">",
"      Hameed AB, Chan K, Ghamsary M, Elkayam U. Longitudinal changes in the B-type natriuretic peptide levels in normal pregnancy and postpartum. Clin Cardiol 2009; 32:E60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/23\">",
"      Tanous D, Siu SC, Mason J, et al. B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Cardiol 2010; 56:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/24\">",
"      Hameed A, Karaalp IS, Tummala PP, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 2001; 37:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/25\">",
"      Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:e523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/26\">",
"      Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/27\">",
"      Campuzano K, Roqu&eacute; H, Bolnick A, et al. Bacterial endocarditis complicating pregnancy: case report and systematic review of the literature. Arch Gynecol Obstet 2003; 268:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/28\">",
"      Avila WS, de Carvalho ME, Tschaen CK, et al. Pregnancy and peripartum cardiomyopathy. A comparative and prospective study. Arq Bras Cardiol 2002; 79:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/29\">",
"      Bernstein PS, Magriples U. Cardiomyopathy in pregnancy: a retrospective study. Am J Perinatol 2001; 18:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/30\">",
"      Fett JD, Christie LG, Murphy JG. Brief communication: Outcomes of subsequent pregnancy after peripartum cardiomyopathy: a case series from Haiti. Ann Intern Med 2006; 145:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/31\">",
"      Grewal J, Siu SC, Ross HJ, et al. Pregnancy outcomes in women with dilated cardiomyopathy. J Am Coll Cardiol 2009; 55:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/32\">",
"      Elkayam U, Tummala PP, Rao K, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001; 344:1567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/33\">",
"      Oakley GD, McGarry K, Limb DG, Oakley CM. Management of pregnancy in patients with hypertrophic cardiomyopathy. Br Med J 1979; 1:1749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/34\">",
"      Thaman R, Varnava A, Hamid MS, et al. Pregnancy related complications in women with hypertrophic cardiomyopathy. Heart 2003; 89:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/35\">",
"      Autore C, Conte MR, Piccininno M, et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 40:1864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/36\">",
"      Wasywich CA, Ruygrok PN, Wilkinson L, et al. Planned pregnancy in a heart transplant recipient. Intern Med J 2004; 34:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/37\">",
"      Scott JR, Wagoner LE, Olsen SL, et al. Pregnancy in heart transplant recipients: management and outcome. Obstet Gynecol 1993; 82:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/38\">",
"      Branch KR, Wagoner LE, McGrory CH, et al. Risks of subsequent pregnancies on mother and newborn in female heart transplant recipients. J Heart Lung Transplant 1998; 17:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/39\">",
"      Cox JL, Gardner MJ. Treatment of cardiac arrhythmias during pregnancy. Prog Cardiovasc Dis 1993; 36:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/40\">",
"      Silversides CK, Harris L, Haberer K, et al. Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am J Cardiol 2006; 97:1206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/41\">",
"      Secher NJ, Thayssen P, Arnsbo P, Olsen J. Effect of prostaglandin E2 and F2alpha on the systemic and pulmonary circulation in pregnant anesthetized women. Acta Obstet Gynecol Scand 1982; 61:213.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Obstetricians and Gynecologists. Fetal heart rate patterns: Monitoring, interpretation, and management. ACOG technical bulletin 207. Washington, DC 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/43\">",
"      Retzke U, Schwarz R. [Cardiovascular effects of prostaglandin F 2 alpha in early pregnancy]. Zentralbl Gynakol 1976; 98:1356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29097/abstract/44\">",
"      Elkayam U, Bitar F. Valvular heart disease and pregnancy part I: native valves. J Am Coll Cardiol 2005; 46:223.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8148 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-528937E1C1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_26_29097=[""].join("\n");
var outline_f28_26_29097=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6966171\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHYSIOLOGY OF NORMAL PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Antepartum hemodynamic changes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Electrocardiographic changes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Hemodynamic changes during labor and delivery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Minimizing hemodynamic effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ASSESSING RISK",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H92292510\">",
"      Predictors of cardiac events",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H92292543\">",
"      Measurement of BNP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      VALVULAR HEART DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Risk according to valve lesion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Clinical course and management of valve disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Valve replacement in women of childbearing age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      CARDIOMYOPATHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16632464\">",
"      CORONARY ARTERY DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4171842\">",
"      MYOCARDIAL INFARCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      HEART TRANSPLANT RECIPIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      ARRHYTHMIAS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      MANAGEMENT OF LABOR AND DELIVERY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Anesthesia/analgesia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Hemodynamic monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Mode of delivery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Fetal monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Antibiotic prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Postpartum care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6966171\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/8148\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8148|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/12/13519\" title=\"figure 1\">",
"      Causes of maternal death in the UK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8148|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/2/3117\" title=\"table 1\">",
"      Methods to assess cardiovascular disability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/33/17948\" title=\"table 2\">",
"      Severity of AS in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/14/30950?source=related_link\">",
"      Acute coronary syndromes in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/11/2232?source=related_link\">",
"      Antepartum fetal heart rate assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/46/18153?source=related_link\">",
"      Anticoagulation during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/0/19465?source=related_link\">",
"      Causes of dilated cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/29/25050?source=related_link\">",
"      Course and management of chronic aortic regurgitation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/9/149?source=related_link\">",
"      Etiology, clinical features, and evaluation of tricuspid regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/34/1577?source=related_link\">",
"      Management of heart failure in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/53/1882?source=related_link\">",
"      Management of pregnant women with prosthetic heart valves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/40/20105?source=related_link\">",
"      Maternal cardiovascular and hemodynamic adaptations to pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/31/6649?source=related_link\">",
"      Natural history of chronic mitral regurgitation in mitral valve prolapse and flail mitral leaflet",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/17/14617?source=related_link\">",
"      Natural history, screening, and management of rheumatic heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/36/3657?source=related_link\">",
"      Obstetric anesthetic management of women with acquired or congenital heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/10/22696?source=related_link\">",
"      Overview of hypertrophic cardiomyopathy management including treatment of special problems",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/38/42600?source=related_link\">",
"      Overview of postpartum hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33497?source=related_link\">",
"      Percutaneous mitral balloon valvotomy for mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/62/18410?source=related_link\">",
"      Peripartum cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/46/38633?source=related_link\">",
"      Pharmacologic management of pain during labor and delivery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/0/20487?source=related_link\">",
"      Pregnancy after cardiac transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/50/20262?source=related_link\">",
"      Pregnancy and Marfan syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/7/29818?source=related_link\">",
"      Pregnancy in women with congenital heart disease: General principles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/21/35159?source=related_link\">",
"      Pregnancy in women with congenital heart disease: Specific lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29447?source=related_link\">",
"      Pregnancy in women with mitral stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/37/31322?source=related_link\">",
"      Principles of labor induction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/31/27128?source=related_link\">",
"      Pulmonary artery catheterization: Indications and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/1/14362?source=related_link\">",
"      Supraventricular arrhythmias during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/53/36697?source=related_link\">",
"      Surgical procedures for severe chronic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/58/7078?source=related_link\">",
"      Treatment of bicuspid aortic valve stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/31/7674?source=related_link\">",
"      Ventricular arrhythmias during pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_26_29098="Fever and rash in the immunocompetent patient";
var content_f28_26_29098=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Fever and rash in the immunocompetent patient",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/26/29098/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29098/contributors\">",
"     Fred A Lopez, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29098/contributors\">",
"     Charles V Sanders, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/26/29098/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29098/contributors\">",
"     Peter F Weller, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?28/26/29098/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?28/26/29098/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?28/26/29098/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fever with an accompanying rash is a common symptom constellation in patients presenting to clinicians' offices and emergency departments. Skin manifestations may provide the only early clue to an underlying infection, may be the hallmark of contagious disease,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    may be an early sign of a life-threatening infection. The differential diagnosis of fever and rash is extremely broad, but this symptom complex provides an opportunity for the diligent clinician to establish a probable etiology through a careful history and physical examination.",
"   </p>",
"   <p>",
"    A systematic approach is crucial for establishing a timely diagnosis, determining early therapy when appropriate, and considering isolation of the patient if necessary. Epidemiologic clues are important to pursue such as [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age of the patient",
"     </li>",
"     <li>",
"      Season of the year",
"     </li>",
"     <li>",
"      Travel history",
"     </li>",
"     <li>",
"      Geographic location",
"     </li>",
"     <li>",
"      Exposures including to insects, animals, and ill contacts",
"     </li>",
"     <li>",
"      Medications",
"     </li>",
"     <li>",
"      Immunizations and history of childhood illnesses",
"     </li>",
"     <li>",
"      The immune status of the host",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Features of the rash are also important to consider, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Characteristics of the lesions",
"     </li>",
"     <li>",
"      Distribution and progression of the rash",
"     </li>",
"     <li>",
"      Timing of the onset in relation to fever",
"     </li>",
"     <li>",
"      Change in morphology, such as papules to vesicles or petechiae",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite the strong association between the syndrome of fever and rash and infectious diseases, a variety of noninfectious processes can also cause similar presentations including deep venous thrombosis, superficial thrombophlebitis, erythromelalgia, relapsing polychondritis, foreign body reactions, drug reactions, gouty arthritis, cutaneous lupus erythematosus, and erythema nodosum [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/7\">",
"     7",
"    </a>",
"    ]. The approach to the immunocompetent patient with fever and rash and selected presentations that constitute emergencies will be reviewed here. Specific infections with characteristic rashes and fever and rash in immunocompromised patients are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/34/42537?source=see_link\">",
"     \"Infectious causes of fever and rash in non-HIV immunocompromised hosts\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/61/24538?source=see_link\">",
"     \"Fever and rash in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY AND ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidemiologic features are extremely helpful in the approach to a patient with a fever and rash [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/1-4\">",
"     1-4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Diseases that present in childhood",
"    </span>",
"    &nbsp;&mdash;&nbsp;The age of the patient often assists in narrowing the differential diagnosis. Exanthems associated with a variety of viral illnesses are classically seen in the pediatric age group [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/8\">",
"     8",
"    </a>",
"    ]. The constellation of symptoms and a characteristic rash often allow for a clinically-based diagnosis, as illustrated by the following disorders.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Measles (rubeola) is associated with a blanching erythematous \"brick-red\" maculopapular rash beginning in the head and neck area and spreading centrifugally to the trunk and extremities; patients also complain of fever, cough, coryza, and conjunctivitis (",
"      <a class=\"graphic graphic_picture graphicRef57093 \" href=\"UTD.htm?4/26/4512\">",
"       picture 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/11/43192?source=see_link\">",
"       \"Clinical presentation and diagnosis of measles\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Chickenpox is characterized by classic vesicular lesions on an erythematous base that appear in crops and are present in different stages from papules through vesicles to crusting (",
"      <a class=\"graphic graphic_picture graphicRef55533 \" href=\"UTD.htm?36/3/36927\">",
"       picture 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/44/33480?source=see_link\">",
"       \"Clinical features of varicella-zoster virus infection: Chickenpox\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Rubella has a rash that resembles measles, but the patient does not appear to be sick; prominent postauricular, posterior cervical,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      suboccipital adenopathy also assists in the diagnosis. Forscheimer spots, or punctate soft palate macules, can represent a helpful clue.",
"     </li>",
"     <li>",
"      Erythema infectiosum (fifth disease) is due to human parvovirus B19. Children, unlike adults, often develop a characteristic rash with a \"slapped cheeks\" appearance (",
"      <a class=\"graphic graphic_picture graphicRef75125 \" href=\"UTD.htm?11/27/11696\">",
"       picture 3",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22377?source=see_link\">",
"       \"Clinical manifestations and pathogenesis of human parvovirus B19 infection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Roseola infantum or exanthem subitum, a human herpesvirus 6 or 7 infection primarily seen in infants, is characterized by high fever for three to four days, followed by seizures and a generalized maculopapular rash that spreads from the trunk to the extremities but spares the face. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/19/28982?source=see_link\">",
"       \"Roseola infantum (exanthem subitum)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/55/14201?source=see_link&amp;anchor=H9#H9\">",
"       \"Human herpesvirus 7 infection\", section on 'Primary infection'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other infections accompanied by rash also occur primarily in children:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Scarlet fever is an exotoxin (erythrogenic toxin)-mediated diffuse erythematous rash occurring most commonly in the setting of pharyngitis from group A streptococcus (GAS) infection. Scarlet fever is manifested by a coarse, sandpaper-like, erythematous, blanching rash, which ultimately desquamates. This is accompanied by circumoral pallor and a strawberry tongue. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/30/27110?source=see_link\">",
"       \"Complications of streptococcal tonsillopharyngitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acute rheumatic fever (ARF) is another potential sequela of group A streptococcal pharyngeal infection. The classic dermatologic manifestations of ARF are erythema marginatum (transient macular lesions with central clearing found on the extensor surfaces of the proximal extremities and trunk) and subcutaneous nodules often located over bony prominences. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/30/27110?source=see_link\">",
"       \"Complications of streptococcal tonsillopharyngitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23879?source=see_link\">",
"       \"Clinical manifestations and diagnosis of acute rheumatic fever\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Kawasaki syndrome, a disease of unknown etiology, is usually seen in children less than four years of age. In addition to fever lasting &gt;5 days, some of the criteria for this syndrome, as defined by the Centers for Disease Control and Prevention (CDC), are: bilateral conjunctival injection, injected or fissured lips, injected pharynx or 'strawberry tongue' (",
"      <a class=\"graphic graphic_picture graphicRef68321 \" href=\"UTD.htm?0/2/43\">",
"       picture 4",
"      </a>",
"      ), erythema of the palms or soles, edema of the hands or feet or generalized or periungual desquamation, rash, and cervical lymphadenopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/9\">",
"       9",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12248?source=see_link\">",
"       \"Kawasaki disease: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nonpolio enteroviruses (coxsackievirus, echovirus) can cause a variety of rashes and should always be included in the differential diagnosis of a young child with fever and rash of undetermined etiology. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=see_link\">",
"       \"Clinical manifestations and diagnosis of enterovirus and parechovirus infections\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      An evaluation for Epstein-Barr virus (EBV)-associated infectious mononucleosis should be undertaken in older children and adolescents who present with fever, malaise, sweats, anorexia, nausea, chills, sore throat, posterior cervical lymphadenopathy, splenomegaly, and a maculopapular rash, especially after the administration of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"       ampicillin",
"      </a>",
"      &nbsp;(",
"      <a class=\"graphic graphic_picture graphicRef57224 \" href=\"UTD.htm?31/33/32272\">",
"       picture 5",
"      </a>",
"      ). The rash is usually over the trunk but can involve the extremities, including the hands and feet. Other causes of infectious mononucleosis are discussed below. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Selected diseases that present in adulthood'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31018?source=see_link\">",
"       \"Infectious mononucleosis in adults and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Adolescents and young adults with pharyngitis, fever, lymphadenopathy,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <span class=\"nowrap\">",
"       maculopapular/scarlatiniform",
"      </span>",
"      rash whose work-up is negative for group A streptococcus and viral-associated mononucleosis may be infected with Arcanobacterium haemolyticum, a gram-positive rod that appears to be more susceptible to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      than to penicillin [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/10\">",
"       10",
"      </a>",
"      ]. This infection is seen primarily in patients who are 15 to 18 years of age, and the rash, which can be pruritic, is typically seen first over the extensor surfaces before spreading centrally [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/10\">",
"       10",
"      </a>",
"      ]. The rash usually spares the face.",
"     </li>",
"     <li>",
"      Mycoplasma infection may be accompanied by skin findings, which include a mild erythematous maculopapular or vesicular rash, erythema multiforme, or the Stevens-Johnson syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/35/6713?source=see_link&amp;anchor=H10#H10\">",
"       \"Mycoplasma pneumoniae infection in children\", section on 'Skin disease'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Selected diseases that present in adulthood",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exanthems associated with a variety of viral illnesses can be seen in adults. Several to consider include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Measles (rubeola) is associated with a blanching erythematous \"brick-red\" maculopapular rash beginning in the head and neck area and spreading centrifugally to the trunk and extremities (",
"      <a class=\"graphic graphic_picture graphicRef57093 \" href=\"UTD.htm?4/26/4512\">",
"       picture 1",
"      </a>",
"      ); patients also complain of fever, cough, coryza, and conjunctivitis. Despite the availability of an effective measles vaccine, measles outbreaks continue to occur [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/11\">",
"       11",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/11/43192?source=see_link\">",
"       \"Clinical presentation and diagnosis of measles\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/16/42246?source=see_link\">",
"       \"Epidemiology and transmission of measles\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Infectious mononucleosis can be caused by several different pathogens. Young adults who present with fever, malaise, sweats, anorexia, nausea, chills, sore throat, posterior cervical lymphadenopathy, splenomegaly, and a maculopapular rash, especially after the administration of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"       ampicillin",
"      </a>",
"      , should undergo an evaluation for Epstein-Barr virus (EBV)-associated infectious mononucleosis (",
"      <a class=\"graphic graphic_picture graphicRef57224 \" href=\"UTD.htm?31/33/32272\">",
"       picture 5",
"      </a>",
"      ). The rash is usually over the trunk but can involve the extremities, including the hands and feet. About half of all college freshmen have EBV-associated antibodies, and up to 20 percent of those who do not are expected to seroconvert annually during these years. Importantly, these cases are usually asymptomatic [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/12\">",
"       12",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31018?source=see_link\">",
"       \"Infectious mononucleosis in adults and adolescents\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Cytomegalovirus should be considered in the heterophile antibody-negative patient with infectious mononucleosis, although lymphadenopathy and pharyngitis may not be as prominent.",
"      <br/>",
"      <br/>",
"      The acute retroviral syndrome that may occur approximately two to four weeks after primary HIV infection is a mononucleosis-like illness characterized by fever, sore throat, malaise, headache, lymphadenopathy, mucocutaneous ulceration, and rash. The rash, seen in more than 50 percent of patients, is usually transient, maculopapular, nonpruritic, and truncal or facial in location. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/46/18151?source=see_link\">",
"       \"Acute and early HIV infection: Pathogenesis and epidemiology\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Adolescents and young adults with pharyngitis, fever, lymphadenopathy,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a",
"      <span class=\"nowrap\">",
"       maculopapular/scarlatiniform",
"      </span>",
"      rash whose evaluation is negative for group A streptococcus and viral causes of mononucleosis may be infected with Arcanobacterium haemolyticum, a gram-positive rod that appears to be more susceptible to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      than to penicillin [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/10\">",
"       10",
"      </a>",
"      ]. This infection is seen primarily in patients who are 15 to 18 years of age and the rash, which can be pruritic, is typically seen first over the extensor surfaces before spreading centrally [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/10\">",
"       10",
"      </a>",
"      ]. The rash usually spares the face.",
"     </li>",
"     <li>",
"      Approximately 20 percent of cases of erythema infectiosum occur in adults [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/13\">",
"       13",
"      </a>",
"      ]. Constitutional symptoms in primary infection are more pronounced in adults and typically include lymphadenopathy, arthritis, and fever. The rash, when present, is often described as first macular and then lacy and reticulated, spreading initially from the limbs to the trunk and buttocks. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22377?source=see_link\">",
"       \"Clinical manifestations and pathogenesis of human parvovirus B19 infection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Individuals who did not have chickenpox during childhood may develop it later in life. Those who did have chickenpox may develop herpes zoster (shingles), which is caused by reactivation of latent varicella zoster virus. Incidence and severity increases with age and with increasing immunosuppression. In immunocompetent individuals, herpes zoster is typically manifested as vesicular lesions distributed along a dermatome and ending at the midline (",
"      <a class=\"graphic graphic_picture graphicRef79886 \" href=\"UTD.htm?42/52/43842\">",
"       picture 6",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/44/33480?source=see_link\">",
"       \"Clinical features of varicella-zoster virus infection: Chickenpox\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/20/2378?source=see_link\">",
"       \"Clinical manifestations of varicella-zoster virus infection: Herpes zoster\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mycoplasma infection may be accompanied by skin findings, which range from a mild erythematous maculopapular or vesicular rash to the Stevens-Johnson syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/5/3162?source=see_link&amp;anchor=H10#H10\">",
"       \"Mycoplasma pneumoniae infection in adults\", section on 'Skin disease'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Season of the year",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of infections characterized by fever and rash have a distinct seasonal predisposition. As examples, nonpolio enteroviral infections occur in the summer and fall months; Kawasaki syndrome, meningococcal infection, and parvoviral infections present most commonly in the winter or early spring months; measles and rubella are more frequent in the spring; tick-borne diseases such as Lyme disease, ehrlichiosis, and Rocky Mountain spotted fever (RMSF) primarily occur in the spring and summer; tularemia and plague are usually seen in the summer. Vibrio vulnificus infections occur between the months of April and October, when warmer waters facilitate propagation of this organism. Septicemia due to this organism typically occurs after consumption of raw seafood (usually oysters). Vibrio vulnificus- and V. parahaemolyticus-associated wound infections can occur after injury to skin in contaminated water (eg, after natural disasters) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/42/44710?source=see_link\">",
"     \"Vibrio vulnificus infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Geography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Travel to or residence in specific areas of the continental United States or other parts of the world can provide important clues for the diagnosis of fever and rash [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. Examples associated with a principal location in the United States include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Rocky Mountain spotted fever &mdash; south-central and Atlantic states",
"     </li>",
"     <li>",
"      Human monocytic ehrlichiosis &mdash; Midwestern, south-central, and southeastern states",
"     </li>",
"     <li>",
"      Lyme disease &mdash; the Pacific northwest, the midwest, and the northeast",
"     </li>",
"     <li>",
"      The tick vectors for tularemia &mdash; western, southeastern, and south-central states",
"     </li>",
"     <li>",
"      Plague &mdash; western states",
"     </li>",
"     <li>",
"      Relapsing fever due to Borrelia hermsii &mdash; mountainous areas of the western United States",
"     </li>",
"     <li>",
"      Endemic fungal infections including Blastomyces dermatitidis (southeastern states), Coccidioides immitis (southwestern states), and Histoplasma capsulatum (Mississippi and Ohio River valleys)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Several informative reviews on skin manifestations of infections in areas of the world other than the United States are available [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. The CDC website (",
"    <a class=\"external\" href=\"file://www.cdc.gov/travel/index.htm\">",
"     www.cdc.gov/travel/index.htm",
"    </a>",
"    ) is an excellent resource for prospective travelers to other areas of the world. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/48/8967?source=see_link\">",
"     \"Travel advice\"",
"    </a>",
"    .) A number of entities, characterized by rash but not always fever, merit consideration in individuals residing in or returning from trips to international sites [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cutaneous leishmaniasis, which can present with papular, nodular, or ulcerative lesions, occurs in an Old World and New World form caused by different species. Leishmania tropica, L. major, or L. aethiopica occurs in patients who live in or who have visited the Middle East, Far East, or Africa (Old World cutaneous leishmaniasis) (",
"      <a class=\"graphic graphic_picture graphicRef71944 \" href=\"UTD.htm?12/40/12928\">",
"       picture 7",
"      </a>",
"      ). New World cutaneous leishmaniasis is caused by different species in Central and South America. L. braziliensis in South America causes ulcerative lesions with the subsequent development of disfiguring oral, pharyngeal, or nasal lesions. Leishmaniasis has also been reported in central and southern Texas in patients who have not traveled to areas endemic for this organism [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Trypanosoma cruzi, which causes Chagas disease, is found in South and Central America. Findings can include Roma&ntilde;a's sign, a combination of unilateral conjunctivitis and eyelid edema (",
"      <a class=\"graphic graphic_picture graphicRef58601 \" href=\"UTD.htm?11/27/11711\">",
"       picture 8",
"      </a>",
"      ) or the chagoma, an indurated nodular lesion.",
"     </li>",
"     <li>",
"      Skin manifestations of schistosomiasis, acquired by wading or swimming in fresh water, can include nonspecific maculopapular lesions or characteristic verrucoid lesions known as Bilharzia cutaneous tarda. The most common species infecting humans include Schistosoma haematobium (Africa, Middle East), S. mansoni (Africa, Middle East, South America), and S. japonicum (eastern Asia). In addition, in North America similar maculopapular lesions (\"swimmer's itch\") may develop after swimming or wading in water that contains cercariae of avian and other non-human schistosome species. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/38/15977?source=see_link&amp;anchor=H15#H15\">",
"       \"Epidemiology, pathogenesis, and clinical features of schistosomiasis\", section on 'Swimmer's itch'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Dengue virus infections are increasing in incidence, and its primary vector, the Aedes aegypti mosquito, inhabits nearly all tropical latitudes, including the United States [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/24\">",
"       24",
"      </a>",
"      ]. Skin manifestations can include a transient macular rash early in the infection and a generalized morbilliform-like rash sparing the palms and soles when fever resolves on approximately day five. Petechiae, purpura, and ecchymoses are more likely to be seen in dengue hemorrhagic fever or dengue shock syndrome, severe presentations of dengue virus seen in previously sensitized patients [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/25\">",
"       25",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18985?source=see_link\">",
"       \"Clinical presentation and diagnosis of dengue virus infections\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A variety of parasitic larvae can cause a \"creeping eruption\" known as cutaneous larva migrans. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36229?source=see_link\">",
"       \"Cutaneous larva migrans (creeping eruption)\"",
"      </a>",
"      .) Typically, dog and cat hookworm larvae enter the skin of the foot and cause a migratory, pruritic erythematous serpiginous lesion observed intermittently until the parasite's death in the human, a dead-end host (",
"      <a class=\"graphic graphic_picture graphicRef60144 \" href=\"UTD.htm?39/63/40944\">",
"       picture 9",
"      </a>",
"      ). These infections are found worldwide in tropical and subtropical areas and commonly originate on sandy shores.",
"     </li>",
"     <li>",
"      The southern United States, Asia, Africa, Central America, and parts of eastern Europe are geographic foci for infection with the nematode Strongyloides stercoralis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/59/11193?source=see_link\">",
"       \"Strongyloidiasis\"",
"      </a>",
"      .) Skin lesions are polyphasic early but may become maculopapular or urticarial in chronic infection. The classic and pathognomonic lesion of this helminthic infection is larva currens, a short-lived but recurrent pruritic, migratory, serpiginous rash involving the thighs or perineum.",
"     </li>",
"     <li>",
"      Travelers returning from Africa, Central America, and South America who develop painless subcutaneous nodules (usually on the head or bony prominences) or a pruritic dermatitis may have onchocerciasis, a nematode (Onchocerca volvulus) infection transmitted by the black fly (",
"      <a class=\"graphic graphic_picture graphicRef59106 \" href=\"UTD.htm?14/9/14495\">",
"       picture 10",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/30/20970?source=see_link\">",
"       \"Onchocerciasis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Travelers returning from the northeastern or southern African bush country, India, the Mediterranean, or Russia who present with a small (less than 1 cm) necrotic ulcer with surrounding erythema (\"tache-noire\") and subsequently develop fever, headache, regional lymphadenopathy, and a diffuse maculopapular skin rash may have Boutonneuse fever secondary to tick-associated Rickettsia conorii infection. Similar presentations may be seen in travelers returning from eastern Australia who are infected with R. australis (\"Queensland fever\"), from northern Asia who are infected with R. sibirica (\"North Asian fever\"), or from Japan who are infected with R. japonica (\"Oriental spotted fever\"). Included in this group of \" spotted fevers\" is the mouse mite associated rickettsialpox caused by R. akari; it is seen in urban areas of the United States, Russia, and South Africa (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/57/9113?source=see_link\">",
"       \"Potential health hazards in travelers to Australia, New Zealand, and the southwestern Pacific (Oceania)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29220?source=see_link\">",
"       \"Rickettsialpox\"",
"      </a>",
"      ). Scrub typhus, a potentially fatal rickettsial infection transmitted by mites, is characterized by a maculopapular rash, and in some patients, eschars. This entity can be seen in travelers to Southeast Asia, the southern and western Pacific, Nepal, India, Korea, Australia, and China. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/6/18534?source=see_link\">",
"       \"Scrub typhus: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Typhoid fever can occur in travelers to endemic areas like Mexico or India who ingest food or water contaminated by fecal matter. The skin manifestations are small, blanching papules called rose spots, usually found on the trunk, which typically arise in the second week of infection and fade within several days. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/2/42024?source=see_link\">",
"       \"Epidemiology, microbiology, clinical manifestations, and diagnosis of typhoid fever\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Incubation period",
"    </span>",
"    &nbsp;&mdash;&nbsp;Knowledge of the incubation period for infectious agents is particularly helpful to the physician trying to determine the significance of a rash in a patient exposed to another individual with a similar exanthem. A range of incubation periods exists for selected infectious agents that may be associated with fever and rash (",
"    <a class=\"graphic graphic_table graphicRef66762 graphicRef81858 \" href=\"UTD.htm?6/32/6670\">",
"     table 1A-B",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Exposure history",
"    </span>",
"    &nbsp;&mdash;&nbsp;The category of exposures is a broad one in the differential diagnosis of fever and rash. Exposures to food, water, plant materials, animals, and infected human secretions can lead to rashes and can be associated with both occupational and nonoccupational contacts. As an example, the herpetic whitlow, seen in dental workers exposed to HSV-infected mucous membranes and secretions, is a classic occupation-associated infection (",
"    <a class=\"graphic graphic_picture graphicRef75510 \" href=\"UTD.htm?30/31/31231\">",
"     picture 11",
"    </a>",
"    ). Animal handlers, pet owners, and laboratory workers are more vulnerable to such infections, including [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/26-28\">",
"     26-28",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Toxoplasmosis and cat scratch disease from cats and kittens (",
"      <a class=\"graphic graphic_picture graphicRef59249 \" href=\"UTD.htm?25/3/25663\">",
"       picture 12",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/47/23289?source=see_link\">",
"       \"Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Psittacosis from poultry, finches, or parrots. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/14/8425?source=see_link\">",
"       \"Psittacosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cryptococcosis from pigeon, dog, or cat feces",
"     </li>",
"     <li>",
"      Plague from goats, rabbits, dogs, squirrels, or coyotes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/15/11512?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and treatment of plague (Yersinia pestis infection)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Rat bite fever or leptospirosis from rats",
"     </li>",
"     <li>",
"      Tularemia in sheep handlers, wild game cooks, pelt dealers, and veterinarians, which can result in ulceroglandular, oculoglandular, glandular, oropharyngeal, typhoidal, or pneumonic syndromes [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/29\">",
"       29",
"      </a>",
"      ]&nbsp;(",
"      <a class=\"graphic graphic_picture graphicRef75954 \" href=\"UTD.htm?15/21/15697\">",
"       picture 13",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Pasteurella-associated wound infections secondary to cat and dog bites [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/30\">",
"       30",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other environmental occupational exposures include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Papular or nodular lymphocutaneous lesions that develop on the extremities after trauma associated with an aquarium or swimming pool or after handling seafood are consistent with Mycobacterium marinum infections (\"fish tank granuloma\") [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/31,32\">",
"       31,32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Percutaneous injuries inflicted while handling the fish tilapia have been reported to cause Streptococcus iniae cellulitis of the hand [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Erysipelothrix rhusiopathiae, a gram-positive rod whose major host is swine, can produce a localized violaceous, cellulitic process involving primarily the hands or fingers in fish and meat handlers (",
"      <a class=\"graphic graphic_picture graphicRef55885 \" href=\"UTD.htm?33/21/34143\">",
"       picture 14",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      A gram-negative rod known as Edwardsiella tarda can cause fresh water-associated wound infections. Skin and soft tissue infections caused by this organism include abscesses, necrotizing fasciitis, bullae, myonecrosis, necrotizing fasciitis, and cellulitis [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Individuals who work with plants and soil (ie, florists, gardeners, farmers) are at risk for developing sporotrichosis, an infection of the extremities caused by the dimorphic fungus Sporothrix schenckii (",
"      <a class=\"graphic graphic_picture graphicRef65985 \" href=\"UTD.htm?13/63/14320\">",
"       picture 15",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12469?source=see_link\">",
"       \"Clinical features and diagnosis of sporotrichosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A variety of conditions accompanied by fever and rash result from arthropod exposures. As examples, black flies are associated with onchocerciasis, deer flies with loiasis, fleas with plague and endemic typhus, mosquitoes with malaria and dengue fever, assassin or reduviid bugs with Chagas disease, and sand flies with leishmaniasis.",
"   </p>",
"   <p>",
"    A report from the western United States described 15 patients with West Nile Virus fever who presented with a generalized maculopapular rash. A tingling and burning sensation was reported by four patients (27 percent) and pruritus by five patients (33 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The spirochete Borrelia burgdorferi is the etiologic agent of Lyme disease, an ixodid tick-associated infection seen in the United States. The classic skin lesion in this infection is erythema migrans (EM), a red expanding plaque-like lesion with central clearing that develops at the site of the tick bite (",
"    <a class=\"graphic graphic_picture graphicRef81270 \" href=\"UTD.htm?10/10/10400\">",
"     picture 16",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35225?source=see_link\">",
"     \"Clinical manifestations of Lyme disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other tick-borne diseases seen in the United States include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ehrlichiosis can present as human monocytic ehrlichiosis (HME) caused by Ehrlichia chaffeensis or human granulocytic anaplasmosis (HGA) due to Anaplasma phagocytophilum [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/36\">",
"       36",
"      </a>",
"      ]. Rash may or may not accompany ehrlichia infection which has also been termed \"Spotless Rocky Mountain spotted fever\" [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/37\">",
"       37",
"      </a>",
"      ]. A rash is much more likely to be seen in cases of HME than HGE [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/38\">",
"       38",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/5/6234?source=see_link\">",
"       \"Human ehrlichiosis and anaplasmosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Rickettsia rickettsii, the etiologic agent of RMSF, can be transmitted by the dog or wood tick and is primarily seen in the south-central and south Atlantic United States (see below). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/51/14135?source=see_link\">",
"       \"Clinical manifestations and diagnosis of Rocky Mountain spotted fever\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Southern tick-associated rash illness (STARI), presumably caused by a spirochete carried by Amblyomma americanum ticks, is characterized by a flu-like illness and an erythema multiforme-like rash. STARI should be considered in areas where A. americanum ticks are present, but where Lyme disease is absent or uncommon [",
"      <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/39\">",
"       39",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/58/26533?source=see_link\">",
"       \"Southern tick-associated rash illness (STARI)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Recreational activities can result in infections associated with characteristic skin lesions. Exposure to hot tubs or whirlpools can cause Pseudomonas aeruginosa folliculitis (",
"    <a class=\"graphic graphic_picture graphicRef65119 \" href=\"UTD.htm?33/14/34031\">",
"     picture 17",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/40\">",
"     40",
"    </a>",
"    ]. Swimming in contaminated lake water has been associated with the development of hemolytic-uremic syndrome with thrombocytopenia-associated petechial skin lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/41\">",
"     41",
"    </a>",
"    ]. Herpes gladiatorum skin infections have been described in athletes who engage in contact sports like rugby and wrestling [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/42,43\">",
"     42,43",
"    </a>",
"    ], and outbreaks of group A streptococcal skin infections can occur in American and European football players after competition [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. In one report, a cutaneous larva migrans infection secondary to Ancylostoma braziliense was observed in a beach volleyball player [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Medication history",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although drugs can cause a plethora of skin lesions, the relationship between drug fever and rash may not be as strong as many physicians believe. In one systematic analysis of 148 episodes of drug fever, fewer than 20 percent were associated with rash, and fewer than 50 percent of the rashes were urticarial in nature [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/47\">",
"     47",
"    </a>",
"    ]. Hypersensitivity or allergic-type skin reactions (rash, itching, or hives) were evaluated in over 20,000 hospitalized patients in the Boston Collaborative Drug surveillance program, and though associated fever was not evaluated, only about 2 percent of patients receiving drugs developed cutaneous reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/48\">",
"     48",
"    </a>",
"    ]. Antibiotics such as penicillins, cephalosporins, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    were associated with high rates of allergic skin reactions. Other drugs classically associated with fever and hypersensitivity reactions include barbiturates,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/34/36391?source=see_link\">",
"     procainamide",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/48/777?source=see_link\">",
"     quinidine",
"    </a>",
"    . However, only one in every 1000 hospitalized patients develops a severe cutaneous drug reaction like Stevens-Johnson syndrome or toxic epidermal necrolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/49\">",
"     49",
"    </a>",
"    ]. A metabolic predisposition leading to ineffective detoxification of sulfonamide and anticonvulsant metabolites may lead to severe adverse cutaneous drug reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/50\">",
"     50",
"    </a>",
"    ]. These reactions typically develop one to three weeks after the initiation of the culprit agent [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/29/17882?source=see_link\">",
"     \"Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Immunization history",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inadequately immunized individuals are susceptible to the traditional childhood viral infections and serve as an often overlooked reservoir of disease. The current recommended immunizations for children in the United States include hepatitis A and B, diphtheria and tetanus toxoids and pertussis, Haemophilus influenzae type B, rotavirus, poliovirus, measles-mumps-rubella (MMR), varicella virus, meningococcus, and pneumococcus.",
"   </p>",
"   <p>",
"    Follow-up of older children with their primary care physicians provides an opportune time for confirming appropriate immunizations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/56/39818?source=see_link\">",
"     \"Standard immunizations for children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Sexual history",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough sexual history is essential in evaluating the patient with a rash of unknown etiology. Genital or rectal ulcerations may be caused by a variety of infectious agents, including syphilis (",
"    <a class=\"graphic graphic_picture graphicRef50385 \" href=\"UTD.htm?4/40/4739\">",
"     picture 18",
"    </a>",
"    ), herpes simplex (",
"    <a class=\"graphic graphic_picture graphicRef78603 \" href=\"UTD.htm?3/48/3855\">",
"     picture 19",
"    </a>",
"    ), lymphogranuloma venereum (",
"    <a class=\"graphic graphic_picture graphicRef73707 \" href=\"UTD.htm?37/32/38401\">",
"     picture 20",
"    </a>",
"    ), chancroid (",
"    <a class=\"graphic graphic_picture graphicRef76843 \" href=\"UTD.htm?16/5/16464\">",
"     picture 21",
"    </a>",
"    ), and donovanosis (",
"    <a class=\"graphic graphic_picture graphicRef58925 \" href=\"UTD.htm?13/53/14163\">",
"     picture 22",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef60432 graphicRef68988 \" href=\"UTD.htm?39/38/40557\">",
"     table 2A-B",
"    </a>",
"    ). These infections may not be associated with fever.",
"   </p>",
"   <p>",
"    Syphilis can have a variety of cutaneous manifestations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/55/12150?source=see_link\">",
"     \"Pathophysiology, transmission, and natural history of syphilis\"",
"    </a>",
"    .) The primary stage is characterized by the chancre, a painless, often solitary, indurated genital ulceration with elevated, well-defined borders. The skin lesions of secondary syphilis include a generalized papular or maculopapular rash (rarely pustular) that also affects the palms and soles (",
"    <a class=\"graphic graphic_picture graphicRef65500 \" href=\"UTD.htm?6/6/6242\">",
"     picture 23",
"    </a>",
"    ). Other lesions seen during this stage include condylomata lata, flat moist condylomata-like lesions that are gray, infectious, and located around the genitals, mouth, anus, and other moist areas (",
"    <a class=\"graphic graphic_picture graphicRef56162 \" href=\"UTD.htm?22/28/22979\">",
"     picture 24",
"    </a>",
"    ). Approximately 15 to 30 percent of infected patients will manifest mucous membrane ulcerations that are sharply demarcated and covered with a gray exudate, ie, mucous patches. Patchy alopecia resulting in a \"moth-eaten\" appearance of the scalp can also be seen during this stage.",
"   </p>",
"   <p>",
"    Classic skin lesions of late, or tertiary, syphilis include the gumma, generally a solitary granulomatous subcutaneous skin or mucous membrane lesion that is initially nodular before ulcerating. Enlargement of these lesions can result in local tissue destruction. Also seen in tertiary syphilis are noduloulcerative lesions arranged in characteristic ring-like patterns known as lues maligna (",
"    <a class=\"graphic graphic_picture graphicRef51169 \" href=\"UTD.htm?27/28/28097\">",
"     picture 25",
"    </a>",
"    ). Resolution of these lesions results in hyperpigmented scars.",
"   </p>",
"   <p>",
"    Disseminated gonococcal infection causes a rash in as many as 90 percent of patients. The rash consists of fewer than 20 to 30 papular, nodular,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    petechial lesions that develop a vesiculopustular component and then, finally, a necrotic, hemorrhagic appearance [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/52\">",
"     52",
"    </a>",
"    ]. The rash contains lesions that, like those of primary varicella infection, are in different stages of evolution. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/56/3976?source=see_link\">",
"     \"Disseminated gonococcal infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The acute retroviral syndrome that occurs approximately two to six weeks after primary human immunodeficiency syndrome (HIV) infection is characterized by fever, sore throat, malaise, headache, lymphadenopathy, mucocutaneous ulceration, and rash. The rash, seen in more than 50 percent of patients, is usually transient, maculopapular, nonpruritic, and truncal or facial in location [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/53\">",
"     53",
"    </a>",
"    ]. This presentation can often be confused for infectious mononucleosis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/54\">",
"     54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/46/18151?source=see_link\">",
"     \"Acute and early HIV infection: Pathogenesis and epidemiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Immunocompetence of the host",
"    </span>",
"    &nbsp;&mdash;&nbsp;The possible etiologies of fever and rash are quite different if the host is immunosuppressed. Thus, determining the underlying immunologic status of the host is essential in assessing any patient with fever and rash [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic approach to the patient with fever and rash should focus on the appearance of the rash in addition to the detailed epidemiologic history listed above.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Characteristics of the rash",
"    </span>",
"    &nbsp;&mdash;&nbsp;A history of the rash should include the following questions [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Was a prodrome present?",
"     </li>",
"     <li>",
"      Where and when did the rash start?",
"     </li>",
"     <li>",
"      How has the rash progressed anatomically?",
"     </li>",
"     <li>",
"      Has the rash changed in appearance?",
"     </li>",
"     <li>",
"      Has any treatment been instituted for the rash?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In examining a rash, it is essential to characterize the lesions, both individually and collectively, according to morphology and arrangement (annular, linear, serpiginous, dermatomal, etc), distribution (isolated versus generalized, bilateral versus unilateral, symmetric, occurring on exposed areas, etc), and evolution (centrifugal versus centripetal) [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/5,56\">",
"     5,56",
"    </a>",
"    ]. In addition, a differential diagnosis for fever and rash can be based upon the appearance of the rash and its accompanying signs (",
"    <a class=\"graphic graphic_table graphicRef52167 graphicRef63955 graphicRef71663 \" href=\"UTD.htm?13/63/14335\">",
"     table 3A-C",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef78412 graphicRef54445 \" href=\"UTD.htm?38/25/39326\">",
"     table 4A-B",
"    </a>",
"    ). The following definitions are useful in interpreting the tables and characterizing lesions and rashes [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/57\">",
"     57",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Macule &mdash; Nonpalpable, circumscribed lesion that is flat and less than 1 cm in diameter",
"     </li>",
"     <li>",
"      Papule &mdash; Palpable lesion that is solid, elevated, and less than 1 cm in diameter",
"     </li>",
"     <li>",
"      Maculopapular &mdash; Confluent, erythematous rash made up of both macular and papular lesions.",
"     </li>",
"     <li>",
"      Purpura &mdash; Papular or macular nonblanching lesions that are due to extravasation of red blood cells",
"     </li>",
"     <li>",
"      Nodule &mdash; Deep-seated, roundish lesion less than 1.5 cm in diameter that can involve the epidermal, dermal,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      subcutaneous tissue",
"     </li>",
"     <li>",
"      Plaque &mdash; A palpable elevated lesion greater than 1 cm in diameter",
"     </li>",
"     <li>",
"      Vesicle &mdash; A distinct, elevated skin lesion that contains fluid and is less than 1 cm in diameter",
"     </li>",
"     <li>",
"      Bulla &mdash; A vesicle that is more than 1 cm in diameter",
"     </li>",
"     <li>",
"      Pustule &mdash; A vesicle that contains pus",
"     </li>",
"     <li>",
"      Ulcer &mdash; Loss of the epidermis and upper layer of the dermis, resulting in a depressed skin lesion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While these categories are useful and descriptive, many rashes have overlapping features, and a number of infectious agents can present with several different rash morphologies. Different infectious agents can also produce similar types of rashes.",
"   </p>",
"   <p>",
"    Several skin conditions can be identified based upon appearance but can be caused by a variety of infectious and noninfectious etiologies.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Erythema multiforme &mdash; Symmetrically distributed \"target\" lesions that typically involve the palms, soles, and mucous membranes, reflecting epidermal and dermal involvement (",
"      <a class=\"graphic graphic_picture graphicRef74095 \" href=\"UTD.htm?40/61/41951\">",
"       picture 26",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef72248 \" href=\"UTD.htm?20/34/21036\">",
"       table 5",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37672?source=see_link\">",
"       \"Pathogenesis, clinical features, and diagnosis of erythema multiforme\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Erythema nodosum &mdash; Painful red nodular lesions usually found symmetrically on the lower extremities and representing inflammation in the panniculus (",
"      <a class=\"graphic graphic_picture graphicRef80056 \" href=\"UTD.htm?8/46/8943\">",
"       picture 27",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13130?source=see_link\">",
"       \"Erythema nodosum\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Toxic epidermal necrolysis &mdash; A severe skin and mucosal disorder that manifests initially as tender widespread erythema with subsequent loss of the epidermis, usually due to drugs such as sulfonamides,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=see_link\">",
"       allopurinol",
"      </a>",
"      , nonsteroidal antiinflammatory drugs, and anticonvulsants (",
"      <a class=\"graphic graphic_picture graphicRef66134 \" href=\"UTD.htm?17/63/18419\">",
"       picture 28",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef65062 \" href=\"UTD.htm?12/62/13293\">",
"       table 6",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Urticaria &mdash; A skin condition associated with the presence of transient wheals, ie, papules or plaques, due to dermal edema, with no evidence of epidermal involvement or abnormality (",
"      <a class=\"graphic graphic_picture graphicRef81678 \" href=\"UTD.htm?11/2/11311\">",
"       picture 29",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef74764 \" href=\"UTD.htm?41/47/42748\">",
"       table 7",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/24/21898?source=see_link\">",
"       \"New onset urticaria\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Enanthems are mucous membrane lesions often associated with exanthems in systemic infectious diseases. Examples include: oral or genital mucous patches (secondary syphilis), oral gummatous lesions (tertiary syphilis), oral ulcers (disseminated histoplasmosis, gonococcus, or tuberculosis), palatal petechial lesions (rubella and EBV mononucleosis), oral vesicular lesions (Coxsackie-associated hand, foot, and mouth syndrome, varicella, and primary HSV), and strawberry tongue (scarlet fever, Kawasaki syndrome, toxic shock syndrome). Koplik's spots, the tiny punctate elevated white buccal mucosa lesions located adjacent to the lower molars, are pathognomonic of measles and can precede the rash by 24 to 48 hours.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough physical examination should focus on the following [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Vital signs",
"     </li>",
"     <li>",
"      General appearance to assess the severity of illness",
"     </li>",
"     <li>",
"      Strict attention to lymph nodes, mucous membranes, conjunctivae, and genitalia",
"     </li>",
"     <li>",
"      Meningeal signs and complete neurologic evaluation",
"     </li>",
"     <li>",
"      Liver and spleen size",
"     </li>",
"     <li>",
"      Joint examination",
"     </li>",
"     <li>",
"      Skin examination (",
"      <a class=\"graphic graphic_table graphicRef52167 graphicRef63955 graphicRef71663 \" href=\"UTD.htm?13/63/14335\">",
"       table 3A-C",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef78412 graphicRef54445 \" href=\"UTD.htm?38/25/39326\">",
"       table 4A-B",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Appropriate laboratory testing includes [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Nonspecific tests such as complete blood count and urinalysis",
"     </li>",
"     <li>",
"      Blood cultures, including specific media and isolation methods for work-up of bacteria, mycobacterial, and fungal organisms should be inoculated prior to beginning antimicrobial therapy",
"     </li>",
"     <li>",
"      Serologic tests, when appropriate (eg, for Coccidioides immitis, hepatitis B, Toxoplasma gondii, Borrelia burgdorferi, Treponema pallidum, dengue fever, and HIV).",
"     </li>",
"     <li>",
"      Antigen tests, when appropriate (eg, serum cryptococcal antigen)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Fluid from vesicular, pustular, petechial, ulcerative, and bullous lesions can be examined. Vesicular lesions should be unroofed so that the base of the lesion can be swabbed; herpes simplex virus and varicella-zoster virus can be distinguished with rapid fluorescent antibody studies. Viral culture can also be performed. Aspirated fluid from pustules and bullous lesions should be Gram stained and cultured in an expeditious fashion by the microbiology laboratory. In suspected cases of syphilis, exudative material from the ulcer base can be examined by darkfield microscopy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/44/39624?source=see_link\">",
"     \"Diagnostic testing for syphilis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Skin biopsy can be particularly useful in establishing a diagnosis for nodular lesions but can also be obtained for petechial-purpuric, maculopapular, and ulcerative rashes. Aseptically obtained biopsy material should be sent to the microbiology and pathology laboratories for appropriate culture and histopathologic evaluation. In suspected cases of Rocky Mountain spotted fever, direct immunofluorescent demonstration of rickettsial organisms is diagnostic. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/51/14135?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Rocky Mountain spotted fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SELECTED FEVER AND RASH EMERGENCIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several infections associated with fever and rash constitute emergencies that must be recognized promptly by the evaluating clinician.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Meningococcal infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gram-negative diplococcus N. meningitidis can cause life-threatening infection in children and young adults; outbreaks of infection can occur, especially among groups with confined living conditions such as military bases, day care centers, and dormitories. The infection can also develop in individuals with congenital late terminal complement deficiency, acquired complement deficiency (ie, nephrotic syndrome, systemic lupus erythematosus), and splenectomy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/50/27432?source=see_link\">",
"     \"Epidemiology of Neisseria meningitidis infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Meningococcal infection can result in a number of different clinical presentations, but meningococcemia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    meningitis are the most common. In addition to fever, myalgia, somnolence, headache, and nausea, rash occurs in most patients with meningococcemia. Early lesions may be macular, but rapidly increasing numbers of petechial or purpuric lesions can develop on the distal extremities and trunk, usually sparing the palms and soles (in contrast to RMSF) (",
"    <a class=\"graphic graphic_picture graphicRef52107 \" href=\"UTD.htm?30/28/31168\">",
"     picture 30",
"    </a>",
"    ). An urticarial rash can also be seen [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/58\">",
"     58",
"    </a>",
"    ]. Lesions on mucosal surfaces are also common. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/52/37704?source=see_link\">",
"     \"Clinical manifestations of meningococcal infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one review of 151 patients with meningococcal infection, 75 percent had",
"    <span class=\"nowrap\">",
"     petechial/maculopapular",
"    </span>",
"    lesions, 11 percent",
"    <span class=\"nowrap\">",
"     purpuric/ecchymotic",
"    </span>",
"    lesions, and 14 percent no skin lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/59\">",
"     59",
"    </a>",
"    ]. Mortality was considerably higher in those with",
"    <span class=\"nowrap\">",
"     purpuric/ecchymotic",
"    </span>",
"    lesions.",
"   </p>",
"   <p>",
"    Meningococcemia may be rapidly fatal, with mortality rates of approximately 10 to 25 percent. Prompt recognition, supportive therapy to maintain adequate blood pressure and oxygenation, and pathogen-directed therapy with parenteral antibiotics (usually high doses of penicillin or a third-generation cephalosporin) are essential. Purpura fulminans, a particularly severe complication of meningococcemia, refers to the fulminant hemorrhagic skin necrosis that can be seen in association with disseminated intravascular coagulation (DIC) and shock. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/0/25609?source=see_link\">",
"     \"Treatment and prevention of meningococcal infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Bacterial endocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin lesions may offer a clue to the underlying diagnosis of infective endocarditis (IE). Associated peripheral cutaneous or mucocutaneous lesions include petechiae, splinter hemorrhages, Janeway lesions, Osler's nodes, and Roth spots. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/24/41352?source=see_link\">",
"     \"Diagnostic approach to infective endocarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/23/31094?source=see_link\">",
"     \"Infective endocarditis: Historical and Duke criteria\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Petechiae are not specific for infective endocarditis but are its most common skin manifestation. They may be present on the skin, usually on the extremities, or on mucous membranes such as the palate or conjunctivae, the latter usually as hemorrhages best seen with eversion of either upper or lower eyelids (",
"    <a class=\"graphic graphic_picture graphicRef59982 \" href=\"UTD.htm?6/8/6275\">",
"     picture 31",
"    </a>",
"    ). Splinter hemorrhages, also nonspecific for endocarditis, are nonblanching, linear reddish-brown lesions found under the nail bed (",
"    <a class=\"graphic graphic_picture graphicRef72076 \" href=\"UTD.htm?15/63/16369\">",
"     picture 32",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Janeway lesions, Osler's nodes, and Roth spots are more specific for IE but also less common; Roth spots are particularly rare. Janeway lesions are macular, nonblanching, nonpainful, and erythematous lesions on the palms and soles (",
"    <a class=\"graphic graphic_picture graphicRef58380 \" href=\"UTD.htm?30/54/31585\">",
"     picture 33",
"    </a>",
"    ). By contrast, Osler's nodes are painful, violaceous nodules found in the pulp of fingers and toes and are seen more often in subacute than acute cases of IE (",
"    <a class=\"graphic graphic_picture graphicRef68796 \" href=\"UTD.htm?28/10/28847\">",
"     picture 34",
"    </a>",
"    ). Roth spots are exudative, edematous hemorrhagic lesions of the retina. Of note, conjunctival hemorrhage, Janeway lesions, Osler's nodes, and Roth spots are included as minor criteria in the Duke criteria for the diagnosis of infective endocarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is important to recognize the skin manifestations of endocarditis in order to obtain blood cultures and initiate appropriate therapy. A prospective cohort study reported that S. aureus is the most common cause of infective endocarditis in many locations worldwide [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/61\">",
"     61",
"    </a>",
"    ]. Despite improvements in therapy and the availability of surgical intervention, there is still an appreciable mortality rate of 25 to 40 percent for patients with S. aureus IE who are not injection drug users [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/62\">",
"     62",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/1/26649?source=see_link\">",
"     \"Complications of Staphylococcus aureus bacteremia\"",
"    </a>",
"    .) Significantly, the incidence of infective endocarditis has remained unchanged in the last 20 years [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Rocky Mountain spotted fever",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rocky Mountain spotted fever (RMSF) is a tick-borne disease caused by Rickettsia rickettsii. After an incubation period of as little as two days, fever, headache, malaise, conjunctival suffusion, and myalgia usually develop. In most patients, a rash appears within the following week, initially on the wrists and ankles and later on the palms and soles, before spreading centripetally to include the arms, legs, face, and trunk.",
"   </p>",
"   <p>",
"    The differential diagnosis includes meningococcemia, infective endocarditis, measles, secondary syphilis, and other rickettsial diseases. The rash is at first erythematous and maculopapular. Progression to a petechial rash is often noted and, in severe cases of RMSF, purpura and hemorrhagic necrosis can occur (",
"    <a class=\"graphic graphic_picture graphicRef67850 \" href=\"UTD.htm?40/18/41250\">",
"     picture 35",
"    </a>",
"    ). Associated thrombocytopenia can make the diagnosis of RMSF difficult to distinguish from meningococcemia. However, several clinical clues favor the diagnosis of RMSF, including a history of tick bite or visits to areas where RMSF-associated ticks are present, occurrence of the rash a median of three to four days following the onset of fever, relative leukopenia, and elevated aminotransferases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/51/14135?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Rocky Mountain spotted fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Toxic shock syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initially used in the late 1970s to describe a disease syndrome in children infected with S. aureus, toxic shock syndrome (TSS) became a well-known entity in the early 1980s when its association with young menstruating women and tampon use was described [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/64-66\">",
"     64-66",
"    </a>",
"    ]. Nonmenstrual toxic shock syndrome has been associated with surgical wounds, burns, skin ulcerations, catheters, and nasal packings. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/52/8010?source=see_link\">",
"     \"Staphylococcal toxic shock syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Criteria for the diagnosis of TSS include a temperature above 38.9&ordm;C, hypotension, a desquamating rash, involvement of at least three organ systems, and exclusion of clinical mimics such as RMSF, leptospirosis, and measles [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/67\">",
"     67",
"    </a>",
"    ]. Multiple toxins have been described in association with this syndrome, particularly TSS toxin (TSST-1) in menstrual-associated TSS [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rash seen in TSS is diffuse and erythematous and can resemble a sunburn (",
"    <a class=\"graphic graphic_picture graphicRef77600 \" href=\"UTD.htm?30/23/31103\">",
"     picture 36",
"    </a>",
"    ). The conjunctivae are also often involved (",
"    <a class=\"graphic graphic_picture graphicRef66457 \" href=\"UTD.htm?36/46/37615\">",
"     picture 37",
"    </a>",
"    ). Fever, diarrhea, muscle aches, and",
"    <span class=\"nowrap\">",
"     nausea/emesis",
"    </span>",
"    are commonly present. Desquamation, usually of the palms and soles or at the sites of the original rash, is classically described one to three weeks later.",
"   </p>",
"   <p>",
"    Group A streptococci (GAS) can also produce a toxic shock-like syndrome, most often in association with a skin or soft tissue infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6616?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of streptococcal toxic shock syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Streptococcal pyrogenic exotoxins that cause cytokine production, analogous to staphylococcal TSST-1, appear to be responsible for initiating this syndrome. Several general differences are noted between TSS caused by GAS and by S. aureus. In GAS TSS, mortality is higher (30 versus 3 percent with S. aureus), bacteremia and tissue necrosis are more common, and generalized erythema is less common [",
"    <a class=\"abstract\" href=\"UTD.htm?28/26/29098/abstract/67\">",
"     67",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/20/8519?source=see_link\">",
"     \"Treatment of streptococcal toxic shock syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/59/40881?source=see_link\">",
"       \"Patient information: Scarlet fever (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/31/36338?source=see_link\">",
"       \"Patient information: When to worry about a fever (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20441523\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fever with an accompanying rash is a common symptom constellation in patients presenting to clinicians' offices and emergency departments. Skin manifestations may provide the only early clue to an underlying infection, may be the hallmark of contagious disease,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      may be an early sign of a life-threatening infection. The differential diagnosis of fever and rash is extremely broad, but this symptom complex provides an opportunity for the diligent clinician to establish a probable etiology through a careful history and physical examination. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A systematic approach is crucial for establishing a timely diagnosis, determining early therapy when appropriate, and considering isolation of the patient if necessary. Epidemiologic clues are important to pursue such as:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Age of the patient",
"     </li>",
"     <li>",
"      Season of the year",
"     </li>",
"     <li>",
"      Travel history",
"     </li>",
"     <li>",
"      Geographic location",
"     </li>",
"     <li>",
"      Exposures including to insects, animals, and ill contacts",
"     </li>",
"     <li>",
"      Medications",
"     </li>",
"     <li>",
"      Immunizations and history of childhood illnesses",
"     </li>",
"     <li>",
"      The immune status of the host (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Features of the rash are also important to consider, including:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Characteristics of the lesions",
"     </li>",
"     <li>",
"      Distribution and progression of the rash",
"     </li>",
"     <li>",
"      Timing of the onset in relation to fever",
"     </li>",
"     <li>",
"      Change in morphology, such as papules to vesicles or petechiae (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A number of infections characterized by fever and rash have a distinct seasonal predisposition. As examples, nonpolio enteroviral infections occur in the summer and fall months; Kawasaki syndrome, meningococcal infection, and parvoviral infections present most commonly in the winter or early spring months; measles and rubella are more frequent in the spring; tick-borne diseases such as Lyme disease, ehrlichiosis, and Rocky Mountain spotted fever (RMSF) primarily occur in the spring and summer; tularemia and plague are usually seen in the summer. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Season of the year'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Exposures to food, water, plant materials, animals, and infected human secretions can lead to rashes and can be associated with both occupational and nonoccupational contacts. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Exposure history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A thorough sexual history is essential in evaluating the patient with a rash of unknown etiology. Genital or rectal ulcerations may be caused by a variety of infectious agents, including syphilis (",
"      <a class=\"graphic graphic_picture graphicRef50385 \" href=\"UTD.htm?4/40/4739\">",
"       picture 18",
"      </a>",
"      ), herpes simplex (",
"      <a class=\"graphic graphic_picture graphicRef78603 \" href=\"UTD.htm?3/48/3855\">",
"       picture 19",
"      </a>",
"      ), lymphogranuloma venereum (",
"      <a class=\"graphic graphic_picture graphicRef73707 \" href=\"UTD.htm?37/32/38401\">",
"       picture 20",
"      </a>",
"      ), chancroid (",
"      <a class=\"graphic graphic_picture graphicRef76843 \" href=\"UTD.htm?16/5/16464\">",
"       picture 21",
"      </a>",
"      ), and donovanosis (",
"      <a class=\"graphic graphic_picture graphicRef58925 \" href=\"UTD.htm?13/53/14163\">",
"       picture 22",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef60432 graphicRef68988 \" href=\"UTD.htm?39/38/40557\">",
"       table 2A-B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Sexual history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnostic approach to the patient with fever and rash should focus on the appearance of the rash in addition to the detailed epidemiologic history listed above. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Diagnostic approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A history of the rash should include the following questions:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Was a prodrome present?",
"     </li>",
"     <li>",
"      Where and when did the rash start?",
"     </li>",
"     <li>",
"      How has the rash progressed anatomically?",
"     </li>",
"     <li>",
"      Has the rash changed in appearance?",
"     </li>",
"     <li>",
"      Has any treatment been instituted for the rash? (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Characteristics of the rash'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In examining a rash, it is essential to characterize the lesions, both individually and collectively, according to morphology and arrangement (annular, linear, serpiginous, dermatomal, etc), distribution (isolated versus generalized, bilateral versus unilateral, symmetric, occurring on exposed areas, etc), and evolution (centrifugal versus centripetal). In addition, a differential diagnosis for fever and rash can be based upon the appearance of the rash and its accompanying signs (",
"      <a class=\"graphic graphic_table graphicRef52167 graphicRef63955 graphicRef71663 \" href=\"UTD.htm?13/63/14335\">",
"       table 3A-C",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef78412 graphicRef54445 \" href=\"UTD.htm?38/25/39326\">",
"       table 4A-B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Characteristics of the rash'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Appropriate laboratory testing includes:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Nonspecific tests such as complete blood count and urinalysis",
"     </li>",
"     <li>",
"      Blood cultures, including specific media and isolation methods for work-up of bacteria, mycobacterial, and fungal organisms should be inoculated prior to beginning antimicrobial therapy",
"     </li>",
"     <li>",
"      Serologic tests, when appropriate (eg, for Coccidioides immitis, hepatitis B, Toxoplasma gondii, Borrelia burgdorferi, Treponema pallidum, dengue fever, and HIV).",
"     </li>",
"     <li>",
"      Antigen tests, when appropriate (eg, serum cryptococcal antigen) (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Laboratory testing'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fluid from vesicular, pustular, petechial, ulcerative, and bullous lesions can be examined. Vesicular lesions should be unroofed so that the base of the lesion can be swabbed; herpes simplex virus and varicella-zoster virus can be distinguished with rapid fluorescent antibody studies. Viral culture can also be performed. Aspirated fluid from pustules and bullous lesions should be Gram stained and cultured by the microbiology laboratory. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Laboratory testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Skin biopsy can be particularly useful in establishing a diagnosis for nodular lesions but can also be obtained for petechial-purpuric, maculopapular, and ulcerative rashes. Biopsy material should be sent to the microbiology and pathology laboratories for appropriate culture and histopathologic evaluation. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Laboratory testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several infections associated with fever and rash constitute emergencies that must be recognized promptly by the evaluating clinician. Such infections include meningococcal infection, bacterial endocarditis, Rocky Mountain spotted fever, and toxic shock syndrome. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Selected fever and rash emergencies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Levin S, Goodman LJ. An approach to acute fever and rash (AFR) in the adult. In: Current Clinical Topics in Infectious Diseases, Remington JS, Swartz MN (Eds), Blackwell Science, Boston 1995. p.19.",
"    </li>",
"    <li>",
"     Weber DJ, Cohen MS. The acutely ill patient with fever and rash. In: Principles and Practices of Infectious Diseases, Mandell GL, Douglas RG Jr, Bennett JE (Eds), Churchill Livingstone, New York City 1995. p.549.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/3\">",
"      Valdez, LM, Septimus, EJ. Clinical approach to rash and fever. Infect Dis Pract 1996; 20:1.",
"     </a>",
"    </li>",
"    <li>",
"     Sumaya CV. Acute exanthematous disease. In: Infectious Diseases of Children and Adults. A Step-by-Step Approach to Diagnosis and Treatment, Pickering LK, DuPont HL (Eds), Addison-Wesley, Menlo Park, CA 1986. p.167.",
"    </li>",
"    <li>",
"     Sanders CV. Approach to the diagnosis of the patient with fever and rash. In: The Skin and Infection: A Color Atlas and Text, Sanders CV, Nesbitt LT Jr (Eds), Williams and Wilkins, Baltimore 1995. p.296.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/6\">",
"      Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005; 41:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/7\">",
"      Falagas ME, Vergidis PI. Narrative review: diseases that masquerade as infectious cellulitis. Ann Intern Med 2005; 142:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/8\">",
"      Cherry JD. Contemporary infectious exanthems. Clin Infect Dis 1993; 16:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/9\">",
"      Rauch AM, Hurwitz ES. Centers for Disease Control (CDC) case definition for Kawasaki syndrome. Pediatr Infect Dis 1985; 4:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/10\">",
"      Mackenzie A, Fuite LA, Chan FT, et al. Incidence and pathogenicity of Arcanobacterium haemolyticum during a 2-year study in Ottawa. Clin Infect Dis 1995; 21:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/11\">",
"      Sugerman DE, Barskey AE, Delea MG, et al. Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated. Pediatrics 2010; 125:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/12\">",
"      Andiman WA. The Epstein-Barr virus and EB virus infections in childhood. J Pediatr 1979; 95:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/13\">",
"      Anderson LJ. Role of parvovirus B19 in human disease. Pediatr Infect Dis J 1987; 6:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/14\">",
"      Blake PA, Merson MH, Weaver RE, et al. Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med 1979; 300:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/15\">",
"      Centers for Disease Control and Prevention (CDC). Vibrio illnesses after Hurricane Katrina--multiple states, August-September 2005. MMWR Morb Mortal Wkly Rep 2005; 54:928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/16\">",
"      Suh KN, Kozarsky PE, Keystone JS. Evaluation of fever in the returned traveler. Med Clin North Am 1999; 83:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/17\">",
"      Lupi O, Tyring SK. Tropical dermatology: viral tropical diseases. J Am Acad Dermatol 2003; 49:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/18\">",
"      O'Brien D, Tobin S, Brown GV, Torresi J. Fever in returned travelers: review of hospital admissions for a 3-year period. Clin Infect Dis 2001; 33:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/19\">",
"      Lockwood DN, Keystone JS. Skin problems in returning travelers. Med Clin North Am 1992; 76:1393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/20\">",
"      Mackey SL, Wagner KF. Dermatologic manifestations of parasitic diseases. Infect Dis Clin North Am 1994; 8:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/21\">",
"      Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006; 354:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/22\">",
"      Speil C, Mushtaq A, Adamski A, Khardori N. Fever of unknown origin in the returning traveler. Infect Dis Clin North Am 2007; 21:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/23\">",
"      McHugh CP, Melby PC, LaFon SG. Leishmaniasis in Texas: epidemiology and clinical aspects of human cases. Am J Trop Med Hyg 1996; 55:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/24\">",
"      Centers for Disease Control and Prevention (CDC). Locally acquired Dengue--Key West, Florida, 2009-2010. MMWR Morb Mortal Wkly Rep 2010; 59:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/25\">",
"      Rigau-P&eacute;rez JG, Clark GG, Gubler DJ, et al. Dengue and dengue haemorrhagic fever. Lancet 1998; 352:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/26\">",
"      Goldstein EJ. Household pets and human infections. Infect Dis Clin North Am 1991; 5:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/27\">",
"      Fox JG, Lipman NS. Infections transmitted by large and small laboratory animals. Infect Dis Clin North Am 1991; 5:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/28\">",
"      Hankenson FC, Johnston NA, Weigler BJ, Di Giacomo RF. Zoonoses of occupational health importance in contemporary laboratory animal research. Comp Med 2003; 53:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/29\">",
"      Craven RB, Barnes AM. Plague and tularemia. Infect Dis Clin North Am 1991; 5:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/30\">",
"      Talan DA, Citron DM, Abrahamian FM, et al. Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group. N Engl J Med 1999; 340:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/31\">",
"      Edelstein H. Mycobacterium marinum skin infections. Report of 31 cases and review of the literature. Arch Intern Med 1994; 154:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/32\">",
"      Aubry A, Chosidow O, Caumes E, et al. Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Arch Intern Med 2002; 162:1746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/33\">",
"      Weinstein MR, Litt M, Kertesz DA, et al. Invasive infections due to a fish pathogen, Streptococcus iniae. S. iniae Study Group. N Engl J Med 1997; 337:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/34\">",
"      Slaven EM, Lopez FA, Hart SM, Sanders CV. Myonecrosis caused by Edwardsiella tarda: a case report and case series of extraintestinal E. tarda infections. Clin Infect Dis 2001; 32:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/35\">",
"      Ferguson DD, Gershman K, LeBailly A, Petersen LR. Characteristics of the rash associated with West Nile virus fever. Clin Infect Dis 2005; 41:1204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/36\">",
"      Dumler JS. Is human granulocytic ehrlichiosis a new Lyme disease? Review and comparison of clinical, laboratory, epidemiological, and some biological features. Clin Infect Dis 1997; 25 Suppl 1:S43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/37\">",
"      Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996; 275:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/38\">",
"      Fishbein DB, Dawson JE, Robinson LE. Human ehrlichiosis in the United States, 1985 to 1990. Ann Intern Med 1994; 120:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/39\">",
"      Masters EJ, Grigery CN, Masters RW. STARI, or Masters disease: Lone Star tick-vectored Lyme-like illness. Infect Dis Clin North Am 2008; 22:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/40\">",
"      Silverman AR, Nieland ML. Hot tub dermatitis: a familial outbreak of Pseudomonas folliculitis. J Am Acad Dermatol 1983; 8:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/41\">",
"      Keene WE, McAnulty JM, Hoesly FC, et al. A swimming-associated outbreak of hemorrhagic colitis caused by Escherichia coli O157:H7 and Shigella sonnei. N Engl J Med 1994; 331:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/42\">",
"      Becker TM, Kodsi R, Bailey P, et al. Grappling with herpes: herpes gladiatorum. Am J Sports Med 1988; 16:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/43\">",
"      White WB, Grant-Kels JM. Transmission of herpes simplex virus type 1 infection in rugby players. JAMA 1984; 252:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/44\">",
"      Falck G. Group A streptococcal skin infections after indoor association football tournament. Lancet 1996; 347:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/45\">",
"      Glezen WP, Lindsay RL, DeWalt JL, Dillon HC Jr. Epidemic pyoderma caused by nephritogenic streptococci in college athletes. Lancet 1972; 1:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/46\">",
"      Biolcati G, Alabiso A. Creeping eruption of larva migrans--a case report in a beach volley athlete. Int J Sports Med 1997; 18:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/47\">",
"      Mackowiak PA, LeMaistre CF. Drug fever: a critical appraisal of conventional concepts. An analysis of 51 episodes in two Dallas hospitals and 97 episodes reported in the English literature. Ann Intern Med 1987; 106:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/48\">",
"      Arndt KA, Jick H. Rates of cutaneous reactions to drugs. A report from the Boston Collaborative Drug Surveillance Program. JAMA 1976; 235:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/49\">",
"      Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331:1272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/50\">",
"      Wolkenstein P, Charue D, Laurent P, et al. Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch Dermatol 1995; 131:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/51\">",
"      Wolkenstein P, Revuz J. Toxic epidermal necrolysis. Dermatol Clin 2000; 18:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/52\">",
"      Koss PG. Disseminated gonococcal infection. The tenosynovitis-dermatitis and suppurative arthritis syndromes. Cleve Clin Q 1985; 52:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/53\">",
"      de Jong MD, Hulsebosch HJ, Lange JM. Clinical, virological and immunological features of primary HIV-1 infection. Genitourin Med 1991; 67:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/54\">",
"      Vanhems P, Allard R, Cooper DA, et al. Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive? Clin Infect Dis 1997; 24:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/55\">",
"      Lopez FA, Sanders CV. Dermatologic infections in the immunocompromised (non-HIV) host. Infect Dis Clin North Am 2001; 15:671.",
"     </a>",
"    </li>",
"    <li>",
"     Nesbitt LT Jr. Evaluating the patient with a skin infection: General considerations. In: The Skin and Infection: A Color Atlas and Text, Sanders CV, Nesbitt LT Jr (Eds), Williams &amp; Wilkins, Baltimore 1995. p.1.",
"    </li>",
"    <li>",
"     Glossary. In: Dermatologic Manifestations of Infectious Diseases, Peterson PK, Dahl MV (Eds), The Upjohn Company, Kalamazoo, Michigan 1982. p.4.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/58\">",
"      Ferguson LE, Hormann MD, Parks DK, Yetman RJ. Neisseria meningitidis: presentation, treatment, and prevention. J Pediatr Health Care 2002; 16:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/59\">",
"      Toews WH, Bass JW. Skin manifestations of meningococcal infection; an immediate indicator of prognosis. Am J Dis Child 1974; 127:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/60\">",
"      Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/61\">",
"      Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009; 169:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/62\">",
"      Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111:e394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/63\">",
"      Moreillon P, Que YA. Infective endocarditis. Lancet 2004; 363:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/64\">",
"      Todd J, Fishaut M, Kapral F, Welch T. Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet 1978; 2:1116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/65\">",
"      Davis JP, Chesney PJ, Wand PJ, LaVenture M. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 1980; 303:1429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/66\">",
"      Shands KN, Schmid GP, Dan BB, et al. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med 1980; 303:1436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/67\">",
"      Stevens DL. The toxic shock syndromes. Infect Dis Clin North Am 1996; 10:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?28/26/29098/abstract/68\">",
"      Schlievert PM, Shands KN, Dan BB, et al. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis 1981; 143:509.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2744 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-3E1552308A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_26_29098=[""].join("\n");
var outline_f28_26_29098=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20441523\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY AND ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Diseases that present in childhood",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Selected diseases that present in adulthood",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Season of the year",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Geography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Incubation period",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Exposure history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Medication history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Immunization history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Sexual history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Immunocompetence of the host",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DIAGNOSTIC APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Characteristics of the rash",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SELECTED FEVER AND RASH EMERGENCIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Meningococcal infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Rocky Mountain spotted fever",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Toxic shock syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20441523\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/2744\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2744|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/26/4512\" title=\"picture 1\">",
"      Truncal rash in measles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/3/36927\" title=\"picture 2\">",
"      Rash of primary varicella",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/27/11696\" title=\"picture 3\">",
"      Rash in erythema infectiosum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/2/43\" title=\"picture 4\">",
"      Strawberry tongue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/33/32272\" title=\"picture 5\">",
"      Rash in infectious mono",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/52/43842\" title=\"picture 6\">",
"      Dermatomal herpes zoster",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/40/12928\" title=\"picture 7\">",
"      Cutaneous leishmaniasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/27/11711\" title=\"picture 8\">",
"      Trypanosomiasis Romanas sign",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/63/40944\" title=\"picture 9\">",
"      Cutaneous larva migrans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/9/14495\" title=\"picture 10\">",
"      Nodule of onchocerciasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/31/31231\" title=\"picture 11\">",
"      Herpetic whitlow",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/3/25663\" title=\"picture 12\">",
"      Cat scratch disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/21/15697\" title=\"picture 13\">",
"      Ulceroglandular tularemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/21/34143\" title=\"picture 14\">",
"      Erysipeloid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/63/14320\" title=\"picture 15\">",
"      Lymphocutaneous sporotrichosis leg",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/10/10400\" title=\"picture 16\">",
"      Erythema migrans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/14/34031\" title=\"picture 17\">",
"      Hot tub folliculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/40/4739\" title=\"picture 18\">",
"      Chancre of primary syphilis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/48/3855\" title=\"picture 19\">",
"      Genital herpes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/32/38401\" title=\"picture 20\">",
"      Lymphogranuloma venereum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/5/16464\" title=\"picture 21\">",
"      Penile ulcer due to chancroid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/53/14163\" title=\"picture 22\">",
"      Donovanosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/6/6242\" title=\"picture 23\">",
"      Palmar rash secondary syphilis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/28/22979\" title=\"picture 24\">",
"      Condyloma lata",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/28/28097\" title=\"picture 25\">",
"      Tertiary syphilis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/61/41951\" title=\"picture 26\">",
"      Erythema multiforme",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/46/8943\" title=\"picture 27\">",
"      Erythema nodosum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/63/18419\" title=\"picture 28\">",
"      Toxic epidermal necrolysis I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/2/11311\" title=\"picture 29\">",
"      Giant urticaria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/28/31168\" title=\"picture 30\">",
"      Acute meningococcemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/8/6275\" title=\"picture 31\">",
"      Subconjunctival petechiae in IE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/63/16369\" title=\"picture 32\">",
"      Splinter hemorrhages in infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/54/31585\" title=\"picture 33\">",
"      Janeway lesion in infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/10/28847\" title=\"picture 34\">",
"      Oslers nodes in infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/18/41250\" title=\"picture 35\">",
"      Truncal rash of RMSF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/23/31103\" title=\"picture 36\">",
"      Rash in Staphylococcal toxic shock syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/46/37615\" title=\"picture 37\">",
"      Conjunctival suffusion in Staphylococcal toxic shock syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2744|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/31/1533\" title=\"table 1A\">",
"      Incubation period for rash I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/5/41052\" title=\"table 1B\">",
"      Incubation period for rash II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/50/37676\" title=\"table 2A\">",
"      Description of genital ulcer I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/54/28524\" title=\"table 2B\">",
"      Description of genital ulcer II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/59/23485\" title=\"table 3A\">",
"      DDx of rash by appearance 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/13/9437\" title=\"table 3B\">",
"      DDx of rash by appearance 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/18/6445\" title=\"table 3C\">",
"      DDx of rash by appearance 3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/60/34765\" title=\"table 4A\">",
"      Fever and rash ddx by sign 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/63/23549\" title=\"table 4B\">",
"      Fever and rash ddx by sign 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/34/21036\" title=\"table 5\">",
"      Causes of erythema multiforme",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/62/13293\" title=\"table 6\">",
"      Causes of TEN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/47/42748\" title=\"table 7\">",
"      Infections with urticaria",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/46/18151?source=related_link\">",
"      Acute and early HIV infection: Pathogenesis and epidemiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12469?source=related_link\">",
"      Clinical features and diagnosis of sporotrichosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/44/33480?source=related_link\">",
"      Clinical features of varicella-zoster virus infection: Chickenpox",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/51/14135?source=related_link\">",
"      Clinical manifestations and diagnosis of Rocky Mountain spotted fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23879?source=related_link\">",
"      Clinical manifestations and diagnosis of acute rheumatic fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=related_link\">",
"      Clinical manifestations and diagnosis of enterovirus and parechovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22377?source=related_link\">",
"      Clinical manifestations and pathogenesis of human parvovirus B19 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35225?source=related_link\">",
"      Clinical manifestations of Lyme disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/52/37704?source=related_link\">",
"      Clinical manifestations of meningococcal infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/20/2378?source=related_link\">",
"      Clinical manifestations of varicella-zoster virus infection: Herpes zoster",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/15/11512?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of plague (Yersinia pestis infection)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18985?source=related_link\">",
"      Clinical presentation and diagnosis of dengue virus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/11/43192?source=related_link\">",
"      Clinical presentation and diagnosis of measles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/1/26649?source=related_link\">",
"      Complications of Staphylococcus aureus bacteremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/30/27110?source=related_link\">",
"      Complications of streptococcal tonsillopharyngitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36229?source=related_link\">",
"      Cutaneous larva migrans (creeping eruption)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/24/41352?source=related_link\">",
"      Diagnostic approach to infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/44/39624?source=related_link\">",
"      Diagnostic testing for syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/56/3976?source=related_link\">",
"      Disseminated gonococcal infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/16/42246?source=related_link\">",
"      Epidemiology and transmission of measles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/50/27432?source=related_link\">",
"      Epidemiology of Neisseria meningitidis infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6616?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of streptococcal toxic shock syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/2/42024?source=related_link\">",
"      Epidemiology, microbiology, clinical manifestations, and diagnosis of typhoid fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/38/15977?source=related_link\">",
"      Epidemiology, pathogenesis, and clinical features of schistosomiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13130?source=related_link\">",
"      Erythema nodosum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/61/24538?source=related_link\">",
"      Fever and rash in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/5/6234?source=related_link\">",
"      Human ehrlichiosis and anaplasmosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/55/14201?source=related_link\">",
"      Human herpesvirus 7 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/34/42537?source=related_link\">",
"      Infectious causes of fever and rash in non-HIV immunocompromised hosts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31018?source=related_link\">",
"      Infectious mononucleosis in adults and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/23/31094?source=related_link\">",
"      Infective endocarditis: Historical and Duke criteria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12248?source=related_link\">",
"      Kawasaki disease: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/47/23289?source=related_link\">",
"      Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/5/3162?source=related_link\">",
"      Mycoplasma pneumoniae infection in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/35/6713?source=related_link\">",
"      Mycoplasma pneumoniae infection in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/24/21898?source=related_link\">",
"      New onset urticaria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/30/20970?source=related_link\">",
"      Onchocerciasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/50/37672?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of erythema multiforme",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/55/12150?source=related_link\">",
"      Pathophysiology, transmission, and natural history of syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/59/40881?source=related_link\">",
"      Patient information: Scarlet fever (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/31/36338?source=related_link\">",
"      Patient information: When to worry about a fever (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/57/9113?source=related_link\">",
"      Potential health hazards in travelers to Australia, New Zealand, and the southwestern Pacific (Oceania)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/14/8425?source=related_link\">",
"      Psittacosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29220?source=related_link\">",
"      Rickettsialpox",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/19/28982?source=related_link\">",
"      Roseola infantum (exanthem subitum)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/6/18534?source=related_link\">",
"      Scrub typhus: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/58/26533?source=related_link\">",
"      Southern tick-associated rash illness (STARI)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/56/39818?source=related_link\">",
"      Standard immunizations for children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/52/8010?source=related_link\">",
"      Staphylococcal toxic shock syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/29/17882?source=related_link\">",
"      Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/59/11193?source=related_link\">",
"      Strongyloidiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/48/8967?source=related_link\">",
"      Travel advice",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/0/25609?source=related_link\">",
"      Treatment and prevention of meningococcal infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/20/8519?source=related_link\">",
"      Treatment of streptococcal toxic shock syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/42/44710?source=related_link\">",
"      Vibrio vulnificus infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f28_26_29099="Protocol sq incremental chal";
var content_f28_26_29099=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F56788&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F56788&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Protocol for subcutaneous incremental challenge in patients with histories of prior reactions to local anesthetics",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Step*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Volume, mL",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dilution",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        Saline",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        0.1 cc",
"       </td>",
"       <td>",
"        Undiluted",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        0.5 cc",
"       </td>",
"       <td>",
"        Undiluted",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        1.0 cc",
"       </td>",
"       <td>",
"        Undiluted",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Administered at 20-30 minute intervals.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     A single-blind, subcutaneous saline step may be inserted before a subcutaneous local anesthetic injection for patients in whom the reaction is suspected to be due to the injection, rather than the drug.",
"     <br/>",
"     &Delta; After negative skin testing and a negative saline challenge (step 1), consider proceeding directly to step 4.",
"     <br/>",
"     <span class=\"lozenge\">",
"      &loz;",
"     </span>",
"     The concentration of the local anesthetic (usually 1-2 percent) to be used for the procedure.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_26_29099=[""].join("\n");
var outline_f28_26_29099=null;
var title_f28_26_29100="Prevalence vs PPV and NPV";
var content_f28_26_29100=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F51763&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F51763&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Prevalence vs PPV and NPV",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"3\" rowspan=\"1\">",
"        Disease prevalence = 10 percent",
"       </td>",
"      </tr>",
"      <tr class=\"subtitle2\">",
"       <td class=\"subtitle2\">",
"        &nbsp;",
"        <br/>",
"       </td>",
"       <td class=\"subtitle2\">",
"        Disease present",
"       </td>",
"       <td class=\"subtitle2\">",
"        Disease absent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Test positive",
"       </td>",
"       <td>",
"        99",
"       </td>",
"       <td>",
"        90",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Test negative",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        810",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        Sensitivity = 99 percent; specificity = 90 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        Positive predictive value (99/189 = 53 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        Negative predictive value (810/811 = 100 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"3\" rowspan=\"1\">",
"        Disease Prevalence = 1 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle2\">",
"        Disease present",
"       </td>",
"       <td class=\"subtitle2\">",
"        Disease absent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Test positive",
"       </td>",
"       <td>",
"        9.9",
"       </td>",
"       <td>",
"        99",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Test negative",
"       </td>",
"       <td>",
"        0.1",
"       </td>",
"       <td>",
"        891",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        Sensitivity = 99 percent; specificity = 90 percent&nbsp;&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        Positive predictive value (9.9/108.9 = 9 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        Negative predictive value (891/891.1 = 100 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"3\" rowspan=\"1\">",
"        Disease Prevalence = 0.1 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle2\">",
"        Disease present",
"       </td>",
"       <td class=\"subtitle2\">",
"        Disease absent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Test positive",
"       </td>",
"       <td>",
"        0.99",
"       </td>",
"       <td>",
"        100",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Test negative",
"       </td>",
"       <td>",
"        0.01",
"       </td>",
"       <td>",
"        899",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        Sensitivity = 99 percent; specificity = 90 percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        Positive predictive value (0.99/100.99 = 1 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\" rowspan=\"1\">",
"        Negative predictive value (899/899.01 = 100 percent)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_26_29100=[""].join("\n");
var outline_f28_26_29100=null;
var title_f28_26_29101="CRC in genetic syndromes";
var content_f28_26_29101=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F58291&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F58291&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cumulative incidence of colorectal cancer by age in subjects with genetic syndromes compared with the general public",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 387px; height: 191px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    FAP: familial adenomatous polyposis; HNPCC: hereditary nonpolyposis colorectal cancer.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Winawer SW, Fletcher RH, Mille L, et al. AGA guidelines: Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 1997; 112:594.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_26_29101=[""].join("\n");
var outline_f28_26_29101=null;
var title_f28_26_29102="Tissue bag for laparoscopy";
var content_f28_26_29102=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57113&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57113&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Tissue bag for laparoscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 140px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Tissue bags such as this are used for removal of tissue fragments, ovarian masses, or fallopian tubes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_26_29102=[""].join("\n");
var outline_f28_26_29102=null;
var title_f28_26_29103="Differential splicing mu and delta mRNA";
var content_f28_26_29103=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F50773&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F50773&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 584px\">",
"   <div class=\"ttl\">",
"    Differential splicing of &micro; and &delta; mRNA",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 564px; height: 228px; background-image: url(data:image/gif;base64,R0lGODlhNALkAOYAAP////7+/m5ubm1tbbS0tC8vLwAAAG9vb7W1tbOzsy4uLmxsbDAwMO3t7cfHxyEhIU1NTZCQkBQUFOzs7D4+Ptra2tnZ2QkJCX9/f11dXaKiok5OTsbGxgEBAQgICBUVFZGRkY+Pjz09PSIiIkxMTF5eXqGhoba2tiAgIKOjo35+fi0tLbKyshMTE+7u7tjY2FxcXOvr68jIyNvb2woKCmtraz8/P4CAgP39/TExMQcHB09PT8XFxSMjIxYWFpKSko6Ojn19fTw8PF9fX3BwcB8fHxISEurq6sTExKSkpAICAktLS9fX11tbW3x8fKCgoLe3twsLCwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAA0AuQAAAf/gACCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmJmam5ydnp+goaKjpKWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zNzs/Q0dLT1NXW19jZ2tvc3d7f4OHi4+Tl5ufo6err7O3u7/Dx8vP09fb3+Pn6+/z9/v8AAwocSLCgwYOqAghUKIghwocQHQXA0IPBAwgAGDqstxGDAgYZKkQcSZIhBhEuMmIotPFegQEuAoBY6bAlyZsAA0hw0HKjQpvwNIwwNKNCAKA4k+JzaIBggAMCDA1w4ECp1X0bO0xgiQhpuwEHCCmMMMTr1bPwGFIAMagBALYA/ywQ4DpPaMa2GAQwQMsXnwMJAhBEkABAQUYCURvOc/jgQIMAEfJqAEAhQt+HChEM0lgJ6E9GZoU1iCAAhMgCghAkztcAQ4ECAirkSABAwOrLTgU1vWtpo0WLG2IOilCgA2/FNYd5RQ2AQFjk+wasLKEZN8Ldd0M7YjAXQIgHm3Ur4ryMwQACIp5rd6exQQYCk61fP7RekYITd9cWwt71ODCk9x2QQHeK2WNTffLtw59/lTBQHQBQ8RbAgvQ1w1x4SxmCYIIcEYJdcpYU8GAJIYTXlAM/jCXDhrZ8JmFDHIjVEIvjJOcThwZRmIkC3XHwgVuEGKdaRgIQ2IxZ5MUDIv+NONrTwWsF/CBjJQVsIAAEI1SlEAclUJABAAjAdoCIyTB5D4hNGmRmhYI4gEACVRHSAAFxIgABAQRs8CCGo/TE5yVIrVmNoBp+Qmiayi1iJoIIDCBIkTdCd2h/pASqy6QSFfhnb5ugiag2nmaCFGKPGukppom4iOmB2TFISZKYhJqqi5Ggmmqrny425a6PkAdUAyIBUAGQp/hpaCuT0ipMpK7mmo5qAkB1wAADFKkYYmDZpu2220Kl7bQCVBvuuN/aVi1+XTmEGLfstssutebahm4AJ5Dr7r3tinsAgeGCVW22+Aas7SDreivwwdMaqSgI4h48LrjagqAQCAcs4DD/t9kOYJmwtkF88bYDGOUsNQIo0K/FA5jskAAFLPBvv9TGLHO1LiugwAALuEwtAyvgTK3LLDs6qyApz2z00UjLbPIgJdOc9NMz1xCuAuoZoHPOPkOt9W5Pmawz0l8//fXNCCpAgtYz99svCcwVcHbWaM8MQQGZtRCzxWFrHa4Ee44MjW0thcub4Agy5LJ/1c44CFi33iXAAp0SHdVRB9TQbCXUDqIjJtg97knm9RVAGyTkJcAcA6NLgkNGCezV3IVUKuy3M4IXYjEhmUsSQO64O9pS4rwSUjunuK8Wrq21CQ3A5pdgNy3yYK2nkOiXEOB6AbJHYrogBBh2iQJ9z14M/1DDD3I70wMwNAEHDqV+yOGF8F68I+ULwgHOJoS3UYxAHa5Q/QC43wDyp6kADkAFL0AE8JbnnxhEQDoWOEQMQjCAEiGic+krBAdcRkBYASB1G1lgI6g3iAqoQAAhiAEiYrQZArTNfRsUQP5aooEFgCAG7XNd98LzAhVUcAItsYAKFmAkHtVKU6w6YiMstanG8UUhuXNItVYGubvo4DEAMIEILket3ylPMQsMgAY0oC4E/O+LtVGACRJAgskdhwMZoFuhpiiIihWoBgzQQAIggMaMUMAEIfCACg2xAPUYRzEvQMEAEhACCdhIBSpIwBK+dIjOufEoAyjAGvmYCBI0xf8mIhyEBlJAsLkEAHWiLEIIEjCALW7kBRHgmiBYgJoAkLA2BdAAAThJiARkAAFNMAxDdhiAHQ7CBCiIACuF4B8YKBMF8QEA9uozIARsBTSNMxY2AeCAEjikAsECQANi5AACIICFAWgAAghALLQwZFqGsA0YvwgBC9bzRgyRH9G+yJDhNcAHJWLIAzZ2vEFwwAiEOMIhIsC2QgEAdMnjDQcIM4hBIuKWYHSjLAEgAgsCwKI30sAWKzmI5w3iL4S4JoaCkAEDwEqEConBBzYGgAdITJqmBIAOEigIHBaIBQP45CC2J83R8aAFKbWReIbKHBfyxgMRFASxWlKClWTEiI7/UIJtJBBNBjFJVnRx6knBo5AMqECaGzjADh4QowoM4APhSwpnAMg49G1GpILwwDXRpM+HKk8jCyzZZhBwgYbwLgALyACzBqsApNAxeVJUbCMm4AGebiRaDTnkXQzQTro8VAQ8uCDTbjMAGHh2OBjZ3O0ueyECFDYjqFNIAsgKneMsyHrTG90AKHm5DyL1LkQ15gfBc5wgZmADClUIVhuxmxS4zgQFsEGMLDA3ClSlAhGoV20sIIAZlOA18RFACgqAkbjM7QDVOQADIBCTBmSSAt67ywciGIAPnIYACpGBBIBEpgJGBFoGY1lipAibcb1EQoLUorIIkTOpoFEhC2CA/21A4AHNMGQDIwiXequ4z/EIgqhcyaS3WkaIGvSxQAyBwG1wJ+FoLagDYGUdDHi7H9tEmMO766OLHKAAFW5uAC2m1gFAcAECYThaB5DA6EA8CCDgyUPHYUELoKLkR6HRAiGgaQBigII9JQAwB4CA94oZ30GEgAAsaMgEXEjAwuwgWudZxCExsIEs2sAFFfjABCpQFf1+8AIUiIoBCnAAC0ymARIQSQcsUxkAjEAzbQxACaKiAcNMGgARcF1DSnCDAHDgAdMzcqdx2luEQAvOUDlwgTK5LfMUggQh2AAQBCFHVvbOwQVktQAkQAJCWMAAHQsaIUIgAlnJljnKEnC0VP+dkQgwsz8KIUGv/6RsASyoBSxk7gWzxWxMU2A8A0CBAooDO8MxwFvT+gAEGPLraNnmAwlQyAs8gGIKqpSB1/rAVvHrnZEypAEk4MA1JzCCWffyA9WCgKYtQO9C2DsjDElAfBWQ1nDF1UMFeEAB3CKCHVBZMxFQuEuhcCHsECCONMDPbmwjA+LK8wLeasoF3CLWsQLArLTml9C4cxU/AfB8Vj7OE0agV0F4jwB/pavvCiG1ABA2nLXZgfC+SNl4A+AFupzchSTeLKk57otHuMDoLLBG3zFH2tqU51IXJ4JrnrXWjrJ6An5rCKHCcxBVz4ihgSqIFRQCxodQ+2EuMAP/ptV5ENi7y80EMYESJQAGsNsoUUmY96troPEPyB/BDU4IYxLA74PoWU8t40vm6La8hTGjI4xDgB9JM5LrdAEMIGCBABindYM4pAYeUBUjrrxIzIGK7d9kTgYWE3aCsG+iBcFzhUAgPg5CXj8eRyvBR7QQEkC9Dmz2gC/C79a4hs1GLrCn2jGEAyJ4gM0SYOvCCAIGKPCAAtA5v6ATAv3iVgD7hWYYAgzaZhEASquxUQ+lfm7jfh8EOQMwAgrwAKFVSf2ERuhngPuXEXKkOYgAdNK0GgEgdoRwSzEAAfmnAtQFAE3gKBGgAAagAHDRHNeTZvYjAuK2AghAAhZAWe6l/wMFYDNx8kFNVWYTAAFFYDMI1Gsw4CgyiAJtNwjLxQi7oQKoIQAjhWcFkAQB8Guvg4FP8SUN0AOasRtQ0QAzd3NRUQBnFUA1NRcagHwBkAEah3j8FgEoMAgjkG2XATjxcxvWdwje034QxmGLA4iLIwCD0U4RQFx2pQgJUEVlpgjAEwCeo4hCc4GLAFHMw4Tcc2IkZX+JkACWAwCaVomrUYh3AQKgRgiolIFx14i9dD3usx9XJTvDxBwIwIpT90G2aHSqp22CAAF1VgIjkHEW4CMF0FJggmy70QAaRwGPhm/ydIg2IGHiJAIj8ABb9GkisAHlFhcGQFMFEIwX4RYSMP8CNHaHS7c4z2FlC6Z4H7Z0kHiOHYYh1TJKhfBkvPF9iOBLgjCHjQB0kdiJlFQEjrBa+KYIBbAVJvBXioBBi/B4CsGPjJA4CjFGLaQwiYcIIdBrbJQILpRbXTFf0pRASrU9ZBY8IYARu8Qr/UUotFI4BQIkEEBTU2Jsp4UjAISHQbeOoPhhgOgyXoQrAKCBigBA4UEA+Ud34GY8GdSJ+edI2kFHE0Ip0iQCK7B4bIKBRHMAZpEAKLCDH7Aee7gIF4kIFKABQRBVfMIC3jOWtGICGZAAZ0gXCMAAmcGKG/FHQWBZmjKWiuJhKOZVhcIZWPIAkhU8veJfi6UUAvCJvCH/QsPjE2bRV/LTT7cRKBGiiIIYkauBMw2ZmYsAdICHJtPDJ0lUkHaUKkiXKQ+llYHpH3zJEp7BG5MHg57lQQRTSwgAelIpFhtBg4tSk4h5mBjyGbFJOqVGEvWTY7fIK14xmX7FJ0KJFGGpQQEICXUFIZpoUB6FTYKnWcU1CKYVGhvBNYSTCDywnX1ZSDJCnIXAc365KST5mqr5OgphTPiEK34in7eSmE2kKLY5nFfZRAsmffpwmvXHiX9iLIeVEZwpFStWW5IjKgy2mdnpUIwwPMzDnoZpWyW1lH2pHbsjAGWTPYrTkC+4ocEZACTZPUykKiyBSl8VoMHJJjEGnBbq/ycEig+ZZGJ3AxuDAxs/My4yAzMzYzMyYzFGGjYLsDRc0RJEcDNg8y8/kzThgjI+Wkc9I6VHAzOPQ6VImo4GgDNY8zRdqqR3ozNC1TRigzda+jQrEBY0OT1vkzRAgzdcugANBYokgDVXI6Z5QzNjmqcEYDcDYGJdejcz8zV22gIk6lBM1JcASpoWCpzadJxWMSYapi2ERmDoBmfVAhUvAzABIy4Nc6WXA0UF9jHuAjBMWhsMYDEHI2QN4y6bSmuE5m7kQqoB5qkH0Kuz+hoNESYtM6q76i5jkgONeghzgy+FFGCkahtVIgja6G7FKjBjUl4gUGCzOqraUi0s+CqW6v9fkVopNnoVlyk8esiBnbAyD0ofRDkJ7DpaniB4j0U8tZGunDCdinCuxvkoicGvk1BX+goJdyc+z7BOLHECRmKP/QmvhICwfpkAF6dEqUEgDLsJDPsm4jqf3IMuGYEAEzsJFxuxHsuxzdEdEhuuiEAAo3OxTDIgBosNvlKuuqOyx5KjxXJaOPuhneGo4HqjsRKzzKCh43osKos8/4kKtrI6NssJDLE6RxE5DbubFXIoOyu0s4CjkVOjG8spXEuu4OoVVwsKLkqzYYu16VCa8pG0xKC2aMsPY7tNyEIptsK2u2C3ffK2CBG3gFIs0he1k+q061offNuvEIei/jm1evv/CxDLGxdrj0j7sMlakevKsCObCRlbHSzJPUbSuJg7uYYAsj9rjwpbPaonur3huYvbtphVCOWJnaUwsK7brpegdk/Bmp3SqxHYCdEiRbRLCbL7l8F7oYnxrhJxmcN7obi7usUAs8fxuCHbs50XvQRDvZKAuifrCRkLuu9ZSp3HvY9wuYtQfML5vZmRUzVLvthbCarLvMzAtFQrtdZQt4GbKO6bG0iiuGcrt6hSuJDat7HwtUtktuXbtfcLKk1bCjiLt6awISC6LCbLCv57wOvaveuZEEYrCzQywRFMsfoDlA5LweDAwbRAwvtprzoJwb9gwiLsCSysv2RrwGnhwVsb/8Mv3MKQALnV2z6aGwpOlz020r4hzD0WBibgCwmNy7Ax6hAaOwhC/Coam793Qb6V8GRO94rGaY9WLMMcib44zAuFFDh/pbuiAEXqOpP3Oq+b+buVIHhknMI8m8YN0bubgJMeBmFsvJtkfJ3G+T/F646UEEpfrAsls6vdlrIEqhFUPL7Wq5qlW7Ha+yCLnAmeK75VXMRL9MQn/LEt2x1mYk6ZsYtQfMSD/Ao2YCVwZhsUcHh3US/VqqrtQgRSGk2P6sIwrMHZVMGrwJ+9Qr+lzAsTYABQJwgn8AGFIAIqpi+wHDDTkgEz15KGcALbusz/Ai7oNcWpvMzsMi3oNUy46v8xDjPNgcEbDaDNqyoAXbXLvywPEeABsuN/xOJ/UJcs4YEAb1ii+pN95gwyDaMAlBQAG0AB4qzNO/MlCrEDgfYtA30xq6wYGqBv+9ytAlACOpASiZu9hkvEnGu6G83FiaDJ6xwLG+ABZ2xt/IKIThtCwGhV4ooAFNUJYTIIEkDKjhAmDMGoCawIBPDSD1WOmEABJQAJyeuIrAmwkqB2Qz2UeRzSPswIF3Bm0SyNvcjSorBODmAAPXgIDEDVmuBpxixOl1gJDvDVDeCdm2AAFi1NpMQJYtjD40vThqDFmCyy3WHJvWLXG1qc9krDA+zR8nsku7lYgGsCFGUTILAXCuH/ATJwuDEsCCowAml9HAhQdJ9wSLiV03LGPXRDtCGSOjowzNILADewXxZ8KcXiAhFwABgA2qM5Tv4xAVltmP1UADLJyw3rOkoVF4XX13cxJ42rTkDCAfEc2cZwKvWYzd5iKhAQ1BBaAR6QGcbsvwXA3DLCS13NGxKw2AdgWn6NTQHgA1UhALyFKhmQGA5wAX8r1QwMC4kMw42BACrA07zRFDLwzydF3f3JEBGwRZ21jvdZd7cSAS3IvwTgAwIAA/bVHB6wA6GmEFctNDfswilA3M0hZMG2AT1wHC0Q2+FBA4WXAT5NCg3gAWvNG7/mFgRqRAxgGauiePhB23A8Cdkq/wgRYAOYvQgVcAFx0t623OOMYD1tISwhoBdw0RQVcFMlAwEyYAFsgQApoI0WRhxvFh4FIGEVQAA2IALdAQIOoAI9nBguKwMisNXLs4bTRgAUsF40B3IaQAEUsNtMs4YZEISJB+RkeIwFMAO2ZEoQkGTPIBMG4MVs8gEEglKnVQAlQuirkAIe0E4AjXryWwJaSQOgDcAZ4Cg0wFOdYAE0IAglUKFhKwDEBc2DMAQEHdHnvNCqas0WtwhiSB1A0noc4AI7wUA7dFzcZAIxnUl8RhgpgBJYSAgQAAEI8BcWUAGJZkuAYSQuJceCkGcOMAErYQBsQQFSwgOFR2e1ATkg0f8akD4hUkIBIjADE9Uc3tNRr5OSJNTovNfduLARIUADHL6xAmADDJEBkD6cEy0DDUcI8DsK36UYDSDMN9444p3joXAAJWABOoC4k3ABItFlovAAA/adDTACKPDKDqPxqy7O0mLOAEO9FpBJF1BnJ+A98tQUMT2GqZEDT5EYxiECa93sozURQiMAK9FfQeKvhIABNHZIEdIaFPAAeyEARHBKcxHTUHavCtEUCRAFCiABlNSRDGABDIAfbQ4AGDAEyqDfHsDh/44hMUB4guAD6SwjLqTtDr/XguACI3CGu5PvnnACBTDjIMwpYZJpZEvby9NZnXDeu90ShCX3LQIoDOz/ED6AJ8zBOCqPGvwB5LnTFO4pVBkRIUjtKNQznlCUjrUBp0slTw+AAXNiGIJDJgTg8jt/fSpP+t+WhQmwA2QCARKQcUiJDO0c2+uxARjh3B09WATgAgbwABqwvjmqulddFS5QZKPwF6YeCmN9aaAw0QkwFKPAMoeAARdgGZMsCXJd8FoM1ywB0veHLg3QAnLhOnVo63S54vYT05HYFM0fzJcVFZ/GfDyh85qTEuX9sBQFCBwBHQEAAwIABg0AEQUBBwIBBQQABAUAmIUGmAKIiQAIlwAUA5WiBR8IAB6LAA8OhZiys7S1tre4ubixtSAXHLq4FjQNKhCcnrMCpRKK/8vB0MGdALwAGA8uKgzR3LcGDKrd4gaT4t2hGBDV5tANLRizLiISDpwH7LzTAJDsswP3AAQA7IfpQCloMyh8KPBAAygPDD1tCgWAQwEGBZIQYBDgEKZNMQoUyLBpFr+ADx4gCpAj3CwDIhiMSMbpQQ4KnwIiAiGhAIRt0wqoovgS07+PpjBNeADCEiYEBk6kwIkJQwZqBLPioxUrgoF6BCkIeBABEwFKtAiogoBTbaa3WuGaRSurEIMMHxLEhdasFda9sz4oAlwrQAOY8P4STnthAiYHIyg4fko32jq3ABK47EdAL4ATntd1S1A5l+iNlmdVa1DoxQfFpuvKKrkuVv/tvbxE5469uHdh2DIMlM1KQPBkXZp3BxCddXdhFzQkyPWNqYB02IsVXKdOTXA95r1hUAgQ4QJN7Km5Tu8GHmt7bu3Bo976+IOCHmDRq/amnn7/XesF+Bt3BGIlgw4gFPJeMA9QpVg1EMqm31a6KaaBQxJSV8IxAmoVQAYcEghBSQXK4sIFIlwQjm2LsSgOeMsBgEOH8PlHY4YTVrigLhF62OMtP5ZYYCEVeJBYXKSlJ9uONd4mZC5nlRhlgQSA8GQsGpRgQYvoufjkkAMyKSaT1ATp3I04prnff6p5+aWHSj1AwoNvovnlmdTh2dyadb5ZIZxs9kmQnu6pCeCA2Dn/aYuOGRJqjm1BFmqnoLEV4OCEwUSqHnNkEqhgnZ1SypuQMHKJqaiPfpopbO+FOp2mfO6nqn6uxnoqqtxsMEIrtWbqaKmAKToqrsSuCuqSxf4Xo6G+MmsqkKMuayy0f80KaLLXrgmCBxVQWVolm2HWKzcIfIvtuehyM+Wjc5m1GTtTnjVuJuWma++9oubmQFTzZnrAARDqg0yJhQxwEL4IJ2zIwf3o49GgBg2slUD9Kmyxwng2cMGRBGomF2iznGCub+tebHKxmCkpi7ygqDIvAuHUq1W9FZ9sM8IBMBCioE7WfPPPQE97KzQ+B2300QMOMIJjRQ97aJ5NIy11m5Py/5gnnS9OrbXFvBBwQX59dhr10FuXvaitRINJttls/1zIiRz7Gejc/YzdNtAVA+upjXf3TSkFONk9KKJ+F37sns+ubfjiyZpADNphl3kl44sLrjbflGcO2AQemFB1XCWb5dlT7+Yps+aFh64kASdQo7o4mMFcaK0yW4761qqKQJWb3Aksi0D+nFd0NSfd3rfvj+pTfD8nHTUxwMZHb44GF7BGOMmld9b1is4SlKT0bb/+dCwItJ7ZyFaTXoj43XQG/vuxNSDBcJ+byinB8LM9Y7b1I1qz7fnT2gFEoTie+YZ3AUxgAaHVs6wBUIFBq4ABttSfBzrLghAsm6tmhcAMev8QVXYpwQIv97QPSg+DgzOhCtMmCwRUD3zKYQ+OOrjCEu6NhDXM4XoKcB4D5gtZdYMLrHSINt5B6l5/QhwRNVgLAkiHhlTqBCQ6MbpMEGCKnThEJ7bIxS560YsGgQT9JCUrIFprieySFqm6l57/jRCNJotFASJwxjdRwAYGEwjgamEDsSxDIFj8oiAHaRABoKADkREAAvwCx6vVCAATIAAGBvnFQm6xdG/sUiYh10itJeA1dCvQB4ChoApcoBYX2NL+epMbBGCgBAowwAUUcIAUUNBpjmrkjiygAQEwQAIdQMEGKPnFfxzijrOoACQCSUwpajE0KOyk0ewCvWjSYhj/sPkA2BzwREfewgG9ZIAHyFGCCMiATzEaojS5QoAbZIABBqABAwTwA2AEEQAOoEHXJNBMSlJgZwn4Yz+LKYAqrnNrDrhADK5Xoh+I4lMQiMTv1BHKrA2rAicYAAVagMgNYCABLmDoQT9lAQQIgAIPMEAiCdCt/g3oa7K4wZzeSIARvGUDpMjiQLsIAREclG0QECGxIlqLCGxDFgWwUroaIMkNpPQDFDgAAV7ASTQ64AcLECc5MtCUWBWNAiqQBQx6yB4SASAVLsXEYRb606kFgHMtxdUDCLCOw7yEkUjkAAgyUABZ8lADYBvX/XxYR8JEEgNONQBUBWDLPmHAQTlA/1805ooJF5g1LGN85AHjcqYFDTaXUGTh2dgljkbIbToTMECPHpACTKTgARirRQVSIIACXICcGMCk0Ng4JA7yzQEmqC1HfYIBAhwntC2SwSkx0QKwPcqjZjmqVkBggzJqErnpKyy1ditaCW3QadatoBAXFapYjCCziyGAQLZIhCy6DBMaUMBvSnAVAGRAqAmLjwsIoNGUPgACUsWrDXGlt9HWAgFB4GsHLlCAAUTgOwN2ZAA8AJZN9CoWGJipAEpQs9RaT7ubvMUEQCAADFAQQttowDlp0QAIbzcWtVWqgUUKAhnfojS5lAUHEJCAWzrgnAFwgT0BUIEh85YWL+iA9f+oc0UtcnEHKKhLCYTqotdigrUXM5NsJPkTxYolBVSdsTW3y9BqVAABA7ABMCNzgAQcp4iRo8ANAoCAKGslAT2ojo1JCwAbjFFYEQ7GCA7gyu3QYhMOqO8qE11anDBSUUHQQFxt8TBcSDc1hfDJAAowBLtcoFsJkC4FHkdGY93gUt6kxQfoUgAMvSUWSm5AB07mWVs4IAIwKIAHGJyBEBi51ocbL1dkEIF33jYH5UTLsgAduZj61LRxKQkNwnxP8thgsOC1DFEAsAgLgGDTSp21twuiMwdYoCwESMFPKBEAEPjkPCI5wAwQQAERsDsEDijuLDKQAl79rgAb4MABQFT/DgDAsgCeCwAiLBCCAzAAHrxAgAYgUAAHpIABMy1HaqszgA0E4ARHtYAEIKDUWi2HAXt+kwB8+pFFMGeO0MZZmmrFy5MKpgA7UMHIxpwoFqvXqR1ogQ0EIOmqCtvo3OHBKZHXjxGw1AOcVasiYnGC9VpdAMqOgF/GNQEaZOAETEMAPeTHAwDM2ikZ2AA+NeCU2r5ABtKZygQscNkNbAAB3LSAa7b0S6nWJQUNVk3aK0JbBhT5Og6ZgA+2tIniJEB+3YJxAYpMg7JQwEpCwScohWJ4olhFA5dy1WEE/KWuU5UAsC11QOxOVpmL1FkTQPMOUioBsSDgzSBONQc0MAAG/wiGAR7VbbU6FJ87YYLCFChLxTwa8yDGwgYyfsAGjLlFvxOZAgaggKv7UYHaeuAYG1kO8CYiX1aU6QSXeNgmKOC5nMjCI5MsRIkB0BJa1NgVCOCFB9iqE6RUwtiUMGsJIAoMQFeycBIl4REFMAI5IAEykGlqsQOhRg0jUA/mN0IakHoGBAHqIAA7UwvcRA9B41uBpioIEAEl0FcMRnQzYE0BIEnvZAAQMQCAhSnFJ2anJQsUcA3CNy2IlQEH4TMRQBUuBA0WoAISwE/URhASADOi8AyNtw1mFWoKJxEAUHCXNQ3Kcw8KUBpd2H+xYFb6sAkpgAIPCA6fAHLVsRljSP8NBiEJxkVh1UEJSSVfdCcSF5By3CAA9SUqRdIAc6QLF7BcGbR7AqAA43QXEYBjp1IqRKIBB0ABzfBfWPdmfnNqgxEXJ/AABQcYsrYI0wcfCEACBgABdJFEsuAA4TABElABTuEK9TARl8AAw6GKl9CGJXAPdqUMiOAAqccA9dCJmLABVjIAITALtPgYbSgAMMBtD6AKsmgXldGG/VcOCbUIX+hEl4ABzQgAoPcpYoIJDOAQPKeDAuABM6ALe2RCsTBvJzWJHkUAS5Y+LYSC4sRg5VQ65SgoHHAB+oQbHZCJIYYVIhABEtSCN0JSAwAR5jNj19cTDVEJDKYSSOEUDiD/EgWQApbwCFYIiHcxa8pwEGMxE+JYGQFQATagXorBAQyAEb10ADOyCQ3wAAwgBM9odi94CTmjbIZghdWYfwDwA7sSWdXhCBUYCzpAepkyQcTiNYZ2C7ITQJ2CADcAAU8lFiyFC5EkABvQAwYgdDQYee8zSykUCw/QTUUDAmIRIrlHCxOAARJQgCOEAJcmWgrSChXQTdTiIjviiDM0NH+CilthSsRSCA0yLPuYLjm2JgFwa3wlg/O0iLRVADpADkPwUeNzZFNDASL0PxCgdpppGrJ2AQ1pl5mAATSgACcQQ2yybQ55GzKwEK8gQ+gULcPHLD+CbQJicqiRmE9RmjrE/yJ8STczkAKb1gJ/BRZk4hzYZTTuAxgl05yjRQEj0C+xEAMHoAMQMI+h5Ea0WZtycz+ApiqdggE7kFZtNTi11pfdxZ45pE4ylDKCJQsWQAEboybDOXOLiZhRR2b0GCbRsErdwHTBNpBSaTXrCaDdlUGFZZ39KRoI8AGG55CqhzkWhRspdJty0Za7cBK+CUff5Z5v9KEFGmK6yT9x0QAQcAHblyMLqlmxsZ/K8nrFUg4kmp44ukIBoAE0cDA3mkBomKNCOqQY2pgjAJoGiqNySaRM2qQWNZMPwCs/+j4K0INOeqVYKgsxMAKXNqXREwB+lqViOqYs9l8VSqYSg6ZqKv+kdSUBR+KlxvMMazqnOKpGCTVpdAoAgBeaedqnKlRbflofgTqo62QYvzCoAkmoikpECudxSSpNOdNaizqpOvQCUJensZABfUipnOpBheADzjWnTtSppPpB44ie6RkANBCqpdqq0kOga6qprjqr7wMBcUOnCWWJtLqrjCOMfRqIvNo3LviolBMfNICneUoAPjBmzEqrcPpBopECLdCn66AAK/FDmxWsxiedNbQBC7CoXvNoa3Q1DcqplsOt73lNBhBSz5o5onFH+whA7cqgIASpsjBPZ6qmhdAAHqAB0WQ3DnAWpESfHkOqDqCrKaoWi1QIEyAyLodGvnUDEvBhxPr/UybwQvm6Fw6glFmhM1w5m2ZxAJc1qQVQmj4ToZ3wABxmAQPQhCP1GBdgkotKcV/iq3vxhfg0sW+hWqSaeaiaFgREVFe4mvYKSfdJqkvBIQDks4vRiRBwA3VhYf65pkxLGPMBABZwqQxgUBWlQDP5gZxqAReQWQrSNEvatHTxMJpQYHR6toThmiXBtGrEoYxjRBYgJ/NaiGMLn+xQtbhxthCQArbReJ6gSHzKpDYbF6HQjqlXAHohCialofDjJg7gAUg6qzLgAXTUteJgo2iLCRGggdx2SioZEAaYt+5agGNDl2oVka5whiFLt7dTDdsCcbOqIAeCXoQRpD97r5w4/wI70Ap4RhaV0BOowD1+qgAjIBIcBhgIABEM8ACeIwEj0I0QERH0Wgsl4AGthboJBCGVa7u9wRAYgV/BIjlyUbpY572zy0p0wguO8BmtN7mZ4IsPkI7amooXAJp2c664oL5Wmr81clQqyb4+BAA34AHX2rtZyhwT0AMowLEoer62UMDWt6j/Crnze0KPkRKsKsABsAExS6Mw2ioZ+50bWkDMSR/5yRXLaS+ye7gIKsOpRsP/qQsTsL0bLMCMcAHdyAhD1iPM0X1btAA6RX3MZDBh5GRedAhO/A/VtwxTxMQCRcVXtwwGA8VZhEVTZElS1EVGrMVfvEVOBglPLMWHwP9MXVRIAYwqRKxTSyxQVmfFXGTGVazGXSxFRiwQ1LfFcvxHXWzFWtTHcpzGVLxM/2DEalx9abxFkiVetIABF0AByMrDElIBD1CBGgNT3UN1LTAAC5DFBgMBnyzKoGzKWHzKpwwBEgDKyxDKA0DKWQzLscxPphzKAgDLNZDKqkwCn7zLYbwANUDLuYzFtCzLC2AQBoPLoEzLzYzFCqAAulzMT2zKWXwAK7DDIIQALbAA3mzMJNDKwCzKWFzMryzK4ezMh4DMqnwIpEgCeXQIoazO8tzMoqwdtzzL8pzKvGwwBuCt1gzL9JzF0KzNcpEgshABH4ACrWPAuvQ7F9AMMvj/gEhHAAqgHAkgXwESKRa9oR2tRq9IobSQ0VO7GwSwAglJad+6QM5zLl1DQLMwgK/GQjL9IB1dwQbAta+JFTXQpXMjGgbAAuvBbJhgxP/pAvDUOqg3PylsybsAAgYQ1R0ghyJ90upR095FIzc90hqtGCSdbZiA1RTKC1+9NgpSabJbaS5tFjCNFWVNfE3U1TGN0tORADn9lzciAHT9oh+h01Pbk8biACgQ1QrwSz/g0IUKF30V1VHdGEfHTl1N1m0t0pkx2UlxGTqJNZD81n+dGfLlJuQpFwZjLZ6l1sVSDa65MpYdSpzN1rdg11ybTri5aVDUQUF9K2r0Fqb9Hwlw/1tSfQ+IjaOQwdhSvTRo0toAwAIXbXTVgNxlzQss8FBApCZX+xvtkdEv7A8M0w27XZiqXdd7HQNGRgACChvOHdkxbQCV8QIqMAAgwDRcUXb+sNfUEFwDYGRKEQELkHCzAZSYUAEqIAAhoKsccAi3BABGHQxeQdwdcLkMTKsNEAEb4AEB2QFRCmdbHdMw/YKzwAMIG9YaLS0WLRplHQMhIAAqcOC0IN+eLQsTcOIpbgvsLQD2NIGxYAKgbE/VMAH6fYwLIwsvgAEOxn+2INTdjS0IINduDdMeMBkaIAS6EN0VrOSywAJ3jQkmgAIhkAALwHIdDgN1OQByrQAQwAIm4P+4tKACHxV4stABQo3lWp4AA+DlsiACGmACEkBtRz4LEBCQUs3YlRzc9loI+dZXxm0oCEDfspAAis5+mBADl3oLUl4L5/3fDzAACRACHyAaDAeSLY61KIDpIaCXYgUCJmAElHC1ZE4AZ25QAaACQUAAJNCMBgPnWy4AUM4cIwLYSFcnGb7olwYBw0ECIfAelY7TdOEBW8KwsBECJKDkYi4LKjBT1ADfcEGFszE63IIVEwAeRTBkhwAjDYB9BhCQI3ED8vjgIJwJLnAh4gkKVP7pWOHsoDsn8hHvzq2TyefiRS4AJFLTQjAcb3U/zzDpxvAWuFcXJuBTy1AIF/ACd3n/CyoAA7Om1l7662EN0yZAFR5wBB0S0jEd75XQAZ7BAjbFmIsO7QS0AvwNLQvAliQf1naWCywAz2+BPLahoqSQlU7NHffDsv+yRRCA73JtGDqACSLQfosygZSO76JgAESewgHw7/HbAR+uRgUABJ+uAC2PC7gOC7WeABpYISGwBJ9QW+sV9Lr7JN2HRRtA9NXSGAsfDCCf8q+d0+tD17wABAnw5qZQDZuGVH7/3yHg45iABBIwGZpQ8pO95aPzAlnOBO/HQ//yD2tvwz1Pm288RTsA96qR9Jzz8Z4/0k8/NFI7gJoQDRGA0i+o0WheR7HAAiXQjKGc3CKPFRygAI5R//ENlsxSZPh9YgFdtAGWzdnETgJaDwAaLedcbQvInRlX/gKEmNAD0O2YoNy0EO2YQAIYIC0TQAJIMBlI0Fy00AHsZgFHXw0hUP20UPtGYa1fTD+CTqcNtB/HPgsSDgTqEABdDQgKAIMALAWEiAmCiIOGg0Y8jAGSAB2EioMtHIyIkwAhDxODCIcBEBiehKmMBgADAwAWHpyDOIMCKAoKBgwDAoOrAau0xMXGxggrtJiIJigeDYOLCbAAnsyM2IwEBgSeCrABEyEABDCHgwmlhAOLAAkSL9YJHDEhIyYAPJqcBgmEBarZewdD0AsLg1ZEACbgFzBaw4Ydm0ixosWLGP8zatzIsSMniQTcJVIwKdUEAw8STEIHQCQBZZy0XYIpQESMQU5aWiOwgFCrSSEHDRAhCoAKAOgQwAIVbZIipy0sOOUw4F8ABu/SfXDVE8CKahOAUJPGCkBDidY8qi3HMlEBYYhakEjrQRcKAatkphOZyB+hBhuKMFgRxAIEADBgwXhwQUEkoW2dKSggwgKJFxN0TCjwocBkRB3+DWoAIZeCwodhCLDwoMCDDHBdOZToCe3Dtbhz697Nu/dHWgj47qUFQQKhycgRscAaU3ghdAFw6dpw1enSFR0ULEygbNKCEdORpoOFckUB2ARYakDhWciLBaKVDcj1YNOrQRNImHb/QqAaTJ+yAVNSWr5NlEpwy0BHSQDojDXSMs69YwACtt0X1G3ssCTRTwxYRYtfxAzQkzarLODQbyh2UuCKLLboolq2DZIehBO9RRYhMzZHy4UEHtfIiYikR5t471SzTVuMVHVjkl0Nk0BXSAoF5IsW8fggMZMs0l82zumVTgcsFBPCYQTMFaJwqcTTklTEgCnmXAmYSUtDGaUSI5V45qknnheuYiUxb2V5JZc7RgmQKCYY6VYxK4iiQVeEhqgBAA04twCk28AwCAqUmLhnRX0m8h8xWmL6TpcipcKNh7SIYIIKTBTTDkSDmJBBAhgY040xrqqAEDF0firssMQW6wmC/5IwM2Ba3wAUpCC1yYiqiseJoMBXPc4TIQAMiFAAtjqeSZmh91GSwAO6tECLicsW+xCCwahDEVosQLsNX9eA+FC02XKywLZ20hrArlj2iJYv7ias8MK8TYKsgKeqgpGXOWYzKiNt8RvxgiRJTGAAXgpFgMeqlBuTopwIAIstDJfjTircGQhRxQNiEtGqGOZszKz9HrMKwcbc6WnLRBdtNESehNRuAA8zSzK1Vl6TajoaMqJpMKrYnLOmOqdzMSIhOEAtO0auwkEEMS5QzZ15HruInfKmWHDccEfIgj8xsg3AvxvV5mbQQQd79OCEE32CBGoLoPYrJHzgyysqq724iP+vUC5ADQNsIIHllw4AQQuYq6z4ACRsTvkrl0peuYiR+1Lc45hbjvrjlavsuemrr27iADXYvvpkkl9e+eK+D//vAUYj0ILoszceuomJTw7544mXzjrqAlg/O+UkdLDB6MVf2jrnoy9QgBGdqz757qyrL6IBJBSfe+W90267AApMWfj+/LcNQAUCOEBDAhhAXzBvgARsiAAfJzrfLVCAB0zgAH2xQAMOAIIEfKABEahADiLwgio7AAY9OEABLhCBGMTgBge4gANscIMIMJoFOigAIjTkhfe7oAUDqEIRNrCGHzyAiVD4uBTesIcjnOAPC5jCFqKQhlD0oAsl6MMHxrD/f1jM4or0NjafzUtiAaNEMQIWxrUsKzYRsU20lla02IxRjL/RGBmfZpEhGQxwMNKiHveosDL2jItdw+NF1Ng3DAFSZ4fUUyL7dadFfrFOBduNI/lIyUoaK5IaOWMhu/gxS+qmXbfB2tgAiRY21nGQnkylKglnxzeyjYtrlBu1/AjGVq7ykYts5BtxKTeNcTJvXZvkLYd5S0ea8o8RYaRHXrlLMAaSmHRcUC+nKctqPlOMoMRSNq8JzW56E46jxCQnZaZMce6ylBD7phllSUsWJdOLhDSnOudJTDduM5oo0iU+n8ZMfL6Tnl50WibB2TBaPVKeAE3oPCdAgKa4IAFF/+liMNDZs2PAYBPbrMAMWOYxQjINAQQoSgMQ0IBJcCCiJHWaMAnnALENwgEyCGhFOxIBEIhyNJswpDVuOgoCNBRHv5rBDAjhgF+VZKUKTSrDlsUNhwigG2TsgC3LeZECXBEtNf2jTlNhgIZIYFIEuMAGrMGAkQHAAV3tJDELcIFoNIAGLyMEKQpG0VhEYCEGNVm/HJCBcD6zqwLwwaQqwakAuJAQF2COUhdryWGk5wE3KUABRlYCBhQgBeUwwAAiYAEQDCICFQhABBxwg5FpoAAUcCkhHIKAq07CARQoQK4YgAEKUAAhBKAAAyAgCp8C4AcpsG0FGBEBDdh2AgKQ7f8gWgGA07KlAMOd7CAgMIAPIJV/CqAuACIAgUNUYAOoFdsBJHAAkJrVqRUYQAVIw4DZjAYCDoiGKgBzngYMoAQbYEAMv9stsVXAswRIQXevmJYIBJcC9qXtcmtViq4upIWf3cAHfsXYCnsyPRjAAAhUIN1JNUACFqhANxwgJKSMrADkJYBxG1CBD8h3wQEiRIsdMIGj1BcDhykqAHAcIAbAoAEqOAwiClCCBtzgAQ0FMQCYy+P0EGCsZR1EW1GQU29O1jgPmGsFxOaArYAAyQB0CHMNUAABVAAFI8uAohoQgQdg9iEP8KwGOJBcCzjAOBaIKQe2QgCsDAC6Xe7ReSb/gIEsf3i4TBayARrwALM4hAIaKMENLExpLC6NFIweQQOsWo4SsPUEAbAEAOZqYhNPwgYb8MUHzApjxSHiBiVAhAJGNiMji6A1AZr1qPkiXQLkYBBRJvMDGCCKuRbAApw27o77+s1ZJ1cAOYoAeKWao2CN+aUfaAh4EbEBCzQAGoTgwAgQYe1BgAACOWjFjMpdC1PP9Soj40VrXDCJVgggAgEMQAMucFZOcbPSAL+kqt4iQKQgQAP1MfiSB3GCUkRZui3BAAFaW9K0MDeABCp4WjjdZwA8AAMMPQSd9MuWTvTa4SOzhPKiIaQnS7c4rjHOv/lY1glIoAEzysAGhtoK/1JfEMbMJcAIEHACAqh24aV2WFuCZQmdh1blIhfzvjjOAGEEm2kfKEorGH3YCCS2AAYY7j4DTvaEzQgukxVArBswgni74KzjdkGWuXVeCuCHwgOLhpqDJIFJxFS6c110AEBwiMOe3OTeyJF0f4KBQ+RIAT4YGQ1uAgAUiO26g+P0KA6RAw0EQMTlGMEkMNDXGfxE1Pt2aU4nMeE1ESIGNBjuBGZYjVYUYFKmHzVWNM5cQkRZ8d4QdeOtoYRbtAAWNsgHADJwlJmW/fl7ilbFTMzoAthg7gN4DQAo8ADuxzDKg8jAsB8g9uV66wEHWIUAeoBablEoKBGQQAG664r05/+A1tBZSQwfD2qpTncDpEYAHYAAKSAChEB6Y0dJJKd0Z9UZJcBclhUCDfABCjAE1/ZS43ciAaABGYAAk/YQCGdZFsB7ZyV/GWAJHYcwSOcJnEZqwZYWEHAYzLVvAjAB/GZSPQB9Ojg4R+VMGBFGvWdQgcRM6FRXQuhG6oSE/IJ5/MRL8tRPU7WDUhh9BNWE4hQtQahVB5Uz9xRH0sSE+2MnvkQJHNVR/jRzaAg4XShIU9iGVIKEW5iGBSVRbBhwh7SG7PSDy+SGfNiHfviHgBiIgjiIhFiIhniIiJiIiriIjNiIjviIkBiJkjiJlFiJlniJmJiJmriJnNiJnviJoBg9iqI4iqRYiqZ4iqiYiqq4iqzYiq74irAYi7I4i7RYi7Z4i7iYi7q4i7zYi774i8AYjMI4jMRYjMZ4jAAXCAA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A single primary RNA transcript extending over both &micro; and&nbsp;&delta; loci, if spliced in the two different ways shown, may generate a mature mRNA encoding the IgM heavy chain, or a different one encoding IgD. The IgD hinge region is encoded by a separate exon between C&delta;1 and C&delta;2 (not shown).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Bona C, Bonilla FA. Textbook of Immunology, 2nd ed. Harwood Academic Publishers GmbH, Amsterdam 1996. Copyright &copy; 1996 Overseas Publishers Association, N.V. Permission granted by Gordon and Breach Publishers.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f28_26_29103=[""].join("\n");
var outline_f28_26_29103=null;
